col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


1484 Results       Page 1

 [1] 
Frontiers Media SA: Frontiers in Immunology
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―24 Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 Elena Pettini, Donata Medaglini, Annalisa Ciabattini
2 [GO] 2022―Nov―23 Cellular immune states in SARS-CoV-2-induced disease Keywan Mortezaee, Jamal Majidpoor
3 [GO] 2022―Nov―23 Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience Elena Sánchez-Zapardiel, María Alós, Pilar Nozal, Miguel González-Muñoz, Esteban Frauca-Remacha, Lucía Blanca Gavilán, et al. (+3)
4 [GO] 2022―Nov―22 Corrigendum: A potential bioelectromagnetic method to slow down the progression and prevent the development of ultimate pulmonary fibrosis by COVID-19 Syed Muzzammil Masaud, Oliver Szasz, A. Marcell Szasz, Huma Ejaz, Rana Attique Anwar, Andras Szasz
5 [GO] 2022―Nov―22 Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives Qiugang Zhu, Yan Xu, Ting Wang, Feiting Xie
6 [GO] 2022―Nov―21 Platelets’ morphology, metabolic profile, exocytosis, and heterotypic aggregation with leukocytes in relation to severity and mortality of COVID-19-patients Basma A. Yasseen, Aya A. Elkhodiry, Riem M. El-Messiery, Hajar El-sayed, Malak W. Elbenhawi, Azza G. Kamel, et al. (+6)
7 [GO] 2022―Nov―21 SARS-COV-2 infections in inborn errors of immunity: A single center study Kimberley Cousins, Nicholas DeFelice, Stephanie Jeong, Jin Feng, Ashley Sang Eun Lee, Karina Rotella, et al. (+5)
8 [GO] 2022―Nov―21 Preparing for the next pandemic: Simulation-based deep reinforcement learning to discover and test multimodal control of systemic inflammation using repurposed immunomodulatory agents Chase Cockrell, Dale Larie, Gary An
9 [GO] 2022―Nov―18 Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections Partha Chattopadhyay, Pallavi Mishra, Priyanka Mehta, Jyoti Soni, Rohit Gupta, Bansidhar Tarai, et al. (+2)
10 [GO] 2022―Nov―17 Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19 Eduardo I. Cardenas, Sandra Ekstedt, Krzysztof Piersiala, Marianne Petro, Agneta Karlsson, Åsa Kågedal, et al. (+3)
11 [GO] 2022―Nov―17 Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer Jinyong Kim, Jiyun Jeong, Chan Mi Lee, Dae-Won Lee, Chang Kyung Kang, Pyeong Gyun Choe, et al. (+6)
12 [GO] 2022―Nov―17 Age-dependent NK cell dysfunctions in severe COVID-19 patients Cinzia Fionda, Silvia Ruggeri, Giuseppe Sciumè, Mattia Laffranchi, Isabella Quinti, Cinzia Milito, et al. (+7)
13 [GO] 2022―Nov―17 Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS-CoV-2: Prospects for mass scale immunity-screening in large populations Chrysanthi Tsamadou, Carolin Ludwig, Judith Scholz, Matthias Proffen, Janina Hägele, Immanuel Rode, et al. (+7)
14 [GO] 2022―Nov―16 An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response Li Chen, Haiwei Zhang, Moxuan Li, Bihao Wu, Zhe Zhang, Rui Gong
15 [GO] 2022―Nov―16 Pathophysiological mechanisms of thrombosis in acute and long COVID-19 Haijiao Jing, Xiaoming Wu, Mengqi Xiang, Langjiao Liu, Valerie A. Novakovic, Jialan Shi
16 [GO] 2022―Nov―16 The published trend of studies on COVID-19 and dietary supplements: Bibliometric analysis Wenzhong Hu, Yun Xu
17 [GO] 2022―Nov―16 Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls Jintao Xu, Bing He, Kyle Carver, Debora Vanheyningen, Brian Parkin, Lana X. Garmire, et al. (+2)
18 [GO] 2022―Nov―15 Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits Sung-Hee Kim, Jiseon Kim, Ji Yun Jang, Hyuna Noh, Jisun Park, Haengdueng Jeong, et al. (+35)
19 [GO] 2022―Nov―15 Clinical characteristics of the host DNA-removed metagenomic next-generation sequencing technology for detecting SARS-CoV-2, revealing host local immune signaling and assisting genomic epidemiology Sun Zhaoyang, Song Guowei, Pan Jing, Zhou Yundong, Lu Xinhua, Wei Muyun, et al. (+3)
20 [GO] 2022―Nov―15 Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan Chiao-Hsuan Chao, Dayna Cheng, Sheng-Wen Huang, Yung-Chun Chuang, Trai-Ming Yeh, Jen-Ren Wang
21 [GO] 2022―Nov―14 Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines Ping Li, Dawei Shi, Wenlong Shen, Shu Shi, Xinjie Guo, Jia Li, et al. (+3)
22 [GO] 2022―Nov―14 C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19 Mohamed Zakaria Bouayed, Ilyass Laaribi, Charaf Eddine Mohammed Chatar, Iliass Benaini, Mohammed Amine Bouazzaoui, Younes Oujidi, et al. (+5)
23 [GO] 2022―Nov―14 Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes Melina Messing, Mypinder S. Sekhon, Michael R. Hughes, Sophie Stukas, Ryan L. Hoiland, Jennifer Cooper, et al. (+9)
24 [GO] 2022―Nov―14 Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages Yorjagis Mendez-Cortina, Ana Lucía Rodriguez-Perea, Mateo Chvatal-Medina, Tulio Jose Lopera, Natalia Alvarez-Mesa, Jan Karlo Rodas-Marín, et al. (+3)
25 [GO] 2022―Nov―14 A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains Sandra Nakandakari-Higa, Roham Parsa, Bernardo S. Reis, Renan V. H. de Carvalho, Luka Mesin, Hans-Heinrich Hoffmann, et al. (+9)
26 [GO] 2022―Nov―14 Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals Yun Shan Goh, Angeline Rouers, Siew-Wai Fong, Nicole Ziyi Zhuo, Pei Xiang Hor, Chiew Yee Loh, et al. (+20)
27 [GO] 2022―Nov―14 Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients Gabriela Profírio Jardim-Santos, Heidi Luise Schulte, Patricia Shu Kurizky, Ciro Martins Gomes, Otávio Tolêdo Nóbrega, Eliana Teles de Gois, et al. (+19)
28 [GO] 2022―Nov―09 Analysis of macular structure in age-related cataract patients with different antibody levels of severe acute respiratory syndrome coronavirus-2 vaccine Xiaochun Li, Xiaoguang Cao, Zhongting Pan, Xinping Sun, Yongzhen Bao
29 [GO] 2022―Nov―09 Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression Xiaojun Gao, Dan Fang, Yu Liang, Xin Deng, Ni Chen, Min Zeng, Mao Luo
30 [GO] 2022―Nov―09 A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™) Fethi Gül, Zeynep Burcin Gonen, Olcay Y. Jones, Neslihan Pakize Taşlı, Gökmen Zararsız, Ekrem Ünal, et al. (+13)
31 [GO] 2022―Nov―09 Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2 Alice Halliday, Anna E. Long, Holly E. Baum, Amy C. Thomas, Kathryn L. Shelley, Elizabeth Oliver, et al. (+41)
32 [GO] 2022―Nov―09 Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2 Pedro J. Alcolea, Jaime Larraga, Daniel Rodríguez-Martín, Ana Alonso, Francisco J. Loayza, José M. Rojas, et al. (+14)
33 [GO] 2022―Nov―09 A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants Yu Liu, Danhua Zhao, Yichang Wang, Zhian Chen, Li Yang, Wenjuan Li, et al. (+13)
34 [GO] 2022―Nov―09 Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses Xiaoming Sun, Ce Gao, Ke Zhao, Yanhui Yang, Yelizaveta Rassadkina, Jesse Fajnzylber, et al. (+4)
35 [GO] 2022―Nov―09 SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients Jitka Smetanova, Tomas Milota, Michal Rataj, Jana Hurnakova, Hana Zelena, Rudolf Horvath
36 [GO] 2022―Nov―08 Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac) Yuting Liao, Yingping Chen, Bo Chen, Zhenzhen Liang, Xiaosong Hu, Bo Xing, et al. (+5)
37 [GO] 2022―Nov―07 Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study Jing Li, Menglei Ge, Shuzhi Dai, Qinwei Song, Weijie Liu, Ying Wang, et al. (+2)
38 [GO] 2022―Nov―07 Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure Kezhen Yang, Jipeng Liu, Yu Gong, Yinyin Li, Qingguo Liu
39 [GO] 2022―Nov―04 Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung Yoko Miura, Hirotsugu Ohkubo, Akiko Nakano, Jane E. Bourke, Satoshi Kanazawa
40 [GO] 2022―Nov―03 Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19 Martijn Zoodsma, Aline H. de Nooijer, Inge Grondman, Manoj Kumar Gupta, Agnes Bonifacius, Valerie A. C. M. Koeken, et al. (+19)
41 [GO] 2022―Nov―03 Exploration of blood-derived coding and non-coding RNA diagnostic immunological panels for COVID-19 through a co-expressed-based machine learning procedure Mohadeseh Zarei Ghobadi, Rahman Emamzadeh, Majid Teymoori-Rad, Elaheh Afsaneh
42 [GO] 2022―Nov―03 Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection Shima Shahbaz, Olaide Oyegbami, Suguru Saito, Mohammed Osman, Wendy Sligl, Shokrollah Elahi
43 [GO] 2022―Nov―02 The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients Weiji Qiu, Qiqing Shi, Fang Chen, Qian Wu, Xiya Yu, Lize Xiong
44 [GO] 2022―Nov―02 SARS-CoV-2 infected children form early immune memory responses dominated by nucleocapsid-specific CD8+ T cells and antibodies Karina Lima, Julia C. Fontoura, Priscila Oliveira de Souza, Tiago Fazolo, Gabriel Hilario, Renata Zorzetto, et al. (+20)
45 [GO] 2022―Nov―01 A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients Claire Tardiveau, Guillaume Monneret, Anne-Claire Lukaszewicz, Valérie Cheynet, Elisabeth Cerrato, Katia Imhoff, et al. (+17)
46 [GO] 2022―Nov―01 The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study Shanhai Ou, Zehong Huang, Miaoling Lan, Jianghui Ye, Jijin Chen, Huilin Guo, et al. (+14)
47 [GO] 2022―Oct―31 Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, Anna Felis-Giemza, Krzysztof Bonek, Anna Kornatka, et al. (+9)
48 [GO] 2022―Oct―31 Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study Giorgio Fedele, Filippo Trentini, Ilaria Schiavoni, Sergio Abrignani, Guido Antonelli, Vincenzo Baldo, et al. (+25)
49 [GO] 2022―Oct―31 Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project Valéria Valim, Olindo Assis Martins-Filho, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, Daniel Antunes Maciel Villela, Sheila Maria Barbosa de Lima, et al. (+9)
50 [GO] 2022―Oct―31 Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Xiaojian Zhu, Zhengming Zhu, Qinrong Wu, Rongfa Yuan
51 [GO] 2022―Oct―31 Vitamin D supplementation for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Lara S. Kümmel, Hanna Krumbein, Paraskevi C. Fragkou, Ben L. Hünerbein, Rieke Reiter, Konstantinos A. Papathanasiou, et al. (+4)
52 [GO] 2022―Oct―31 Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination Krystallenia Paniskaki, Margarethe J. Konik, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, et al. (+9)
53 [GO] 2022―Oct―31 SARS-CoV-2 modulates inflammatory responses of alveolar epithelial type II cells via PI3K/AKT pathway Ahmed A. Al-Qahtani, Ioanna Pantazi, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, et al. (+2)
54 [GO] 2022―Oct―31 SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response Zheng Liu, Chenglu Yang, Haokun Zhang, Guojie Cao, Senzhen Wang, Siwen Yin, Yanming Wang
55 [GO] 2022―Oct―28 Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19 Giuseppe Lapadula, Roberto Leone, Davide Paolo Bernasconi, Andrea Biondi, Emanuela Rossi, Mariella D’Angiò, et al. (+7)
56 [GO] 2022―Oct―28 Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV Cheng Yan, Yandie Niu, Xuannian Wang
57 [GO] 2022―Oct―28 SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells Yang Liu, Jian Rao, Yingjie Mi, Lan Chen, Lijuan Feng, Qi Li, et al. (+6)
58 [GO] 2022―Oct―28 Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants Justin Mark Lunderberg, Sanjucta Dutta, Ai-Ris Y. Collier, Jeng-Shin Lee, Yen-Ming Hsu, Qiao Wang, et al. (+7)
59 [GO] 2022―Oct―27 Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages Zhen Qin Aw, Chee Keng Mok, Yi Hao Wong, Huixin Chen, Tze Minn Mak, Raymond T. P. Lin, et al. (+3)
60 [GO] 2022―Oct―27 CD8+ T-cell immune escape by SARS-CoV-2 variants of concern Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, Tengchuan Jin
61 [GO] 2022―Oct―27 Differential activation of human neutrophils by SARS-CoV-2 variants of concern Samuel Lebourgeois, Ambroise David, Houssem Redha Chenane, Vanessa Granger, Reyene Menidjel, Nadhira Fidouh, et al. (+8)
62 [GO] 2022―Oct―26 Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group Kangsan Kim, Madhusudhanan Narasimhan, Lenin Mahimainathan, Ray Zhang, Ellen Araj, Elizabeth Kim, et al. (+8)
63 [GO] 2022―Oct―26 Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism Ding-Ping Chen, Ying-Hao Wen, Wei-Tzu Lin, Fang-Ping Hsu
64 [GO] 2022―Oct―25 MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil Erick C. Castelli, Mateus V. de Castro, Michel S. Naslavsky, Marilia O. Scliar, Nayane S. B. Silva, Raphaela N. Pereira, et al. (+28)
65 [GO] 2022―Oct―25 Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, Mohammad Darvishi, Saeid Fathi, Mohammad Javanbakht, et al. (+2)
66 [GO] 2022―Oct―25 A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice Jide Tian, Barbara J. Dillion, Jill Henley, Lucio Comai, Daniel L. Kaufman
67 [GO] 2022―Oct―24 In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose Paola Stolfi, Filippo Castiglione, Enrico Mastrostefano, Immacolata Di Biase, Sebastiano Di Biase, Gianna Palmieri, Antonella Prisco
68 [GO] 2022―Oct―24 Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins Kyle L. O’Donnell, Tylisha Gourdine, Paige Fletcher, Chad S. Clancy, Andrea Marzi
69 [GO] 2022―Oct―24 New-onset dermatomyositis following COVID-19: A case report Hiroshi Shimizu, Haruki Matsumoto, Tomomi Sasajima, Tomohiro Suzuki, Yoshinori Okubo, Yuya Fujita, et al. (+6)
70 [GO] 2022―Oct―24 SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions Smita Vinjamuri, Lenong Li, Marlene Bouvier
71 [GO] 2022―Oct―24 Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer Rui Song, Li Liu, Qingbo Pan, Jin Liu, Jiahe Tan, Juan Deng, et al. (+6)
72 [GO] 2022―Oct―21 Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human Yuwei Zhang, Mingxiao Yao, Xingyu Guo, Shanshan Han, Shu Zhang, Jinzhong Zhang, et al. (+8)
73 [GO] 2022―Oct―21 Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis Meitong Liu, Huijuan Wang, Lu Liu, Saijin Cui, Xiangran Huo, Zhuoyun Xiao, et al. (+4)
74 [GO] 2022―Oct―21 Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients Laura E. Martínez-Gómez, Isabel Ibarra-González, Cynthia Fernández-Lainez, Teresa Tusie, Hortensia Moreno-Macías, Carlos Martinez-Armenta, et al. (+30)
75 [GO] 2022―Oct―20 Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin Jorge Adrian Masso-Silva, George Sakoulas, Jarod Olay, Victoria Groysberg, Matthew Geriak, Victor Nizet, et al. (+2)
76 [GO] 2022―Oct―20 Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome Eirini Apostolou, Muhammad Rizwan, Petros Moustardas, Per Sjögren, Bo Christer Bertilson, Björn Bragée, et al. (+2)
77 [GO] 2022―Oct―20 The lymphatic system and COVID-19 vaccines Masayuki Miyasaka
78 [GO] 2022―Oct―20 An update on the interaction between COVID-19, vaccines, and diabetic kidney disease Yang Yang, Shubiao Zou, Gaosi Xu
79 [GO] 2022―Oct―20 Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID Lucy Kundura, Renaud Cezar, Sonia André, Mauricio Campos-Mora, Claire Lozano, Thierry Vincent, et al. (+10)
80 [GO] 2022―Oct―20 Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells Noémi Miltner, Tamás Richárd Linkner, Viktor Ambrus, Aya S. Al-Muffti, Hala Ahmad, János András Mótyán, et al. (+3)
81 [GO] 2022―Oct―19 Levels of soluble complement regulators predict severity of COVID-19 symptoms Anna L. Tierney, Wajd Mohammed Alali, Thomas Scott, Karen S. Rees-Unwin, Simon J. Clark, Richard D. Unwin
82 [GO] 2022―Oct―19 Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children Nina Li, XueYun Li, Jiani Wu, Shengze Zhang, Lin Zhu, Qiqi Chen, et al. (+9)
83 [GO] 2022―Oct―18 Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2 Yalong Yang, Fenghua Xu
84 [GO] 2022―Oct―18 The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity Sterre L. Siekman, Tamas Pongracz, Wenjun Wang, Jan Nouta, Peter G. Kremsner, Pedro Vieira da Silva-Neto, et al. (+7)
85 [GO] 2022―Oct―17 Macrophage Boolean networks in the time of SARS-CoV-2 Ugo Avila-Ponce de León, Osbaldo Resendis-Antonio
86 [GO] 2022―Oct―17 Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection Stephen T. Yeung, Thomas A. Premeaux, Li Du, Toshiro Niki, Satish K. Pillai, Kamal M. Khanna, Lishomwa C. Ndhlovu
87 [GO] 2022―Oct―17 Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV Shi Zou, Wei Guo, Songjie Wu, Fangzhao Ming, Yuting Tan, Mengmeng Wu, et al. (+2)
88 [GO] 2022―Oct―17 HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections Eleonora Loi, Loredana Moi, Paola Cabras, Giulia Arduino, Giulia Costanzo, Stefano Del Giacco, et al. (+4)
89 [GO] 2022―Oct―14 Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19 Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, Inga Hemmerling, Tim Rahmel, Jan N. Thon, et al. (+18)
90 [GO] 2022―Oct―14 Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie-Ève Hamelin, et al. (+11)
91 [GO] 2022―Oct―13 Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment Laura Thümmler, Margarethe Konik, Monika Lindemann, Neslinur Fisenkci, Michael Koldehoff, Anja Gäckler, et al. (+10)
92 [GO] 2022―Oct―13 Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases Catherine E. Raptis, Christoph T. Berger, Adrian Ciurea, Diego O. Andrey, Christos Polysopoulos, Pierre Lescuyer, et al. (+10)
93 [GO] 2022―Oct―13 Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection Nathalie Rohmann, Paula Stürmer, Corinna Geisler, Kristina Schlicht, Katharina Hartmann, Kathrin Türk, et al. (+8)
94 [GO] 2022―Oct―12 SARS-CoV-2 specific antibody trajectories in mothers and infants over two months following maternal infection Melanie A. Martin, Monica Keith, Ryan M. Pace, Janet E. Williams, Sylvia H. Ley, Celestina Barbosa-Leiker, et al. (+13)
95 [GO] 2022―Oct―12 Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina Pamela E. Rodriguez, Andrea P. Silva, Esteban A. Miglietta, Pablo Rall, Carla A. Pascuale, Christian Ballejo, et al. (+14)
96 [GO] 2022―Oct―12 COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy Li Wang, Jiawei Li, Silin Jiang, Yan Li, Rong Guo, Yuyuan Chen, et al. (+8)
97 [GO] 2022―Oct―12 Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Ihor Arkhypov, et al. (+7)
98 [GO] 2022―Oct―12 Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis Dora Nemeth, Hajnalka Vago, Laszlo Tothfalusi, Zsuzsanna Ulakcsai, David Becker, Zsofia Szabo, et al. (+3)
99 [GO] 2022―Oct―12 Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy Matthew P. Lennol, María-Salud García-Ayllón, Mariano Esteban, Juan García-Arriaza, Javier Sáez-Valero
100 [GO] 2022―Oct―11 Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines Chi-Ho Lee, Victor Gray, Jia Ming Nickolas Teo, Anthony Raymond Tam, Carol Ho-Yi Fong, David Tak-Wai Lui, et al. (+5)
101 [GO] 2022―Oct―10 Adaptive immunity to SARS-CoV-2 infection: A systematic review Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, Luana Nepomuceno Gondim Costa Lima
102 [GO] 2022―Oct―10 Adherence to Sars-CoV2 vaccination in hematological patients Justine Narinx, Margaux Houbiers, Laurence Seidel, Yves Beguin
103 [GO] 2022―Oct―07 Changes in the urinary proteome before and after quadrivalent influenza vaccine and COVID-19 vaccination Xuanzhen Pan, Yongtao Liu, Yijin Bao, Lilong Wei, Youhe Gao
104 [GO] 2022―Oct―06 Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19 Sixten Körper, Eva Vanessa Schrezenmeier, Hector Rincon-Arevalo, Beate Grüner, Daniel Zickler, Manfred Weiss, et al. (+19)
105 [GO] 2022―Oct―06 Sustaining surveillance as an intervention during the COVID-19 pandemic in Cabo Verde and implications for malaria elimination Adilson DePina, Helga Barros, Amanda Tiffany, Gillian Stresman
106 [GO] 2022―Oct―06 Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates Bert Malengier-Devlies, Jessica Filtjens, Kourosh Ahmadzadeh, Bram Boeckx, Jessica Vandenhaute, Amber De Visscher, et al. (+21)
107 [GO] 2022―Oct―06 Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination Estefanía Salgado Del Riego, María Laura Saiz, Viviana Corte-Iglesias, Blanca Leoz Gordillo, Cristina Martin-Martin, Mercedes Rodríguez-Pérez, et al. (+3)
108 [GO] 2022―Oct―06 Coronavirus disease 2019 vaccination uptake and hesitancy among Polish patients with inborn errors of immunity, autoinflammatory syndromes, and rheumatic diseases: A multicenter survey Ewa Więsik-Szewczyk, Marcin Ziętkiewicz, Agata Będzichowska, Katarzyna Napiórkowska-Baran, Aleksandra Matyja-Bednarczyk, Anna Felis-Giemza, Karina Jahnz-Różyk
109 [GO] 2022―Oct―06 The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection Emilia Barreto-Duran, Artur Szczepański, Adrianna Gałuszka-Bulaga, Marcin Surmiak, Maciej Siedlar, Marek Sanak, et al. (+4)
110 [GO] 2022―Oct―06 Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernaíndez, Craig Ryan Joseph, Sara Gil Edwards, Zhen Wei Neo, et al. (+4)
111 [GO] 2022―Oct―05 Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases Hu Li, Yuting Wang, Ling Ao, Mingxia Ke, Zhiwei Chen, Min Chen, et al. (+6)
112 [GO] 2022―Oct―04 Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults Srabanti Rakshit, Vasista Adiga, Asma Ahmed, Chaitra Parthiban, Nirutha Chetan Kumar, Pratibha Dwarkanath, et al. (+19)
113 [GO] 2022―Oct―04 Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients Bilgin Osmanodja, Johannes Stegbauer, Marta Kantauskaite, Lars Christian Rump, Andreas Heinzel, Roman Reindl-Schwaighofer, et al. (+11)
114 [GO] 2022―Oct―04 A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4+ T lymphocytes in unexposed individuals Jinchan Li, Simon Reinke, Yu Shen, Lena Schollmeyer, Yuk-Chien Liu, Zixu Wang, et al. (+11)
115 [GO] 2022―Oct―04 Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis Jenna N. Kelly, Laura Laloli, Philip V’kovski, Melle Holwerda, Jasmine Portmann, Volker Thiel, Ronald Dijkman
116 [GO] 2022―Oct―04 Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination Somr Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, Zheng Quan Toh, Paul V. Licciardi, Patimaporn Wongprompitak, et al. (+4)
117 [GO] 2022―Oct―03 Distinct responses of newly identified monocyte subsets to advanced gastrointestinal cancer and COVID-19 Alessandra Rigamonti, Alessandra Castagna, Marika Viatore, Federico Simone Colombo, Sara Terzoli, Clelia Peano, et al. (+2)
118 [GO] 2022―Oct―03 Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study Annamaria Mascolo, Gabriella di Mauro, Federica Fraenza, Mario Gaio, Alessia Zinzi, Ciro Pentella, et al. (+3)
119 [GO] 2022―Oct―03 MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity Monica Gelzo, Alice Castaldo, Antonietta Giannattasio, Giulia Scalia, Maddalena Raia, Maria Valeria Esposito, et al. (+7)
120 [GO] 2022―Oct―03 A randomized clinical trial to stimulate the cholinergic anti-inflammatory pathway in patients with moderate COVID-19-pneumonia using a slow-paced breathing technique Elisabeth Maria Balint, Beate Grüner, Sophia Haase, Mandakini Kaw-Geppert, Julian F. Thayer, Harald Gündel, Marc N. Jarczok
121 [GO] 2022―Oct―03 Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity Rajat Desikan, Susanne L. Linderman, Carl Davis, Veronika I. Zarnitsyna, Hasan Ahmed, Rustom Antia
122 [GO] 2022―Oct―03 SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants Yesica Longueira, Diego S. Ojeda, Rocio B. Antivero Battistelli, Lautaro Sanchez, Santiago Oviedo Rouco, Daniel Albano, et al. (+4)
123 [GO] 2022―Oct―03 Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag A. Patel, Rajashri Bezbaruah, et al. (+2)
124 [GO] 2022―Sep―30 Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients Anna Julia Pietrobon, Roberta Andrejew, Ricardo Wesley Alberca Custódio, Luana de Mendonça Oliveira, Juliete Nathali Scholl, Franciane Mouradian Emidio Teixeira, et al. (+13)
125 [GO] 2022―Sep―30 Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project Giulia Collatuzzo, Giovanni Visci, Francesco S. Violante, Stefano Porru, Gianluca Spiteri, Maria Grazia Lourdes Monaco, et al. (+16)
126 [GO] 2022―Sep―30 SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance Monica Franzese, Luigi Coppola, Romina Silva, Stefano Angelo Santini, Luigi Cinquanta, Cosimo Ottomano, et al. (+2)
127 [GO] 2022―Sep―30 SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant Larissa Laine, Marika Skön, Elina Väisänen, Ilkka Julkunen, Pamela Österlund
128 [GO] 2022―Sep―29 Single cell meta-analysis of EndMT and EMT state in COVID-19 Lanlan Zhang, Chuang Tang, Min Zhang, Xia Tong, Yingying Xie, Ruitong Yan, et al. (+4)
129 [GO] 2022―Sep―29 The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Langjiao Liu, Chunxu Wang, Yufeng Wang, et al. (+2)
130 [GO] 2022―Sep―29 Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants Yudi Xie, Lei Liu, Jue Wang, Yaqiong Zheng, Chen Luo, Wenxu Ni, et al. (+7)
131 [GO] 2022―Sep―29 Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis Maria Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, Daniela Tudor, Fernando Real, Aiwei Zhu, et al. (+15)
132 [GO] 2022―Sep―29 Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality Francis Schneider, Pierrick Le Borgne, Jean-Etienne Herbrecht, François Danion, Morgane Solis, Sophie Hellé, et al. (+6)
133 [GO] 2022―Sep―29 Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine Tomohito Sato, Ryotaro Nihei, Daisuke Sora, Yoshiaki Nishio, Masaru Takeuchi
134 [GO] 2022―Sep―29 Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern Erika Rudi, Pablo Martin Aispuro, Eugenia Zurita, Maria M. Gonzalez Lopez Ledesma, Daniela Bottero, Juan Malito, et al. (+7)
135 [GO] 2022―Sep―29 Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders Hideyuki Iwayama, Naoko Ishihara, Kohei Kawahara, Yuta Madokoro, Yasuko Togawa, Kanji Muramatsu, et al. (+8)
136 [GO] 2022―Sep―29 The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, Gabiria Pastore, Adele Santoni, Martina Simoncelli, et al. (+7)
137 [GO] 2022―Sep―28 Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh Taufiqur Rahman Bhuiyan, Hasan Al Banna, M. Hasanul Kaisar, Polash Chandra Karmakar, Al Hakim, Afroza Akter, et al. (+14)
138 [GO] 2022―Sep―28 Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98% Romy de Laat-Kremers, Raf De Jongh, Marisa Ninivaggi, Aernoud Fiolet, Rob Fijnheer, Jasper Remijn, Bas de Laat
139 [GO] 2022―Sep―28 Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker Maozhang He, Yixuan Huang, Yun Wang, Jiling Liu, Maozhen Han, Yixuan Xiao, et al. (+6)
140 [GO] 2022―Sep―28 Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report Romana Rysava, Martina Peiskerova, Vladimir Tesar, Jan Benes, Martin Kment, Ágnes Szilágyi, et al. (+2)
141 [GO] 2022―Sep―27 N-3 polyunsaturated fatty acids may affect the course of COVID-19 Barbora Lampova, Ivo Doskocil, Lenka Kourimska, Aneta Kopec
142 [GO] 2022―Sep―27 Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients Laura Sánchez-de Prada, Óscar Gorgojo-Galindo, Inmaculada Fierro, Ana María Martínez-García, Guillermo Sarmentero-López de Quintana, Rocío Gutiérrez-Bustillo, et al. (+6)
143 [GO] 2022―Sep―27 Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis Zaigham Abbas Rizvi, Prabhakar Babele, Srikanth Sadhu, Upasna Madan, Manas Ranjan Tripathy, Sandeep Goswami, et al. (+4)
144 [GO] 2022―Sep―27 COVID-19 vaccine hesitancy and associated factors among infertile couples undergoing assisted reproductive treatment Xinyan Wang, Huiyan Wang, Aijun Du, Junchao Wang, Jie Shi, Yunshan Zhang, et al. (+5)
145 [GO] 2022―Sep―27 Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile Rocío Rubio, Ruth Aguilar, Mariona Bustamante, Erica Muñoz, Miquel Vázquez-Santiago, Rebeca Santano, et al. (+11)
146 [GO] 2022―Sep―27 OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines Rebekka Duhen, Michael Beymer, Shawn M. Jensen, Srinivas Abbina, Suraj Abraham, Nikita Jain, et al. (+5)
147 [GO] 2022―Sep―27 3’UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling Jinjin Yuan, Ziheng Feng, Qiaowen Wang, Lifen Han, Shenchan Guan, Lijuan Liu, et al. (+3)
148 [GO] 2022―Sep―26 Low baseline IFN-γ response could predict hospitalization in COVID-19 patients Marion Cremoni, Jonathan Allouche, Daisy Graça, Kevin Zorzi, Céline Fernandez, Maxime Teisseyre, et al. (+9)
149 [GO] 2022―Sep―26 Public awareness should be raised on a crucial but neglected factor for COVID-19 vaccination Hao Yuan, Yining Song, Xiu-Xiang Zhang, Jingbo Zhai, Jin Zhang, Zi-Guo Yuan
150 [GO] 2022―Sep―26 SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna® vaccinated patients on maintenance immunoapheresis - a cohort study Martina Gaggl, Constantin Aschauer, Christof Aigner, Gregor Bond, Andreas Vychytil, Robert Strassl, et al. (+3)
151 [GO] 2022―Sep―26 Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation Olga Krysko, Joshua H. Bourne, Elena Kondakova, Elena A. Galova, Katharine Whitworth, Maddy L. Newby, et al. (+11)
152 [GO] 2022―Sep―26 Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay Luciana D’Apice, Maria Trovato, Giulia Gramigna, Francesca Colavita, Massimo Francalancia, Giulia Matusali, et al. (+8)
153 [GO] 2022―Sep―23 Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer’s disease Yifan Fu, Zhirong Guo, Yulin Wang, Haonan Zhang, Feifan Zhang, Zihao Xu, et al. (+6)
154 [GO] 2022―Sep―23 Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19 Priyanka S. Hastak, Christopher R. Andersen, Anthony D. Kelleher, Sarah C. Sasson
155 [GO] 2022―Sep―23 Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience Adrian M. Shields, Susan Tadros, Adam Al-Hakim, Jeremy M. Nell, Me Me Nay Lin, Michele Chan, et al. (+17)
156 [GO] 2022―Sep―23 COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience Sylwia Kołtan, Marcin Ziętkiewicz, Elżbieta Grześk, Rafał Becht, Elżbieta Berdej-Szczot, Magdalena Cienkusz, et al. (+23)
157 [GO] 2022―Sep―23 Real-world effectiveness and protection of SARS-CoV-2 vaccine among patients hospitalized for COVID-19 in Xi’an, China, December 8, 2021, to January 20, 2022: A retrospective study Xiaowei Li, Yinjuan Xu, Xiaomeng Li, Wenbin Liu, Dan Yao, Weichao Chen, et al. (+6)
158 [GO] 2022―Sep―23 Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission Jian-Nan Zhang, Yang Gao, Xin-Tong Wang, Na-Na Li, Xue Du, Yu-Jia Tang, et al. (+6)
159 [GO] 2022―Sep―23 Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea Eliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, Ju-Yeon Choi, Eu Suk Kim, Hye-Jin Kim, et al. (+20)
160 [GO] 2022―Sep―23 Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital Vidya Arankalle, Archana Kulkarni-Munje, Ruta Kulkarni, Sonali Palkar, Rahul Patil, Jitendra Oswal, et al. (+2)
161 [GO] 2022―Sep―23 Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma Hongwei Fang, Zhun Sun, Zhouyi Chen, Anning Chen, Donglin Sun, Yan Kong, et al. (+2)
162 [GO] 2022―Sep―23 Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens Aristo Vojdani, Elroy Vojdani, Ashley L. Melgar, Joshua Redd
163 [GO] 2022―Sep―23 Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study Terese L. Katzenstein, Line D. Rasmussen, Camilla Helberg Drabe, Carsten Schade Larsen, Ann-Brit Eg Hansen, Mette Stærkind, et al. (+3)
164 [GO] 2022―Sep―23 Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid hybridoma screening and high-throughput single-cell V(D)J sequencing Xi Yang, Hang Chi, Meng Wu, Zhenshan Wang, Qiaoli Lang, Qiuxue Han, et al. (+14)
165 [GO] 2022―Sep―22 Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection Marta Molinero, Silvia Gómez, Iván D. Benítez, J. J. Vengoechea, Jessica González, Dinora Polanco, et al. (+22)
166 [GO] 2022―Sep―20 Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19 Rebekah Penrice-Randal, Xiaofeng Dong, Andrew George Shapanis, Aaron Gardner, Nicholas Harding, Jelmer Legebeke, et al. (+14)
167 [GO] 2022―Sep―20 Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Eric T. Ndifon, Jason Oakes, et al. (+6)
168 [GO] 2022―Sep―20 Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study Flavio Bruni, Panteleimon Charitos, Maurin Lampart, Stephan Moser, Martin Siegemund, Roland Bingisser, et al. (+6)
169 [GO] 2022―Sep―20 Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines Siling Wang, Dinghui Wu, Hualong Xiong, Juan Wang, Zimin Tang, Zihao Chen, et al. (+14)
170 [GO] 2022―Sep―20 Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review Eliete Neves Silva Guerra, Vitória Tavares de Castro, Juliana Amorim dos Santos, Ana Carolina Acevedo, Hélène Chardin
171 [GO] 2022―Sep―20 Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods Shengman Yu, Xiaoyan Li, Zhuoyuan Xin, Liyuan Sun, Jingwei Shi
172 [GO] 2022―Sep―20 The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses Lu Zhang, Hongquan Chen, Su Yang, Yang Zhao, Xiaoyun Shen, Xiaowen He, et al. (+5)
173 [GO] 2022―Sep―20 The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials Robert L. Murphy, Eustache Paramithiotis, Scott Sugden, Todd Chermak, Bruce Lambert, Damien Montamat-Sicotte, et al. (+2)
174 [GO] 2022―Sep―16 Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2 Xiaohui Wei, Na Rong, Jiangning Liu
175 [GO] 2022―Sep―16 Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library Dmitri Dormeshkin, Michail Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr Migas, et al. (+2)
176 [GO] 2022―Sep―16 Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients Chien-Chia Chen, Yi-Jen Huang, Mei-Jun Lai, Min-Huey Lin, Wei-Chou Lin, Hui-Ying Lin, et al. (+5)
177 [GO] 2022―Sep―15 Autoantibodies during infectious diseases: Lessons from malaria applied to COVID-19 and other infections Juan Rivera-Correa, Ana Rodriguez
178 [GO] 2022―Sep―15 Tissue-specific pathway activities: A retrospective analysis in COVID-19 patients Nhung Pham, Finterly Hu, Chris T. Evelo, Martina Kutmon
179 [GO] 2022―Sep―15 COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity Andrea R. Daamen, Prathyusha Bachali, Catherine A. Bonham, Lindsay Somerville, Jeffrey M. Sturek, Amrie C. Grammer, et al. (+2)
180 [GO] 2022―Sep―15 IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA Qingcong Zheng, Du Wang, Rongjie Lin, Qi Lv, Wanming Wang
181 [GO] 2022―Sep―15 Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies Giorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, Margaret Mascherpa, Rossana Orabona, Cristina Zanardini, et al. (+9)
182 [GO] 2022―Sep―14 Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes Victòria Ceperuelo-Mallafré, Laia Reverté, Joaquim Peraire, Ana Madeira, Elsa Maymó-Masip, Miguel López-Dupla, et al. (+10)
183 [GO] 2022―Sep―14 Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency Lisa Göschl, Daniel Mrak, Katharina Grabmeier-Pfistershammer, Karin Stiasny, Helmuth Haslacher, Lisa Schneider, et al. (+10)
184 [GO] 2022―Sep―14 Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2 Yun Ji, Qi Zhang, Lin Cheng, Jiwan Ge, Ruoke Wang, Mengqi Fang, et al. (+14)
185 [GO] 2022―Sep―14 Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines Binwei Duan, Gongming Zhang, Wenjing Wang, Jiming Yin, Mengcheng Liu, Jing Zhang, et al. (+3)
186 [GO] 2022―Sep―14 SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications Anja Schlör, Stefan Hirschberg, Ghada Ben Amor, Toni Luise Meister, Prerna Arora, Stefan Pöhlmann, et al. (+5)
187 [GO] 2022―Sep―14 SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK Sona Aramyan, Kirk McGregor, Samarth Sandeep, Angela Haczku
188 [GO] 2022―Sep―14 Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine Laura M. Kasman
189 [GO] 2022―Sep―13 Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance Rosanna Ruggiero, Nunzia Balzano, Raffaella Di Napoli, Annamaria Mascolo, Pasquale Maria Berrino, Concetta Rafaniello, et al. (+3)
190 [GO] 2022―Sep―13 Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis Zejun Li, Shouhuan Liu, Fengming Li, Yifeng Li, Yilin Li, Pu Peng, et al. (+3)
191 [GO] 2022―Sep―13 Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections Suelen H. Qassim, Mohammad R. Hasan, Patrick Tang, Hiam Chemaitelly, Houssein H. Ayoub, Hadi M. Yassine, et al. (+18)
192 [GO] 2022―Sep―13 The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals Jingliang Cheng, Jiewen Fu, Qi Tan, Zhiying Liu, Kan Guo, Lianmei Zhang, et al. (+5)
193 [GO] 2022―Sep―13 SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability Chiara Agostinis, Miriam Toffoli, Mariagiulia Spazzapan, Andrea Balduit, Gabriella Zito, Alessandro Mangogna, et al. (+11)
194 [GO] 2022―Sep―13 SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling Tai-Wei Li, Adam D. Kenney, Jun-Gyu Park, Guillaume N. Fiches, Helu Liu, Dawei Zhou, et al. (+7)
195 [GO] 2022―Sep―12 Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity Mai Chan Lau, Yang Yi, Denise Goh, Chun Chau Lawrence Cheung, Benedict Tan, Jeffrey Chun Tatt Lim, et al. (+20)
196 [GO] 2022―Sep―12 Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection Patricia Pérez, David Astorgano, Guillermo Albericio, Sara Flores, Pedro J. Sánchez-Cordón, Joanna Luczkowiak, et al. (+4)
197 [GO] 2022―Sep―12 Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system Congqin Chen, Fang Fu, Lingqing Ding, Jie Fang, Jie Xiao
198 [GO] 2022―Sep―12 Could vitamin D supplementation play a role against COVID-19? Bi Li, Shuangshuang Yang, Ning Hou
199 [GO] 2022―Sep―12 Durable antibody and effector memory T cell responses in breastmilk from women with SARS-CoV-2 Vignesh Narayanaswamy, Brian T. Pentecost, Janice C. Telfer, Amy S. Burnside, Sallie S. Schneider, Dominique Alfandari, et al. (+4)
200 [GO] 2022―Sep―12 Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants Qi Li, Fiachra Humphries, Roxie C. Girardin, Aaron Wallace, Monir Ejemel, Alla Amcheslavsky, et al. (+16)
201 [GO] 2022―Sep―12 Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein Jia Tong Loh, Joey Kay Hui Teo, Kong-Peng Lam
202 [GO] 2022―Sep―12 Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2 Hai-yun Li, Ning Gao, Cheng-yang Liu, Xiao-ling Liu, Feng Wu, Nini Dai, et al. (+2)
203 [GO] 2022―Sep―09 Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination Fuzhen Wang, Baoying Huang, Huakun Lv, Lizhong Feng, Weihong Ren, Xiaoqi Wang, et al. (+17)
204 [GO] 2022―Sep―09 Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children Maya W. Keuning, Marloes Grobben, Merijn W. Bijlsma, Beau Anker, Eveline P. Berman-de Jong, Sophie Cohen, et al. (+12)
205 [GO] 2022―Sep―08 Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19 Kuang-Den Chen, Ying-Hsien Huang, Wei-Sheng Wu, Ling-Sai Chang, Chiao-Lun Chu, Ho-Chang Kuo
206 [GO] 2022―Sep―08 Corrigendum: The effects of COVID-19 on the placenta during pregnancy Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, Mark C. Allenby, Sajad Razavi Bazaz, Majid E. Warkiani, et al. (+3)
207 [GO] 2022―Sep―08 Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity Amir Ghaemi, Parisa Roshani Asl, Hedieh Zargaran, Delaram Ahmadi, Asim Ali Hashimi, Elahe Abdolalipour, et al. (+2)
208 [GO] 2022―Sep―08 Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Michael Asamoah-Boaheng, Brian Grunau, Mohammad Ehsanul Karim, Agatha N. Jassem, Jennifer Bolster, Ana Citlali Marquez, et al. (+2)
209 [GO] 2022―Sep―08 mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals Stephanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca Brown, Hailey R. Hornsby, Naomi Meardon, et al. (+9)
210 [GO] 2022―Sep―08 Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity Arne Søraas, Gunnveig Grødeland, Beathe Kiland Granerud, Thor Ueland, Andreas Lind, Børre Fevang, et al. (+26)
211 [GO] 2022―Sep―08 Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions Mercedes Lachén-Montes, Naroa Mendizuri, Karina Ausín, Miriam Echaide, Ester Blanco, Luisa Chocarro, et al. (+5)
212 [GO] 2022―Sep―07 Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity Julius Nückel, Elisa Planatscher, Anne Wiebe Mohr, Karolin Deichl, Hrvoje Mijočević, Martin Feuerherd, et al. (+12)
213 [GO] 2022―Sep―06 Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy Saeid Najafi-Fard, Elisa Petruccioli, Chiara Farroni, Linda Petrone, Valentina Vanini, Gilda Cuzzi, et al. (+11)
214 [GO] 2022―Sep―06 Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes Meshach Asare-Werehene, Michaeline McGuinty, Agatha Vranjkovic, Yannick Galipeau, Juthaporn Cowan, Bill Cameron, et al. (+4)
215 [GO] 2022―Sep―06 Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, et al. (+21)
216 [GO] 2022―Sep―06 Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic Jonny Jonny, Terawan Agus Putranto, Raoulian Irfon, Enda Cindylosa Sitepu
217 [GO] 2022―Sep―05 Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China Min Hu, Wei Guo, Li Liu, Yu Yang, Qiling Xu, Fang Cheng, et al. (+2)
218 [GO] 2022―Sep―05 Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells Moriah J. Castleman, Megan M. Stumpf, Nicholas R. Therrien, Mia J. Smith, Kelsey E. Lesteberg, Brent E. Palmer, et al. (+6)
219 [GO] 2022―Sep―05 IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike Jérôme Gatineau, Charlotte Nidercorne, Aurélie Dupont, Marie-Line Puiffe, José L. Cohen, Valérie Molinier-Frenkel, et al. (+2)
220 [GO] 2022―Sep―05 Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernaíndez, Craig Ryan Joseph, Sara Gil Edwards, Zhen Wei Neo, et al. (+4)
221 [GO] 2022―Sep―02 COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19 Jung Yeon Heo, Yu Bin Seo, Eun Jin Kim, Jacob Lee, Young Rong Kim, Jin Gu Yoon, et al. (+10)
222 [GO] 2022―Sep―02 Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens Matheus Oliveira de Souza, Bharat Madan, I-Ting Teng, Aric Huang, Lihong Liu, Ahmed S. Fahad, et al. (+9)
223 [GO] 2022―Sep―02 Potential mouse models of coronavirus-related immune injury Fu-Yao Nan, Cai-Jun Wu, Jia-Hui Su, Lin-Qin Ma
224 [GO] 2022―Sep―02 Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection Chang Chu, Anne Schönbrunn, Kristin Klemm, Volker von Baehr, Bernhard K. Krämer, Saban Elitok, Berthold Hocher
225 [GO] 2022―Sep―02 Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination Furong Qi, Yingyin Cao, Shuye Zhang, Zheng Zhang
226 [GO] 2022―Sep―02 SARS-CoV-2 vaccination in androgen sensitive phenotypes - A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients Zhihua Fan, Shixin Duan, Fangfen Liu, Wei Shi, Ziye Yang, Ruiyang Bai, et al. (+5)
227 [GO] 2022―Aug―31 The intersection molecule MDA5 in Cancer and COVID-19 Renjing Jin, Xiaoqing Cao, Mingjun Lu, Qing Gao, Teng Ma
228 [GO] 2022―Aug―31 Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach Lu Lu, Le-Ping Liu, Rong Gui, Hang Dong, Yan-Rong Su, Xiong-Hui Zhou, Feng-Xia Liu
229 [GO] 2022―Aug―31 Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, et al. (+26)
230 [GO] 2022―Aug―31 Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients Kiarash Saleki, Moein Shirzad, Mostafa Javanian, Sheyda Mohammadkhani, Mohammad Hossein Alijani, Niloufarsadat Miri, et al. (+2)
231 [GO] 2022―Aug―31 Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination Simon Faissner, Neele Heitmann, Carlos Plaza-Sirvent, Paulina Trendelenburg, Ulas Ceylan, Jeremias Motte, et al. (+9)
232 [GO] 2022―Aug―30 The role of B cells in COVID-19 infection and vaccination Shiru Chen, Fei Guan, Fabio Candotti, Kamel Benlagha, Niels Olsen Saraiva Camara, Andres A. Herrada, et al. (+6)
233 [GO] 2022―Aug―30 Immune modulation as a consequence of SARS-CoV-2 infection Metin Yusuf Gelmez, Fatma Betul Oktelik, Ilhan Tahrali, Vuslat Yilmaz, Umut Can Kucuksezer, Nilgun Akdeniz, et al. (+11)
234 [GO] 2022―Aug―29 Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review Amir Bahador Boroumand, Mahtab Forouhi, Farzaneh Karimi, Arman Soltani Moghadam, Leila Ghanbari Naeini, Pajman Kokabian, Delaram Naderi
235 [GO] 2022―Aug―29 Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis Cong-wen Yang, Ru-dong Chen, Qing-run Zhu, Shi-jie Han, Ming-jie Kuang
236 [GO] 2022―Aug―26 A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19 Shivani Singh, Noemi Alejandra Saavedra-Avila, Sangeeta Tiwari, Steven A. Porcelli
237 [GO] 2022―Aug―26 Immune responses in COVID-19 and tuberculosis coinfection: A scoping review Kevin Flores-Lovon, Brando Ortiz-Saavedra, Luis A. Cueva-Chicaña, Shalom Aperrigue-Lira, Elizbet S. Montes-Madariaga, David R. Soriano-Moreno, et al. (+2)
238 [GO] 2022―Aug―26 COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses Jia Yi, Jiameng Miao, Qingwei Zuo, Felix Owusu, Qiutong Dong, Peizhe Lin, et al. (+4)
239 [GO] 2022―Aug―26 Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination Marta Sisteré-Oró, Naina Andrade, Diana D.J. Wortmann, Juan Du, Natalia Garcia-Giralt, María González-Cao, et al. (+2)
240 [GO] 2022―Aug―26 A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines Xiaofeng He, Jiao Su, Yu’nan Ma, Wenping Zhang, Shixing Tang
241 [GO] 2022―Aug―25 The effects of nutrition bio-shield superfood powder on immune system function: A clinical trial study among patients with COVID-19 Farid Azizi Jalilian, Gheisar Keshavarz, Salman Khazaei, Manije Nezamdoost, Seyed Hamid Hashemi, Mojgan Mamani, et al. (+13)
242 [GO] 2022―Aug―25 The association between peritraumatic distress, perceived stress, depression in pregnancy, and NR3C1 DNA methylation among Chinese pregnant women who experienced COVID-19 lockdown Liqing Wei, Xiaohong Ying, Mengxi Zhai, Jiayu Li, Dan Liu, Xin Liu, et al. (+2)
243 [GO] 2022―Aug―25 Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period Andrea Sonaglioni, Michele Lombardo, Adriana Albini, Douglas M. Noonan, Margherita Re, Roberto Cassandro, et al. (+4)
244 [GO] 2022―Aug―25 Regulated necrosis in COVID-19: A double-edged sword Chen Sun, Yunze Han, Ruoyu Zhang, Simon Liu, Jing Wang, Yuqing Zhang, et al. (+5)
245 [GO] 2022―Aug―24 C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d Daria Kowalska, Alicja Kuźniewska, Yaiza Senent, Beatriz Tavira, Susana Inogés, Ascensión López-Díaz de Cerio, et al. (+3)
246 [GO] 2022―Aug―24 Serum peptidome profiles immune response of COVID-19 Vaccine administration Wenjia Zhang, Dandan Li, Bin Xu, Lanlan Xu, Qian Lyu, Xiangyi Liu, et al. (+6)
247 [GO] 2022―Aug―24 Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, Madeleine Batke, Léa-Sophie Dreveton, Brogan Geurts, et al. (+7)
248 [GO] 2022―Aug―24 Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab Clara Luzia Magnus, Andreas Hiergeist, Philipp Schuster, Anette Rohrhofer, Jan Medenbach, André Gessner, et al. (+2)
249 [GO] 2022―Aug―23 The striking mimics between COVID-19 and malaria: A review Emadeldin Hassan E. Konozy, Makarim El-fadil M. Osman, George Ghartey-Kwansah, Hind Mohamed Abushama
250 [GO] 2022―Aug―23 Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin Anna Ohradanova-Repic, Rostislav Skrabana, Laura Gebetsberger, Gabor Tajti, Peter Baráth, Gabriela Ondrovičová, et al. (+5)
251 [GO] 2022―Aug―22 Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data Zehua Dong, Qiyu Yan, Wenxiu Cao, Zhixian Liu, Xiaosheng Wang
252 [GO] 2022―Aug―22 Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine Marina Saresella, Federica Piancone, Ivana Marventano, Ambra Hernis, Daria Trabattoni, Mattia Invernizzi, et al. (+2)
253 [GO] 2022―Aug―19 Is hemolysis a novel therapeutic target in COVID-19? Daiki Ousaka, Masahiro Nishibori
254 [GO] 2022―Aug―18 Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study Maria Laura Idda, Maristella Pitzalis, Valeria Lodde, Annalisa Loizedda, Jessica Frau, Monia Lobina, et al. (+23)
255 [GO] 2022―Aug―18 Editorial: Pandemic influenza vaccine approaches: Current status and future directions Michael Schotsaert, Rebecca Jane Cox, Corey P. Mallett
256 [GO] 2022―Aug―17 SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients - a comparative long term post-infection study Jessica Brehm, Alexander Spaeth, Lars Dreßler, Thomas Masetto, Rainer Dannenberg, Christoph Peter, Matthias Grimmler
257 [GO] 2022―Aug―17 Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission Michael W. Russell, Jiri Mestecky
258 [GO] 2022―Aug―17 Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses Patricia Almendro-Vázquez, Marta Chivite-Lacaba, Alberto Utrero-Rico, Cecilia González-Cuadrado, Rocio Laguna-Goya, Miguel Moreno-Batanero, et al. (+6)
259 [GO] 2022―Aug―17 Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques Qian He, Qunying Mao, Jialu Zhang, Fan Gao, Yu Bai, Bopei Cui, et al. (+18)
260 [GO] 2022―Aug―17 Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches M. Nazmul Hoque, Md. Murshed Hasan Sarkar, Md. Arif Khan, Md. Arju Hossain, Md. Imran Hasan, Md. Habibur Rahman, et al. (+12)
261 [GO] 2022―Aug―16 Bioinformatics analysis of potential pathogenesis and risk genes of immunoinflammation-promoted renal injury in severe COVID-19 Zhimin Chen, Caiming Chen, Fengbin Chen, Ruilong Lan, Guo Lin, Yanfang Xu
262 [GO] 2022―Aug―16 COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds Beeke Tappe, Chris D. Lauruschkat, Lea Strobel, Jezreel Pantaleón García, Oliver Kurzai, Silke Rebhan, et al. (+14)
263 [GO] 2022―Aug―16 High baseline expression of IL-6 and IL-10 decreased CCR7 B cells in individuals with previous SARS-CoV-2 infection during BNT162b2 vaccination Alberto Ponciano-Gómez, Martha Iris Valle-Solis, Myriam Campos-Aguilar, Rafael Jijón-Lorenzo, Elena de la C. Herrera-Cogco, Roberto Ramos-Alor, et al. (+18)
264 [GO] 2022―Aug―15 A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19 Morgane Crausaz, Guillaume Monneret, Filippo Conti, Anne-Claire Lukaszewicz, Jean-Baptiste Marchand, Perrine Martin, et al. (+2)
265 [GO] 2022―Aug―15 Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study Jiram Torres-Ruiz, Julieta Lomelín-Gascón, Ana Sofía Vargas-Castro, Jaquelin Lira-Luna, Alfredo Pérez-Fragoso, Roberto Tapia-Conyer, et al. (+21)
266 [GO] 2022―Aug―15 Four cases of cytokine storm after COVID-19 vaccination: Case report Kazuhiro Murata, Naoki Nakao, Naoki Ishiuchi, Takafumi Fukui, Narutaka Katsuya, Wataru Fukumoto, et al. (+9)
267 [GO] 2022―Aug―15 Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine Raj S. Patel, Babita Agrawal
268 [GO] 2022―Aug―15 Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2 Mariette Barbier, Katherine S. Lee, Mayur S. Vikharankar, Shriram N. Rajpathak, Nandkumar Kadam, Ting Y. Wong, et al. (+14)
269 [GO] 2022―Aug―15 Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection Nuri Lee, Seri Jeong, Kibum Jeon, Min-Jeong Park, Wonkeun Song
270 [GO] 2022―Aug―15 Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis Yi-Ling Cheng, Chiao-Hsuan Chao, Yen-Chung Lai, Kun-Han Hsieh, Jen-Ren Wang, Shu-Wen Wan, et al. (+4)
271 [GO] 2022―Aug―12 Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality Philomène Lavis, Sofia Morra, Carmen Orte Cano, Nurhan Albayrak, Véronique Corbière, Véronique Olislagers, et al. (+12)
272 [GO] 2022―Aug―12 Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit Gabriele Monte, Stefano Pro, Fabiana Ursitti, Michela Ada Noris Ferilli, Romina Moavero, Laura Papetti, et al. (+5)
273 [GO] 2022―Aug―12 Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study Qianhui Hua, Hangjie Zhang, Pingping Yao, Nani Xu, Yisheng Sun, Hangjing Lu, et al. (+9)
274 [GO] 2022―Aug―12 I’ve looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections Ivona Pandrea, Kelsie Brooks, Rahul P. Desai, Minali Tare, Jason M. Brenchley, Cristian Apetrei
275 [GO] 2022―Aug―12 Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner Xiang-Hong Ran, Jia-Wu Zhu, Ya-Yun Chen, Run-Ze Ni, Dan Mu
276 [GO] 2022―Aug―12 Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface Hongguan Xing, Liyan Zhu, Pingping Wang, Guoping Zhao, Zhihua Zhou, Yi Yang, et al. (+2)
277 [GO] 2022―Aug―11 Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients Alessandra Giannella, Silvia Riccetti, Alessandro Sinigaglia, Chiara Piubelli, Elisa Razzaboni, Piero Di Battista, et al. (+6)
278 [GO] 2022―Aug―11 Defying convention in the time of COVID-19: Insights into the role of γδ T cells Marta Sanz, Brendan T. Mann, Alisha Chitrakar, Natalia Soriano-Sarabia
279 [GO] 2022―Aug―11 Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes Rhiane Moody, Sabrina Sonda, Fay H. Johnston, Kylie J. Smith, Nicola Stephens, Michelle McPherson, et al. (+2)
280 [GO] 2022―Aug―11 Opinion: The use of chicken IgY in the control of pandemics Michael G. Wallach
281 [GO] 2022―Aug―10 Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, et al. (+7)
282 [GO] 2022―Aug―09 Protective antigenic epitopes revealed by immunosignatures after three doses of inactivated SARS-CoV-2 vaccine Mian Peng, Xiaowen Dou, Xiuming Zhang, Mingchen Yan, Dan Xiong, Ruiwei Jiang, et al. (+5)
283 [GO] 2022―Aug―08 T cell perturbations persist for at least 6 months following hospitalization for COVID-19 Melissa Govender, Francis R. Hopkins, Robin Göransson, Cecilia Svanberg, Esaki M. Shankar, Maria Hjorth, et al. (+4)
284 [GO] 2022―Aug―08 Roles and functions of SARS-CoV-2 proteins in host immune evasion Farooq Rashid, Zhixun Xie, Muhammad Suleman, Abdullah Shah, Suliman Khan, Sisi Luo
285 [GO] 2022―Aug―05 Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies Roberto Alfonso-Dunn, Jerry Lin, Vanessa Kirschner, Joyce Lei, Grant Feuer, Michaela Malin, et al. (+3)
286 [GO] 2022―Aug―05 Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses Yajie Lin, Jiajie Zhu, Zongming Liu, Chaonan Li, Yikai Guo, Ying Wang, Keda Chen
287 [GO] 2022―Aug―05 Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study Nan Xu, Jinjin Pan, Li Sun, Cuimei Zhou, Siran Huang, Mingwei Chen, et al. (+5)
288 [GO] 2022―Aug―05 Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study Hong-Yan Li, Li-Yuan Shao, Min Song, Shi-Min Hu, Yao-Xian Yue, Hai-Feng Li
289 [GO] 2022―Aug―04 Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization Blake M. Hauser, Maya Sangesland, Evan C. Lam, Jared Feldman, Alejandro B. Balazs, Daniel Lingwood, Aaron G. Schmidt
290 [GO] 2022―Aug―03 Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa John Woodford, Issaka Sagara, Halimatou Diawara, Mahamadoun Hamady Assadou, Abdoulaye Katile, Oumar Attaher, et al. (+18)
291 [GO] 2022―Aug―03 Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection Mayada Abu Shanap, Maher Sughayer, Osama Alsmadi, Ismail Elzayat, Abeer Al-Nuirat, Abdelghani Tbakhi, Iyad Sultan
292 [GO] 2022―Aug―02 Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic Marina Averyanova, Polina Vishnyakova, Svetlana Yureneva, Oksana Yakushevskaya, Timur Fatkhudinov, Andrey Elchaninov, Gennady Sukhikh
293 [GO] 2022―Aug―01 Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination Boyun Liang, Tiandan Xiang, Hua Wang, Ziwei Li, Xufeng Quan, Xuemei Feng, et al. (+11)
294 [GO] 2022―Aug―01 Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases Yen-Ju Chen, Po-Liang Cheng, Wen-Nan Huang, Hsin-Hua Chen, Hong-Wei Chen, Jun-Peng Chen, et al. (+7)
295 [GO] 2022―Jul―29 Serum concentration of extracellular cold-inducible RNA-binding protein is associated with respiratory failure in COVID-19 Felix Schagatay, Klara Diamant, Mats Lidén, Alicia Edin, Simon Athlin, Olof Hultgren, et al. (+6)
296 [GO] 2022―Jul―29 IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19 Ingrid Fricke-Galindo, Alfonso Martínez-Morales, Leslie Chávez-Galán, Ranferi Ocaña-Guzmán, Ivette Buendía-Roldán, Gloria Pérez-Rubio, et al. (+13)
297 [GO] 2022―Jul―28 Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic Giulia Garzi, Francesco Cinetto, Davide Firinu, Giulia Di Napoli, Gianluca Lagnese, Alessandra Punziano, et al. (+9)
298 [GO] 2022―Jul―28 The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials Zhenbei Qian, Zhijin Zhang, Haomiao Ma, Shuai Shao, Hanyujie Kang, Zhaohui Tong
299 [GO] 2022―Jul―28 Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries Maria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, Riccardo Levi, Maximiliano Mollura, Riccardo Sarti, et al. (+16)
300 [GO] 2022―Jul―28 Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants Eduardo Cheuiche Antonio, Mariana Rost Meireles, Marcelo Alves de Souza Bragatte, Gustavo Fioravanti Vieira
301 [GO] 2022―Jul―28 BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein Mohanraj Manangeeswaran, Derek D. C. Ireland, Seth G. Thacker, Ha-Na Lee, Logan Kelley-Baker, Aaron P. Lewkowicz, et al. (+7)
302 [GO] 2022―Jul―28 Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation Nazar Beirag, Chandan Kumar, Taruna Madan, Mohamed H. Shamji, Roberta Bulla, Daniel Mitchell, et al. (+6)
303 [GO] 2022―Jul―28 Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency Bibi Uhre Nielsen, Camilla Heldbjerg Drabe, Mike Bogetofte Barnkob, Isik Somuncu Johansen, Anne Kirstine Kronborg Hansen, Anna Christine Nilsson, Line Dahlerup Rasmussen
304 [GO] 2022―Jul―28 Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, et al. (+18)
305 [GO] 2022―Jul―27 The role of interleukin-22 in lung health and its therapeutic potential for COVID-19 Si Fang, Dianwen Ju, Yong Lin, Wei Chen
306 [GO] 2022―Jul―27 Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave Alessandra Aiello, Adriano Grossi, Silvia Meschi, Marcello Meledandri, Valentina Vanini, Linda Petrone, et al. (+14)
307 [GO] 2022―Jul―26 Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 infection and primary Sjogren’s syndrome Hong Luo, Xia Zhou
308 [GO] 2022―Jul―26 Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies Songfeng Wu, Yuan Xu, Jian Zhang, Xiaoju Ran, Xue Jia, Jing Wang, et al. (+7)
309 [GO] 2022―Jul―26 Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses Christina Woopen, Urszula Konofalska, Katja Akgün, Tjalf Ziemssen
310 [GO] 2022―Jul―26 SARS-CoV-2’s Variants of Concern: A Brief Characterization Aline Miranda Scovino, Elizabeth Chen Dahab, Gustavo Fioravanti Vieira, Leonardo Freire-de-Lima, Celio Geraldo Freire-de-Lima, Alexandre Morrot
311 [GO] 2022―Jul―25 Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study Abdisa Tufa, Tewodros Haile Gebremariam, Tsegahun Manyazewal, Tewodros Getinet, Dominic-Luc Webb, Per M. Hellström, Solomon Genet
312 [GO] 2022―Jul―25 BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults Alina Seidel, Michelle Zanoni, Rüdiger Groß, Daniela Krnavek, Sümeyye Erdemci-Evin, Pascal von Maltitz, et al. (+12)
313 [GO] 2022―Jul―22 Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate Shan Mei, Zhangling Fan, Xiaoman Liu, Fei Zhao, Yu Huang, Liang Wei, et al. (+7)
314 [GO] 2022―Jul―22 Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study) Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, et al. (+14)
315 [GO] 2022―Jul―22 Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine Magdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, Bogdan Biedunkiewicz, Alicja Kubanek, Zuzanna Ślizień, et al. (+11)
316 [GO] 2022―Jul―20 Editorial: Immunometabolic mechanisms underlying the severity of COVID-19 Julia Kzhyshkowska, Vishwanath Venketaraman, Galileo Escobedo
317 [GO] 2022―Jul―19 Pyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients Yingkui Tang, Peidong Zhang, Qiuyu Liu, Luyang Cao, Jingsong Xu
318 [GO] 2022―Jul―19 The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes Patricia Urbán, Paola Italiani, Diana Boraschi, Sabrina Gioria
319 [GO] 2022―Jul―19 Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections Iris Medits, David N. Springer, Marianne Graninger, Jeremy V. Camp, Eva Höltl, Stephan W. Aberle, et al. (+10)
320 [GO] 2022―Jul―18 Metabolite profile of COVID-19 revealed by UPLC-MS/MS-based widely targeted metabolomics Jun Liu, Zhi-Bin Li, Qi-Qi Lu, Yi Yu, Shan-Qiang Zhang, Pei-Feng Ke, et al. (+2)
321 [GO] 2022―Jul―18 SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma Li Chen, Junqing Yue, Shengding Zhang, Wenxue Bai, Lu Qin, Cong Zhang, et al. (+9)
322 [GO] 2022―Jul―18 Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS Margherita Bellucci, Francesco Germano, Stefano Grisanti, Chiara Castellano, Francesco Tazza, Emanuela Maria Mobilia, et al. (+9)
323 [GO] 2022―Jul―15 A Landscape Study on COVID-19 Immunity at the Single-Cell Level Rongguo Wei, Zheng Qin, Qi Huang, Lulu Liu, Fang Cheng, Songdong Meng, Lin Wang
324 [GO] 2022―Jul―15 Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, Paola Adele Lonati, Andrea Gobbini, Mariangela Lorenzo, et al. (+11)
325 [GO] 2022―Jul―15 Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth Marie Carbonnel, Camille Daclin, Nadine Tarantino, Olivia Groiseau, Véronique Morin, Alice Rousseau, et al. (+5)
326 [GO] 2022―Jul―15 Specific CD4+ T Cell Responses to Ancestral SARS-CoV-2 in Children Increase With Age and Show Cross-Reactivity to Beta Variant Kevin Paul, Freya Sibbertsen, Daniela Weiskopf, Marc Lütgehetmann, Madalena Barroso, Marta K. Danecka, et al. (+16)
327 [GO] 2022―Jul―15 Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome Giovanna Clavarino, Corentin Leroy, Olivier Epaulard, Tatiana Raskovalova, Antoine Vilotitch, Martine Pernollet, et al. (+10)
328 [GO] 2022―Jul―15 Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies Adrian Rice, Mohit Verma, Emily Voigt, Peter Battisti, Sam Beaver, Sierra Reed, et al. (+11)
329 [GO] 2022―Jul―14 SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns Elena Vazquez-Alejo, Laura Tarancon-Diez, Itzíar Carrasco, Sara Vigil-Vázquez, Mar Muñoz-Chapuli, Elena Rincón-López, et al. (+10)
330 [GO] 2022―Jul―13 A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses Joseph Torresi, Melissa A. Edeling, Terry Nolan, Dale I. Godfrey
331 [GO] 2022―Jul―12 Effects of Vaccination Against Influenza, Pertussis, and COVID-19 on Human Milk Antibodies: Current Evidence and Implications for Health Equity Soumya Hunagund, Yarden Golan, Ifeyinwa V. Asiodu, Mary Prahl, Stephanie L. Gaw
332 [GO] 2022―Jul―12 SARS-Arena: Sequence and Structure-Guided Selection of Conserved Peptides from SARS-related Coronaviruses for Novel Vaccine Development Mauricio Menegatti Rigo, Romanos Fasoulis, Anja Conev, Sarah Hall-Swan, Dinler Amaral Antunes, Lydia E. Kavraki
333 [GO] 2022―Jul―12 Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω Alessandra Pierangeli, Massimo Gentile, Giuseppe Oliveto, Federica Frasca, Leonardo Sorrentino, Luigi Matera, et al. (+9)
334 [GO] 2022―Jul―12 Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage Tiecheng Wang, Faming Miao, Shengnan Lv, Liang Li, Feng Wei, Lihua Hou, et al. (+18)
335 [GO] 2022―Jul―11 Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine Raja’a Al-Attiyah, Hussain A. Safar, Lotfy Botras, Marina Botras, Fatma Al-Kandari, Wassim Chehadeh, Abu Salim Mustafa
336 [GO] 2022―Jul―08 A Prospective Study on Risk Factors for Acute Kidney Injury and All-Cause Mortality in Hospitalized COVID-19 Patients From Tehran (Iran) Zohreh Rostami, Giuseppe Mastrangelo, Behzad Einollahi, Eghlim Nemati, Sepehr Shafiee, Mehrdad Ebrahimi, et al. (+6)
337 [GO] 2022―Jul―08 The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues Wenping Gong, Huiru An, Jie Wang, Peng Cheng, Yong Qi
338 [GO] 2022―Jul―08 Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study Seyed Mehran Marashian, Mohammadreza Hashemian, Mihan Pourabdollah, Mansour Nasseri, Saeed Mahmoudian, Florian Reinhart, Alireza Eslaminejad
339 [GO] 2022―Jul―08 The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection Zhan Xu, Xue Jiang, Xueyu Dai, Bin Li
340 [GO] 2022―Jul―08 Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples Siyang Yu, Peiyan Zhang, Mingfeng Liao, Juanjuan Zhang, Suisui Luo, Jinglei Zhai, et al. (+6)
341 [GO] 2022―Jul―08 Vascular Endothelial Growth Factor Receptor, fms-Like Tyrosine Kinase-1 (Flt-1), as a Novel Binding Partner for SARS-CoV-2 Spike Receptor-Binding Domain Adel Zaid I. Mutahar, Manjunath Devaramani, Renu Dayal, Dinesh Kumar Saini, Paramahans V. Salimath, Bharathi P. Salimath
342 [GO] 2022―Jul―08 The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2 Hai-yun Li, Ning Gao, Cheng-yang Liu, Xiao-ling Liu, Feng Wu, Nini Dai, et al. (+2)
343 [GO] 2022―Jul―07 Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People Hamid Reza Ghasemi Basir, Mohammad Mahdi Majzoobi, Samaneh Ebrahimi, Mina Noroozbeygi, Seyed Hamid Hashemi, Fariba Keramat, et al. (+5)
344 [GO] 2022―Jul―07 The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection Song Hu, Zuoyu Shao, Wei Ni, Pan Sun, Jialu Qiao, Hexing Wan, et al. (+5)
345 [GO] 2022―Jul―07 Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis Magali Noval Rivas, Rebecca A. Porritt, Mary Hongying Cheng, Ivet Bahar, Moshe Arditi
346 [GO] 2022―Jul―06 Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19 Yean Kong Yong, Won Fen Wong, Ramachandran Vignesh, Indranil Chattopadhyay, Vijayakumar Velu, Hong Yien Tan, et al. (+3)
347 [GO] 2022―Jul―06 A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice Pascal Brandys, Xavier Montagutelli, Irena Merenkova, Güliz T. Barut, Volker Thiel, Nicholas J. Schork, et al. (+9)
348 [GO] 2022―Jul―05 Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study Adrián Sánchez-Montalvá, Daniel Álvarez-Sierra, Mónica Martínez-Gallo, Janire Perurena-Prieto, Iria Arrese-Muñoz, Juan Carlos Ruiz-Rodríguez, et al. (+17)
349 [GO] 2022―Jul―05 Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients Jennifer M. Knight, Mallory R. Taylor, Kelly E. Rentscher, Elisabeth C. Henley, Hannah A. Uttley, Ashley M. Nelson, et al. (+6)
350 [GO] 2022―Jul―05 ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, et al. (+26)
351 [GO] 2022―Jul―05 High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients Dafeng Liu, Xiaoyan Yuan, Fengjiao Gao, Bennan Zhao, Ling Ding, Mingchang Huan, et al. (+2)
352 [GO] 2022―Jul―05 Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination Marta Sisteré-Oró, Diana D. J. Wortmann, Naína Andrade, Andres Aguilar, Clara Mayo de las Casas, Florencia Garcia Casabal, et al. (+11)
353 [GO] 2022―Jul―05 COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review Naim Mahroum, Noy Lavine, Aviran Ohayon, Ravend Seida, Abdulkarim Alwani, Mahmoud Alrais, et al. (+2)
354 [GO] 2022―Jul―05 Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease Antonius T. Otten, Arno R. Bourgonje, Petra P. Horinga, Hedwig H. van der Meulen, Eleonora A. M. Festen, Hendrik M. van Dullemen, et al. (+4)
355 [GO] 2022―Jul―04 Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19 Ming Hao, Dongxu Wang, Qianyun Xia, Shaoning Kan, Lu Chang, Huimin Liu, et al. (+2)
356 [GO] 2022―Jul―04 In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19 Rebeca Viurcos-Sanabria, Aarón N. Manjarrez-Reyna, Helena Solleiro-Villavicencio, Salma A. Rizo-Téllez, Lucía A. Méndez-García, Victoria Viurcos-Sanabria, et al. (+8)
357 [GO] 2022―Jul―04 Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial Céline Grégoire, Nathalie Layios, Bernard Lambermont, Chantal Lechanteur, Alexandra Briquet, Virginie Bettonville, et al. (+5)
358 [GO] 2022―Jul―04 SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation Rachel E. Lamerton, Edith Marcial-Juarez, Sian E. Faustini, Marisol Perez-Toledo, Margaret Goodall, Siân E. Jossi, et al. (+14)
359 [GO] 2022―Jul―04 The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review Yan Xie, Yang Liu, Yi Liu
360 [GO] 2022―Jul―01 SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19 Chenyang Duan, Ruiyan Ma, Xue Zeng, Bing Chen, Dongyao Hou, Ruixue Liu, et al. (+4)
361 [GO] 2022―Jul―01 Editorial: Complement and COVID-19 Disease Zoltán Prohászka, Nicolas S. Merle
362 [GO] 2022―Jul―01 A Path-Based Analysis of Infected Cell Line and COVID-19 Patient Transcriptome Reveals Novel Potential Targets and Drugs Against SARS-CoV-2 Piyush Agrawal, Narmada Sambaturu, Gulden Olgun, Sridhar Hannenhalli
363 [GO] 2022―Jul―01 Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational Study Jonas Herzberg, Bastian Fischer, Heiko Becher, Ann-Kristin Becker, Human Honarpisheh, Salman Yousuf Guraya, et al. (+2)
364 [GO] 2022―Jun―30 Role of IgM Memory B Cells and Spleen Function in COVID-19 Carlo Maria Rossi, Marco Vincenzo Lenti, Stefania Merli, Antonio Di Sabatino
365 [GO] 2022―Jun―30 Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation Francisco C. Ceballos, Ana Virseda-Berdices, Salvador Resino, Pablo Ryan, Oscar Martínez-González, Felipe Peréz-García, et al. (+13)
366 [GO] 2022―Jun―30 Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2 Thilo Samson Chillon, Maria Maares, Kamil Demircan, Julian Hackler, Qian Sun, Raban A. Heller, et al. (+5)
367 [GO] 2022―Jun―30 Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center Narayan Prasad, Shyam Bihari Bansal, Brijesh Yadav, Neha Manhas, Deependra Yadav, Sonam Gautam, et al. (+6)
368 [GO] 2022―Jun―30 Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, Sara Terzoli, Antonio Voza, Joanna Mikulak, et al. (+2)
369 [GO] 2022―Jun―30 Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients Ana Tajuelo, Octavio Carretero, Estéfani García-Ríos, Mireia López-Siles, Olga Cano, Mónica Vázquez, et al. (+9)
370 [GO] 2022―Jun―30 Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum Júlio Souza dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Gustavo Guadagnini Perez, Victor A. Roncaglia-Pereira, et al. (+24)
371 [GO] 2022―Jun―30 Antigenic Determinants of SARS-CoV-2-Specific CD4+ T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling Pedro H. Gazzinelli-Guimaraes, Gayatri Sanku, Alessandro Sette, Daniela Weiskopf, Paul Schaughency, Justin Lack, Thomas B. Nutman
372 [GO] 2022―Jun―28 Surface Display of Peptides Corresponding to the Heptad Repeat 2 Domain of the Feline Enteric Coronavirus Spike Protein on Bacillus subtilis Spores Elicits Protective Immune Responses Against Homologous Infection in a Feline Aminopeptidase-N-Transduced Mouse Model Chu Chen, Ya-Li Li, Fang-Li Lv, Ling-Dong Xu, Yao-Wei Huang
373 [GO] 2022―Jun―28 Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro Bram M. ter Ellen, Jelmer Niewold, Antine Flikweert, Anneke C. Muller Kobold, Peter Heeringa, Matijs van Meurs, et al. (+4)
374 [GO] 2022―Jun―27 Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis Senthilkumar Preethy, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Vaddi Surya Prakash, Nobunao Ikewaki, Yasunori Ikeue, et al. (+4)
375 [GO] 2022―Jun―27 Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review Antonio Tonutti, Francesca Motta, Angela Ceribelli, Natasa Isailovic, Carlo Selmi, Maria De Santis
376 [GO] 2022―Jun―27 Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules? Susanna Esposito, Caterina Caminiti, Rosanna Giordano, Alberto Argentiero, Greta Ramundo, Nicola Principi
377 [GO] 2022―Jun―27 The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection Esther Moga, Elionor Lynton-Pons, Pere Domingo
378 [GO] 2022―Jun―27 Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees Michael Jäger, Sissy Therese Sonnleitner, Stefanie Dichtl, Eliott Lafon, Gabriel Diem, Gernot Walder, et al. (+3)
379 [GO] 2022―Jun―24 Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial Shengli Xia, Kai Duan, Yuntao Zhang, Xiaoqing Zeng, Dongyang Zhao, Huajun Zhang, et al. (+32)
380 [GO] 2022―Jun―24 Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice Isabelle Dubuc, Julien Prunier, Émile Lacasse, Annie Gravel, Florian Puhm, Isabelle Allaeys, et al. (+7)
381 [GO] 2022―Jun―23 Misdiagnosis of Reactive Lymphadenopathy Remotely After COVID-19 Vaccination: A Case Report and Literature Review Qian Yu, Wei Jiang, Ni Chen, Jia Li, Xiaohui Wang, Maoping Li, et al. (+2)
382 [GO] 2022―Jun―23 Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence Susanna Esposito, Caterina Caminiti, Rosanna Giordano, Alberto Argentiero, Greta Ramundo, Nicola Principi
383 [GO] 2022―Jun―23 Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike Kamil Wnuk, Jeremi Sudol, Patricia Spilman, Patrick Soon-Shiong
384 [GO] 2022―Jun―23 Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Richard Stockinger, Hannelore Sprenger-Mähr, Karl Lhotta, Emanuel Zitt
385 [GO] 2022―Jun―23 Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study) Zoltán Kiss, István Wittmann, Lőrinc Polivka, György Surján, Orsolya Surján, Zsófia Barcza, et al. (+14)
386 [GO] 2022―Jun―22 Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity Enrique Alfaro, Elena Díaz-García, Sara García-Tovar, Ester Zamarrón, Alberto Mangas, Raúl Galera, et al. (+5)
387 [GO] 2022―Jun―22 Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection Gerard Espinosa, Carles Zamora-Martínez, Albert Pérez-Isidro, Daniela Neto, Luz Yadira Bravo-Gallego, Sergio Prieto-González, et al. (+4)
388 [GO] 2022―Jun―21 Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines Tomabu Adjobimey, Julia Meyer, Leander Sollberg, Michael Bawolt, Christina Berens, Peđa Kovačević, et al. (+3)
389 [GO] 2022―Jun―21 Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment Beatrice Rivalta, Donato Amodio, Carmela Giancotta, Veronica Santilli, Lucia Pacillo, Paola Zangari, et al. (+11)
390 [GO] 2022―Jun―20 BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages Bernd Jahrsdörfer, Matthias Proffen, Judith Scholz, Janina Hägele, Carolin Ludwig, Christiane Vieweg, et al. (+6)
391 [GO] 2022―Jun―17 Z-RNA and the Flipside of the SARS Nsp13 Helicase: Is There a Role for Flipons in Coronavirus-Induced Pathology? Alan Herbert, Maria Poptsova
392 [GO] 2022―Jun―17 The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2 Davide Ferrari, Michele Rubini, Jorge S. Burns
393 [GO] 2022―Jun―17 SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2 Ruoke Wang, Qi Zhang, Rui Zhang, Zhen Qin Aw, Peng Chen, Yi Hao Wong, et al. (+7)
394 [GO] 2022―Jun―17 Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency Vera Goda, Gergely Kriván, Andrea Kulcsár, Márton Gönczi, Szabolcs Tasnády, Zsolt Matula, et al. (+6)
395 [GO] 2022―Jun―16 Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19 Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, Yuki Togami, Shunichiro Nakao, Hiroshi Matsuura, et al. (+7)
396 [GO] 2022―Jun―16 Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection Taif Shah, Zahir Shah, Nafeesa Yasmeen, Zulqarnain Baloch, Xueshan Xia
397 [GO] 2022―Jun―15 Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19 Andres Agurto-Arteaga, Astrid Poma-Acevedo, Dora Rios-Matos, Ricardo Choque-Guevara, Ricardo Montesinos-Millán, Ángela Montalván, et al. (+12)
398 [GO] 2022―Jun―15 Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNA-Vaccinated People Against Wild-Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern Mandy Schwarze, Andor Krizsan, Alexandra Brakel, Fabian Pohl, Daniela Volke, Ralf Hoffmann
399 [GO] 2022―Jun―15 IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers Bram Decru, Jan Van Elslande, Sophie Steels, Gijs Van Pottelbergh, Lode Godderis, Bram Van Holm, et al. (+4)
400 [GO] 2022―Jun―15 Glucocorticoids Bind to SARS-CoV-2 S1 at Multiple Sites Causing Cooperative Inhibition of SARS-CoV-2 S1 Interaction With ACE2 Hassan Sarker, Rashmi Panigrahi, Eugenio Hardy, J. N. Mark Glover, Shokrollah Elahi, Carlos Fernandez-Patron
401 [GO] 2022―Jun―15 A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients Peifeng Huang, Qingwei Zuo, Yue Li, Patrick Kwabena Oduro, Fengxian Tan, Yuanyuan Wang, et al. (+6)
402 [GO] 2022―Jun―14 Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis Kezhen Zong, Dadi Peng, Hang Yang, Zuotian Huang, Yunhai Luo, Yihua Wang, et al. (+4)
403 [GO] 2022―Jun―10 Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept Study Carolin Christina Drost, Alexandros Rovas, Irina Osiaevi, Matthias Rauen, Johan van der Vlag, Baranca Buijsers, et al. (+5)
404 [GO] 2022―Jun―10 Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand Esmeiry Ventura-Santana, Joshua R. Ninan, Caitlin M. Snyder, Emeka B. Okeke
405 [GO] 2022―Jun―10 An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model Jodi F. Hedges, Deann T. Snyder, Amanda Robison, Heather M. Grifka-Walk, Karlin Blackwell, Kelly Shepardson, et al. (+4)
406 [GO] 2022―Jun―10 Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors Roberta Rovito, Matteo Augello, Assaf Ben-Haim, Valeria Bono, Antonella d’Arminio Monforte, Giulia Marchetti
407 [GO] 2022―Jun―10 Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection Milena Wiech, Piotr Chroscicki, Julian Swatler, Dawid Stepnik, Sara De Biasi, Michal Hampel, et al. (+7)
408 [GO] 2022―Jun―10 Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations Andrea Favalli, Ennio Giulio Favalli, Andrea Gobbini, Elena Zagato, Mauro Bombaci, Gabriella Maioli, et al. (+21)
409 [GO] 2022―Jun―10 The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs Wenqiang Sun, Lihong He, Huicong Lou, Wenhui Fan, Limin Yang, Gong Cheng, et al. (+2)
410 [GO] 2022―Jun―10 Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants Ariel Isaacs, Alberto A. Amarilla, Julio Aguado, Naphak Modhiran, Eduardo A. Albornoz, Alireza A. Baradar, et al. (+11)
411 [GO] 2022―Jun―06 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis Dae Kyu Kim, Su Woong Jung, Ju-Young Moon, Kyung Hwan Jeong, Hyeon Seok Hwang, Jin Sug Kim, et al. (+3)
412 [GO] 2022―Jun―03 Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers Arianna Pani, Alessandra Romandini, Alice Schianchi, Michele Senatore, Oscar M. Gagliardi, Gianluca Gazzaniga, et al. (+18)
413 [GO] 2022―Jun―03 Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides? José M. Pérez de la Lastra, Uttpal Anand, Sergio González-Acosta, Manuel R. López, Abhijit Dey, Elza Bontempi, Antonio Morales delaNuez
414 [GO] 2022―Jun―03 Vaccine Protection Through Placenta and Breastfeeding: The Unmet Topic in COVID-19 Pandemic Ariane Laguila Altoé, Anna Paula Marques Mambriz, Daniela Maira Cardozo, Joana Maira Valentini Zacarias, Jeane Eliete Laguila Visentainer, Larissa Danielle Bahls-Pinto
415 [GO] 2022―Jun―03 Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients Juan Jonathan Gonçalves, Camila Pacheco Silveira Martins da Mata, Alice Aparecida Lourenço, Ágata Lopes Ribeiro, Geovane Marques Ferreira, Thais Fernanda de Campos Fraga-Silva, et al. (+27)
416 [GO] 2022―Jun―03 The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis Kai Wang, Haoyue Deng, Binghui Song, Jiayue He, Shuguang Liu, Jiewen Fu, et al. (+6)
417 [GO] 2022―Jun―02 mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273 Alexander C. Dowell, Annabel A. Powell, Chris Davis, Sam Scott, Nicola Logan, Brian J. Willett, et al. (+32)
418 [GO] 2022―Jun―02 Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation Liyi Chen, Chong Liu, Tuo Liang, Zhen Ye, Shengsheng Huang, Jiarui Chen, et al. (+16)
419 [GO] 2022―Jun―01 Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19 Lyn R. Frumkin, Michaela Lucas, Curtis L. Scribner, Nastassja Ortega-Heinly, Jayden Rogers, Gang Yin, et al. (+20)
420 [GO] 2022―Jun―01 Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19 Raymund R. Razonable, Peter Chen
421 [GO] 2022―Jun―01 COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, Jorge Alfonso Tavares Negrete, Mohammed Sharaf, Jim Q. Ho, et al. (+8)
422 [GO] 2022―Jun―01 Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence Nadezhda V. Yagovkina, Lev M. Zheleznov, Ksenia A. Subbotina, Andrey A. Tsaan, Liubov I. Kozlovskaya, Ilya V. Gordeychuk, et al. (+13)
423 [GO] 2022―Jun―01 Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia Cristiana Barbati, Alessandra Ida Celia, Tania Colasanti, Marta Vomero, Mariangela Speziali, Erisa Putro, et al. (+14)
424 [GO] 2022―Jun―01 Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination Tomohiro Watanabe, Kosuke Minaga, Akane Hara, Tomoe Yoshikawa, Ken Kamata, Masatoshi Kudo
425 [GO] 2022―Jun―01 Neutrophils in COVID-19: Not Innocent Bystanders Ellen McKenna, Richard Wubben, Johana M. Isaza-Correa, Ashanty M. Melo, Aisling Ui Mhaonaigh, Niall Conlon, et al. (+6)
426 [GO] 2022―Jun―01 Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection Garrison Cox, Andres J. Gonzalez, Emmanuel C. Ijezie, Andres Rodriguez, Craig R. Miller, James T. Van Leuven, Tanya A. Miura
427 [GO] 2022―Jun―01 Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers Seri Jeong, Nuri Lee, Su Kyung Lee, Eun-Jung Cho, Jungwon Hyun, Min-Jeong Park, et al. (+2)
428 [GO] 2022―Jun―01 Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety Monika Svorcova, Rene Novysedlak, Robert Lischke, Jiri Vachtenheim, Zuzana Strizova
429 [GO] 2022―Jun―01 The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine Eman Farid, Juber Herrera-Uribe, Nigel J. Stevenson
430 [GO] 2022―Jun―01 Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination Marianne Graninger, Jeremy V. Camp, Stephan W. Aberle, Marianna T. Traugott, Wolfgang Hoepler, Elisabeth Puchhammer-Stöckl, et al. (+4)
431 [GO] 2022―Jun―01 Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals Manca Ogrič, Polona Žigon, Eva Podovšovnik, Katja Lakota, Snezna Sodin-Semrl, Žiga Rotar, Saša Čučnik
432 [GO] 2022―May―31 Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections Salomé Desmecht, Aleksandr Tashkeev, Majdouline El Moussaoui, Nicole Marechal, Hélène Perée, Yumie Tokunaga, et al. (+17)
433 [GO] 2022―May―31 Overview of Breastfeeding Under COVID-19 Pandemic Zehan Pang, Ruolan Hu, Lili Tian, Fuxing Lou, Yangzhen Chen, Shuqi Wang, et al. (+7)
434 [GO] 2022―May―31 Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients Kenneth R. McLeish, Rejeena Shrestha, Aruna Vashishta, Madhavi J. Rane, Michelle T. Barati, Michael E. Brier, et al. (+14)
435 [GO] 2022―May―31 Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection Lindsay Wieczorek, Michelle Zemil, Mélanie Merbah, Vincent Dussupt, Erin Kavusak, Sebastian Molnar, et al. (+9)
436 [GO] 2022―May―30 Case Report: A Severe Paediatric Presentation of COVID-19 in APDS2 Immunodeficiency Nuria Sanchez Clemente, Justin Penner, Judith Breuer, Winnie Ip, Claire Booth
437 [GO] 2022―May―27 Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination Grant Sprow, Mohsen Afarideh, Joshua Dan, Rui Feng, Emily Keyes, Madison Grinnell, et al. (+2)
438 [GO] 2022―May―26 A SARS-CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients Federico Pratesi, Fosca Errante, Lorenzo Pacini, Irina Charlot Peña-Moreno, Sebastian Quiceno, Alfonso Carotenuto, et al. (+10)
439 [GO] 2022―May―26 Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals Eustache Paramithiotis, Scott Sugden, Eszter Papp, Marie Bonhomme, Todd Chermak, Stephanie Y. Crawford, et al. (+7)
440 [GO] 2022―May―26 Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients Christa Meisinger, Yvonne Goßlau, Tobias D. Warm, Vincenza Leone, Alexander Hyhlik-Dürr, Jakob Linseisen, Inge Kirchberger
441 [GO] 2022―May―26 Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models Seyed Reza Banihashemi, Ali Es-haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Alireza Ranjbar, et al. (+12)
442 [GO] 2022―May―25 C/EBPα Epigenetically Modulates TFF1 Expression via mC-6 Methylation in the Jejunum Inflammation Induced by a Porcine Coronavirus Huan Qu, Qiufang Zong, Haifei Wang, Shenglong Wu, Demin Cai, Wenbin Bao
443 [GO] 2022―May―25 Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, Matthew Angel, Ifigeneia Tzannou, Margarita Vlachou, et al. (+11)
444 [GO] 2022―May―24 Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients Juliana de Melo Batista dos Santos, Jonatas Bussador do Amaral, Carolina Nunes França, Fernanda Rodrigues Monteiro, Anuska Marcelino Alvares-Saraiva, Sandra Kalil, et al. (+8)
445 [GO] 2022―May―24 Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine Yi Wang, Xiaoxia Wang, Laurence Don Wai Luu, Shaojin Chen, Fu Jin, Shufang Wang, et al. (+8)
446 [GO] 2022―May―20 An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19 Saeede Soleimanian, Soheila Alyasin, Najmeh Sepahi, Zahra Ghahramani, Zahra Kanannejad, Ramin Yaghobi, Mohammad Hossein Karimi
447 [GO] 2022―May―20 Role of COVID-19 Vaccines in SARS-CoV-2 Variants Zhou Zhou, Yimiao Zhu, Ming Chu
448 [GO] 2022―May―20 Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy Michal Podrazil, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Jan Lastovicka, Alena Vlachova, et al. (+3)
449 [GO] 2022―May―19 Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19 Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andres F. Vallejo, Stephen Poole, Nathan J. Brendish, et al. (+14)
450 [GO] 2022―May―19 N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients Nour Jalaleddine, Mahmood Hachim, Hamza Al-Hroub, Narjes Saheb Sharif-Askari, Abiola Senok, Adel Elmoselhi, et al. (+7)
451 [GO] 2022―May―19 Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients Meng-Li Cheng, Hui-Ying Liu, Chao Zhou, Rui-Ting Li, Jing Zheng, Yan-Hong Qin, et al. (+11)
452 [GO] 2022―May―19 Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection Weizheng Liang, Xiushen Li, Hao Wang, Kechao Nie, Qingxue Meng, Junli He, Chunfu Zheng
453 [GO] 2022―May―19 Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates Yixin Wu, Huicong Zhang, Liuxian Meng, Fusheng Li, Changyuan Yu
454 [GO] 2022―May―18 A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding Jing Yang, Sheng Lin, Honglu Sun, Zimin Chen, Fanli Yang, Xi Lin, et al. (+13)
455 [GO] 2022―May―18 Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity Julio García-Villalba, Laura Hurtado-Navarro, Alejandro Peñín-Franch, Cristina Molina-López, Laura Martínez-Alarcón, Diego Angosto-Bazarra, et al. (+2)
456 [GO] 2022―May―17 Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michal Sekrecki, Hanna Nowicka, et al. (+5)
457 [GO] 2022―May―17 Therapy Targets SARS-CoV-2 Infection-Induced Cell Death Zhoujie Zhu, Jiayi Shi, Long Li, Jinling Wang, Yufen Zhao, Huabin Ma
458 [GO] 2022―May―17 At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant Nagendrakumar B. Singanallur, Petrus Jansen van Vuren, Alexander J. McAuley, Matthew P. Bruce, Michael J. Kuiper, Stella M. Gwini, et al. (+13)
459 [GO] 2022―May―17 Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron Justyna Sieber, Margareta Mayer, Klara Schmidthaler, Sonja Kopanja, Jeremy V. Camp, Amelie Popovitsch, et al. (+7)
460 [GO] 2022―May―13 Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19 María Ángeles Rodríguez-Hernández, David Carneros, María Núñez-Núñez, Ramón Coca, Rosario Baena, Gema M. López-Ruiz, et al. (+9)
461 [GO] 2022―May―13 Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer Yuling Han, Jiaxin Yang, Danshuang He, Yang Feng, Xiaoman Liu, Yu Min, et al. (+3)
462 [GO] 2022―May―12 Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis Karim M. Aloul, Josefine Eilsø Nielsen, Erwin B. Defensor, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, et al. (+3)
463 [GO] 2022―May―12 The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses Yunus Kuijpers, Xiaojing Chu, Martin Jaeger, Simone J. C. F. M. Moorlag, Valerie A. C. M. Koeken, Bowen Zhang, et al. (+12)
464 [GO] 2022―May―12 Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics Bhaswati Chatterjee, Suman S. Thakur
465 [GO] 2022―May―12 Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2 Amanda P. Smith, Evan P. Williams, Taylor R. Plunkett, Muneeswaran Selvaraj, Lindey C. Lane, Lillian Zalduondo, et al. (+5)
466 [GO] 2022―May―12 Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients Bruno Fattizzo, Marta Bortolotti, Nicolò Rampi, Francesca Cavallaro, Juri Alessandro Giannotta, Cristina Bucelli, et al. (+11)
467 [GO] 2022―May―12 SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease Angelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, Maria Orola, Andrea Wessely, Ines Zwazl, et al. (+15)
468 [GO] 2022―May―11 Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the “Green Pass” Policy Immacolata Polvere, Alfredina Parrella, Lucrezia Zerillo, Serena Voccola, Gaetano Cardinale, Silvia D’Andrea, et al. (+4)
469 [GO] 2022―May―10 Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years’ Evidence Summary Yehua Wang, Yewei Xie, Siyue Hu, Wei Ai, Yusha Tao, Huilin Tang, et al. (+2)
470 [GO] 2022―May―10 Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors Athina Kilpeläinen, Esther Jimenez-Moyano, Oscar Blanch-Lombarte, Dan Ouchi, Ruth Peña, Bibiana Quirant-Sanchez, et al. (+12)
471 [GO] 2022―May―09 Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis Esther Silberberg, János G. Filep, Amiram Ariel
472 [GO] 2022―May―09 From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases? Min Zhao, Chang Tian, Shan Cong, Xin Di, Ke Wang
473 [GO] 2022―May―09 Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination Lisa Paschold, Bianca Klee, Cornelia Gottschick, Edith Willscher, Sophie Diexer, Christoph Schultheiß, et al. (+6)
474 [GO] 2022―May―06 Correlation of the Imbalance in the Circulating Lymphocyte Subsets With C-Reactive Protein and Cardio-Metabolic Conditions in Patients With COVID-19 Anton V. Tyurin, Milyausha K. Salimgareeva, Ildar R. Miniakhmetov, Rita I. Khusainova, Alexandr Samorodov, Valentin N. Pavlov, Julia Kzhyshkowska
475 [GO] 2022―May―06 Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, Yuki Togami, Shunichiro Nakao, Hiroshi Matsuura, et al. (+6)
476 [GO] 2022―May―06 Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches Mingkai Yu, Yuejie Zhu, Yujiao Li, Zhiqiang Chen, Zhiwei Li, Jing Wang, et al. (+3)
477 [GO] 2022―May―04 Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19 Sarita Rani Jaiswal, Jaganath Arunachalam, Ashraf Saifullah, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, et al. (+5)
478 [GO] 2022―May―04 Adaptive Immune Responses and Immunity to SARS-CoV-2 Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, Eduard Pavelić, Vilim Molnar, Vid Matišić, et al. (+2)
479 [GO] 2022―May―04 A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model Claire-Maëlle Fovet, Camille Pimienta, Mathilde Galhaut, Francis Relouzat, Natalia Nunez, Mariangela Cavarelli, et al. (+15)
480 [GO] 2022―May―04 Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2 Yen-Chung Lai, Yu-Wei Cheng, Chiao-Hsuan Chao, Yu-Ying Chang, Chi-De Chen, Wei-Jiun Tsai, et al. (+13)
481 [GO] 2022―May―03 HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19 Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, Andrea Stevenazzi, Barbara Vergani, Mattia Marchini, et al. (+6)
482 [GO] 2022―May―03 Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2 Khue G. Nguyen, Siena M. Mantooth, Maura R. Vrabel, David A. Zaharoff
483 [GO] 2022―May―03 Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus Alexander Stewart, Emma Sinclair, Joseph Chi-Fung Ng, Joselli Silva O’Hare, Audrey Page, Ilaria Serangeli, et al. (+17)
484 [GO] 2022―May―02 Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive Analysis Benjamin Meyer, Paola Andrea Martinez-Murillo, Barbara Lemaitre, Géraldine Blanchard-Rohner, Arnaud M. Didierlaurent, Paola Fontannaz, et al. (+10)
485 [GO] 2022―May―02 Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection Jhe-Jhih Lin, Chih-Feng Tien, Yi-Ping Kuo, En-Ju Lin, Wei-Hsiang Tsai, Ming-Yu Chen, et al. (+20)
486 [GO] 2022―May―02 Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months Tulio J. Lopera, Mateo Chvatal-Medina, Lizdany Flórez-Álvarez, Maria I. Zapata-Cardona, Natalia A. Taborda, Maria T. Rugeles, Juan C. Hernandez
487 [GO] 2022―Apr―29 pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury Mei-Chuan Chen, Kevin Shu-Leung Lai, Ko-Ling Chien, Sing Teck Teng, Yuh-Rong Lin, Wei Chao, et al. (+6)
488 [GO] 2022―Apr―29 Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 Months Patricia Kaaijk, Verónica Olivo Pimentel, Maarten E. Emmelot, Martien C. M. Poelen, Alper Cevirgel, Rutger M. Schepp, et al. (+8)
489 [GO] 2022―Apr―29 SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance Yifei Guo, Jiajia Han, Yao Zhang, Jingjing He, Weien Yu, Xueyun Zhang, et al. (+6)
490 [GO] 2022―Apr―29 Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy Arnau Antolí, Gemma Rocamora-Blanch, Mario Framil, Virgínia Mas-Bosch, Sergio Navarro, Carla Bermudez, et al. (+11)
491 [GO] 2022―Apr―28 Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants Chaonan Li, Yikai Guo, Zhongbiao Fang, Haiyan Zhang, Yanjun Zhang, Keda Chen
492 [GO] 2022―Apr―28 Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan Hiroyuki Kondo, Takahiro Kageyama, Shigeru Tanaka, Kunihiro Otsuka, Shin-ichi Tsukumo, Yoichi Mashimo, et al. (+3)
493 [GO] 2022―Apr―28 The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice Cheng Zhang, Huan Cui, Entao Li, Zhendong Guo, Tiecheng Wang, Fang Yan, et al. (+9)
494 [GO] 2022―Apr―28 Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals Edwards Pradenas, Maria Ubals, Víctor Urrea, Clara Suñer, Benjamin Trinité, Eva Riveira-Muñoz, et al. (+10)
495 [GO] 2022―Apr―27 Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19 Denise Battaglini, Miquéias Lopes-Pacheco, Hugo C. Castro-Faria-Neto, Paolo Pelosi, Patricia R. M. Rocco
496 [GO] 2022―Apr―27 In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition Olga I. Isaeva, Steven L. C. Ketelaars, Pia Kvistborg
497 [GO] 2022―Apr―27 Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas Abdouramane Traoré, Merepen A. Guindo, Drissa Konaté, Bourama Traoré, Seidina A. Diakité, Salimata Kanté, et al. (+18)
498 [GO] 2022―Apr―27 Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines Jianyang Liu, Qunying Mao, Xing Wu, Qian He, Lianlian Bian, Yu Bai, et al. (+5)
499 [GO] 2022―Apr―27 Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good Germana Grassi, Stefania Notari, Simona Gili, Veronica Bordoni, Rita Casetti, Eleonora Cimini, et al. (+4)
500 [GO] 2022―Apr―27 Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19 Youssif M. Ali, Nicholas J. Lynch, Priyanka Khatri, Ifeoluwa E. Bamigbola, Andrew C. Y. Chan, Munehisa Yabuki, et al. (+5)
501 [GO] 2022―Apr―27 Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects Zhan Zhang, Qi Shen, Haocai Chang
502 [GO] 2022―Apr―27 Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2 Soumya Sengupta, Gargee Bhattacharya, Sanchari Chatterjee, Ankita Datey, Shubham K. Shaw, Sandhya Suranjika, et al. (+7)
503 [GO] 2022―Apr―26 Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development Zhuolin Wang, Yang Zhang, Rirong Yang, Yujia Wang, Jiapei Guo, Ruya Sun, et al. (+4)
504 [GO] 2022―Apr―25 Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients Fernando Bartolomé, Luigi Rosa, Piera Valenti, Francisco Lopera, Jesús Hernández-Gallego, José Luis Cantero, et al. (+2)
505 [GO] 2022―Apr―25 Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron José M. Casasnovas, Yago Margolles, María A. Noriega, María Guzmán, Rocío Arranz, Roberto Melero, et al. (+8)
506 [GO] 2022―Apr―25 Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients Ana Tajuelo, Octavio Carretero, Estéfani García-Ríos, Mireia López-Siles, Olga Cano, Mónica Vázquez, et al. (+9)
507 [GO] 2022―Apr―22 Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients Antti Hurme, Pinja Jalkanen, Jemna Heroum, Oona Liedes, Saimi Vara, Merit Melin, et al. (+12)
508 [GO] 2022―Apr―22 Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection Amélie Guihot, Isabelle Plu, Cathia Soulié, Alice Rousseau, Cecilia Nakid-Cordero, Karim Dorgham, et al. (+20)
509 [GO] 2022―Apr―22 SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation Madison MacDougall, Jad El-Hajj Sleiman, Philippe Beauchemin, Manu Rangachari
510 [GO] 2022―Apr―22 Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice Yue Du, Shengnan Zhang, Zhaoyong Zhang, Kamran M. Miah, Peilan Wei, Lu Zhang, et al. (+7)
511 [GO] 2022―Apr―21 Coronavirus Infection and Cholesterol Metabolism Jun Dai, Huan Wang, Ying Liao, Lei Tan, Yingjie Sun, Cuiping Song, et al. (+3)
512 [GO] 2022―Apr―20 Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, Simone Lanini, Silvia Rosati, Eleonora Lalle, et al. (+15)
513 [GO] 2022―Apr―20 Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling Noha M. Elemam, Sarah Hammoudeh, Laila Salameh, Bassam Mahboub, Habiba Alsafar, Iman M. Talaat, et al. (+10)
514 [GO] 2022―Apr―20 Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2 Sebastian Wirsching, Laura Harder, Markus Heymanns, Britta Gröndahl, Katja Hilbert, Frank Kowalzik, et al. (+2)
515 [GO] 2022―Apr―19 A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population Stefano Mocci, Roberto Littera, Stefania Tranquilli, Aldesia Provenzano, Alessia Mascia, Federica Cannas, et al. (+10)
516 [GO] 2022―Apr―19 Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein Xiangxiang Tian, Yifan Zhang, Zhangyufan He, Shaoshuai Li, Dongmei Yan, Zhaoqin Zhu, et al. (+2)
517 [GO] 2022―Apr―14 Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients Lucrezia Furian, Francesco Paolo Russo, Gianluigi Zaza, Patrizia Burra, Susan Hartzell, Debora Bizzaro, et al. (+11)
518 [GO] 2022―Apr―14 Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases Carlos Martínez-Chinchilla, Lucía Vazquez-Montero, Natalia Palazón-Carrión, Isabel M. Fernández-Román, José López-Barba, Luis de la Cruz-Merino, et al. (+2)
519 [GO] 2022―Apr―13 BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19 Anna Kaznadzey, Maria Tutukina, Tatiana Bessonova, Maria Kireeva, Ilya Mazo
520 [GO] 2022―Apr―13 High Titers of Low Affinity Antibodies in COVID-19 Patients Are Associated With Disease Severity Jan Hendriks, Richard Schasfoort, Michelle Koerselman, Maureen Dannenberg, Alexander Daniel Cornet, Albertus Beishuizen, et al. (+4)
521 [GO] 2022―Apr―12 Periodontitis-Derived Dark-NETs in Severe Covid-19 Ljubomir Vitkov, Jasmin Knopf, Jelena Krunić, Christine Schauer, Janina Schoen, Bernd Minnich, et al. (+2)
522 [GO] 2022―Apr―12 Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray Sina Hosseinian, Kathleen Powers, Milind Vasudev, Anton M. Palma, Rafael de Assis, Aarti Jain, et al. (+18)
523 [GO] 2022―Apr―12 Response: Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Carlos Alberto Labarrere, Ghassan S. Kassab
524 [GO] 2022―Apr―12 SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19) Richard Stebbings, Christopher Jones, Peter Cotton, Gillian Armour, Shaun Maguire, Vicky Skellett, et al. (+7)
525 [GO] 2022―Apr―11 Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19 Alessandra Soares-Schanoski, Natalie Sauerwald, Carl W. Goforth, Sivakumar Periasamy, Dawn L. Weir, Stephen Lizewski, et al. (+18)
526 [GO] 2022―Apr―11 CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome Mar Guasp, Guillermo Muñoz-Sánchez, Eugenia Martínez-Hernández, Daniel Santana, Álvaro Carbayo, Laura Naranjo, et al. (+6)
527 [GO] 2022―Apr―11 A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques Ariane Volkmann, Gerrit Koopman, Petra Mooij, Ernst J. Verschoor, Babs E. Verstrepen, Willy M. J. M. Bogers, et al. (+8)
528 [GO] 2022―Apr―11 Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma Marlene Plüß, Christina Mitteldorf, Christoph Johannes Szuszies, Björn Tampe
529 [GO] 2022―Apr―08 The Effects of COVID-19 Vaccination on Lactating Women: A Systematic Review of the Literature Joke Muyldermans, Louise De Weerdt, Larissa De Brabandere, Kirsten Maertens, Eline Tommelein
530 [GO] 2022―Apr―08 Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro Ning Luan, Tao Li, Yunfei Wang, Han Cao, Xingxiao Yin, Kangyang Lin, Cunbao Liu
531 [GO] 2022―Apr―08 Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease Alexander M. Xu, Dalin Li, Joseph E. Ebinger, Emebet Mengesha, Rebecca Elyanow, Rachel M. Gittelman, et al. (+19)
532 [GO] 2022―Apr―07 Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis Huan Hu, Nana Tang, Facai Zhang, Li Li, Long Li
533 [GO] 2022―Apr―07 The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections Ren-Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, Chih-Hung Ye, SuiYun Hu, Patrick Chun Theng Chong, et al. (+4)
534 [GO] 2022―Apr―07 Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women Xiaofang Guo, Nihan Semerci, Viviana De Assis, Umit A. Kayisli, Frederick Schatz, Thora S. Steffensen, et al. (+2)
535 [GO] 2022―Apr―07 Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay Xiaoming Bai, Hongmin Sun, Shuo Wu, Yuhuan Li, Lifei Wang, Bin Hong
536 [GO] 2022―Apr―06 Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4 Salvatore Zaffina, Eva Piano Mortari, Reparata Rosa Di Prinzio, Marco Cappa, Antonio Novelli, Emanuele Agolini, et al. (+5)
537 [GO] 2022―Apr―06 Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme Anjing Chen, Wenguo Zhao, Xiaolong Li, Guangyu Sun, Zhaoyin Ma, Lingyu Peng, et al. (+3)
538 [GO] 2022―Apr―06 Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection Jessie J.-Y. Chang, Josie Gleeson, Daniel Rawlinson, Ricardo De Paoli-Iseppi, Chenxi Zhou, Francesca L. Mordant, et al. (+6)
539 [GO] 2022―Apr―06 Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination Pablo Hernández-Luis, Ruth Aguilar, Judit Pelegrin-Pérez, Gemma Ruiz-Olalla, Alberto L. García-Basteiro, Marta Tortajada, et al. (+4)
540 [GO] 2022―Apr―06 Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19 Zhaoli Liu, Gizem Kilic, Wenchao Li, Ozlem Bulut, Manoj Kumar Gupta, Bowen Zhang, et al. (+24)
541 [GO] 2022―Apr―05 Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19 Hong Zhou, Wei-Jian Ni, Wei Huang, Zhen Wang, Ming Cai, Yan-Cai Sun
542 [GO] 2022―Apr―05 Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020 Edmilson F. de Oliveira-Filho, Otávio V. de Carvalho, Ianei O. Carneiro, Fagner D’ambroso Fernandes, Sara Nunes Vaz, Célia Pedroso, et al. (+17)
543 [GO] 2022―Apr―04 Molnupiravir and Its Antiviral Activity Against COVID-19 Lili Tian, Zehan Pang, Maochen Li, Fuxing Lou, Xiaoping An, Shaozhou Zhu, et al. (+4)
544 [GO] 2022―Apr―04 Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients Raffaella Marocco, Anna Carraro, Maria Antonella Zingaropoli, Parni Nijhawan, Eeva Tortellini, Mariasilvia Guardiani, et al. (+10)
545 [GO] 2022―Apr―04 Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses Cillian Gartlan, Tom Tipton, Francisco J. Salguero, Quentin Sattentau, Andrew Gorringe, Miles W. Carroll
546 [GO] 2022―Apr―04 Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing Yanan Wang, Duo Chen, Chaofeng Zhu, Zhenhua Zhao, Shanshan Gao, Jianjun Gou, et al. (+2)
547 [GO] 2022―Apr―04 Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design Varun Jaiswal, Hae-Jeung Lee
548 [GO] 2022―Apr―01 CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives Keywan Mortezaee, Jamal Majidpoor
549 [GO] 2022―Mar―31 Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients Mohammad A. Al-Mterin, Alhasan Alsalman, Eyad Elkord
550 [GO] 2022―Mar―31 Combined Subcutaneous-Intranasal Immunization With Epitope-Based Antigens Elicits Binding and Neutralizing Antibody Responses in Serum and Mucosae Against PRRSV-2 and SARS-CoV-2 Mario Fragoso-Saavedra, Carmen Ramírez-Estudillo, Diana L. Peláez-González, Jorge O. Ramos-Flores, Gustavo Torres-Franco, Leandro Núñez-Muñoz, et al. (+10)
551 [GO] 2022―Mar―31 Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study Gábor J. Szebeni, Nikolett Gémes, Dániel Honfi, Enikő Szabó, Patrícia Neuperger, József Á. Balog, et al. (+5)
552 [GO] 2022―Mar―30 Alterations of Urinary Microbial Metabolites and Immune Indexes Linked With COVID-19 Infection and Prognosis Yixian Jing, Jing Wang, Haiyan Zhang, Kun Yang, Jungang Li, Ting Zhao, et al. (+3)
553 [GO] 2022―Mar―30 An Integrated Platform for Serological Detection and Vaccination of COVID-19 Sung-Chan Wei, Wei-Ting Hsu, Chun-Hsiang Chiu, Feng-Yee Chang, Huei-Ru Lo, Chuan-Yu Liao, et al. (+4)
554 [GO] 2022―Mar―30 Translational Control of COVID-19 and Its Therapeutic Implication Dejiu Zhang, Lei Zhu, Yin Wang, Peifeng Li, Yanyan Gao
555 [GO] 2022―Mar―30 Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection Nurhan Albayrak, Carmen Orte Cano, Sina Karimi, David Dogahe, Anne Van Praet, Audrey Godefroid, et al. (+6)
556 [GO] 2022―Mar―30 Computer-Based Immunoinformatic Analysis to Predict Candidate T-Cell Epitopes for SARS-CoV-2 Vaccine Design Xueyin Mei, Pan Gu, Chuanlai Shen, Xue Lin, Jian Li
557 [GO] 2022―Mar―29 Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review Areez Shafqat, Shameel Shafqat, Sulaiman Al Salameh, Junaid Kashir, Khaled Alkattan, Ahmed Yaqinuddin
558 [GO] 2022―Mar―29 Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2 Neslihan Pakize Taşlı, Zeynep Burçin Gönen, Oğuz Kaan Kırbaş, Nur Seda Gökdemir, Batuhan Turhan Bozkurt, Buse Bayrakcı, et al. (+25)
559 [GO] 2022―Mar―29 Cannabidiol and SARS-CoV-2 Infection Alexandre Vallée
560 [GO] 2022―Mar―29 Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection Manpreet Singh, Obed Barrera Adame, Michael Nickas, Jeremiah Robison, Christopher Khatchadourian, Vishwanath Venketaraman
561 [GO] 2022―Mar―29 Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants Ye-Fan Hu, Jing-Chu Hu, Hua-Rui Gong, Antoine Danchin, Ren Sun, Hin Chu, et al. (+6)
562 [GO] 2022―Mar―29 Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease Sarah Keep, Brigid Veronica Carr, Fabian Z. X. Lean, Albert Fones, Joseph Newman, Giulia Dowgier, et al. (+19)
563 [GO] 2022―Mar―29 Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine Jie Bai, Asako Chiba, Goh Murayama, Taiga Kuga, Naoto Tamura, Sachiko Miyake
564 [GO] 2022―Mar―29 Revisiting the Principles of Preservation in an Era of Pandemic Obesity John T. Langford, Jenna R. DiRito, Natty Doilicho, Graylen R. Chickering, David A. Stern, Xinshou Ouyang, et al. (+2)
565 [GO] 2022―Mar―29 An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19 Julia Y. Wang, Wei Zhang, Victor B. Roehrl, Michael W. Roehrl, Michael H. Roehrl
566 [GO] 2022―Mar―29 Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients Matthijs Oyaert, Marie-Angélique De Scheerder, Sophie Van Herrewege, Guy Laureys, Sofie Van Assche, Melissa Cambron, et al. (+10)
567 [GO] 2022―Mar―28 ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19 María del Carmen Maza, María Úbeda, Pilar Delgado, Lydia Horndler, Miguel A. Llamas, Hisse M. van Santen, et al. (+6)
568 [GO] 2022―Mar―28 Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, Rafael Alves Guimarães, Roberta Luiza Rodrigues, Kaio Mota Ribeiro, et al. (+13)
569 [GO] 2022―Mar―28 Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate Kun Yang, Matthew Holt, Min Fan, Victor Lam, Yong Yang, Tuanzhu Ha, et al. (+3)
570 [GO] 2022―Mar―28 The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3 John T. Schroeder, Anja P. Bieneman
571 [GO] 2022―Mar―28 Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada Guadalein Tanunliong, Aaron C. Liu, Samantha Kaweski, Mike Irvine, Romina C. Reyes, Dale Purych, et al. (+6)
572 [GO] 2022―Mar―28 Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination Maria Gonzalez-Perez, Maria Montes-Casado, Patricia Conde, Isabel Cervera, Jana Baranda, Marcos J. Berges-Buxeda, et al. (+14)
573 [GO] 2022―Mar―27 Commentary: Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? Marijn M. Speeckaert, Joris R. Delanghe
574 [GO] 2022―Mar―26 COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA Hsiuying Wang
575 [GO] 2022―Mar―25 Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19 Ekaterina Martynova, Shaimaa Hamza, Maria Markelova, Ekaterina Garanina, Yuriy Davidyuk, Venera Shakirova, et al. (+6)
576 [GO] 2022―Mar―25 Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival Lara Gibellini, Sara De Biasi, Marianna Meschiari, Licia Gozzi, Annamaria Paolini, Rebecca Borella, et al. (+10)
577 [GO] 2022―Mar―24 Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Jaimin Patel, Lyndsey M. Muehling, Glenda Canderan, et al. (+11)
578 [GO] 2022―Mar―22 Causal Association and Shared Genetics Between Asthma and COVID-19 Ancha Baranova, Hongbao Cao, Jiu Chen, Fuquan Zhang
579 [GO] 2022―Mar―21 SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study Michele Maria Luchetti Gentiloni, Valentino Paci, Valentina Marconi, Marco Gigli, Devis Benfaremo, Raffaella Sordillo, et al. (+5)
580 [GO] 2022―Mar―18 Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19 Lingyun Chen, Pengfei Pang, Huan Qi, Keqiang Yan, Yan Ren, Mingliang Ma, et al. (+12)
581 [GO] 2022―Mar―18 Definition of the Immune Parameters Related to COVID-19 Severity Sarah Birindelli, Maciej S. Tarkowski, Marcello Gallucci, Marco Schiuma, Alice Covizzi, Przemysław Lewkowicz, et al. (+6)
582 [GO] 2022―Mar―17 Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients Renaud Prével, Annabelle Dupont, Sylvie Labrouche-Colomer, Geoffrey Garcia, Antoine Dewitte, Antoine Rauch, et al. (+12)
583 [GO] 2022―Mar―17 Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22) Xilin Wu, Yaxing Wang, Lin Cheng, Fengfeng Ni, Linjing Zhu, Sen Ma, et al. (+13)
584 [GO] 2022―Mar―17 Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination Emilia Cirillo, Ciro Esposito, Giuliana Giardino, Gaetano Azan, Simona Fecarotta, Stefania Pittaluga, et al. (+5)
585 [GO] 2022―Mar―16 Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza Demi Brownlie, Inga Rødahl, Renata Varnaite, Hilmir Asgeirsson, Hedvig Glans, Sara Falck-Jones, et al. (+7)
586 [GO] 2022―Mar―16 Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2 Petra Mooij, Juan García-Arriaza, Patricia Pérez, Adrian Lázaro-Frías, Babs E. Verstrepen, Kinga P. Böszörményi, et al. (+20)
587 [GO] 2022―Mar―16 MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters Robbert Boudewijns, Patricia Pérez, Adrián Lázaro-Frías, Dominique Van Looveren, Thomas Vercruysse, Hendrik Jan Thibaut, et al. (+10)
588 [GO] 2022―Mar―16 Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization Haijun Tang, Long Gao, Zhao Wu, Fang Meng, Xin Zhao, Yun Shao, et al. (+3)
589 [GO] 2022―Mar―15 A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection Md. Aminul Islam, Md. Atiqul Haque, Md. Arifur Rahman, Foysal Hossen, Mahin Reza, Abanti Barua, et al. (+7)
590 [GO] 2022―Mar―14 Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C Peter D. Burbelo, Riccardo Castagnoli, Chisato Shimizu, Ottavia M. Delmonte, Kerry Dobbs, Valentina Discepolo, et al. (+29)
591 [GO] 2022―Mar―14 Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern Ivan Odak, Christian R. Schultze-Florey, Swantje I. Hammerschmidt, Christiane Ritter, Stefanie Willenzon, Michaela Friedrichsen, et al. (+14)
592 [GO] 2022―Mar―14 Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients Anna Bobcakova, Martina Barnova, Robert Vysehradsky, Jela Petriskova, Ivan Kocan, Zuzana Diamant, Milos Jesenak
593 [GO] 2022―Mar―14 The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19 Stefan D. Jevtic, Ishac Nazy
594 [GO] 2022―Mar―11 The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia Fortunato Vesce, Chiara Battisti, Michele Crudo
595 [GO] 2022―Mar―11 On the Origin of Neutrophil Extracellular Traps in COVID-19 Michal Pastorek, Martin Dúbrava, Peter Celec
596 [GO] 2022―Mar―11 Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4 Felipe B. Lima, Karine C. Bezerra, José Carlos R. Nascimento, Gdayllon C. Meneses, Reinaldo B. Oriá
597 [GO] 2022―Mar―11 Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation Kai Jakobs, Leander Reinshagen, Marianna Puccini, Julian Friebel, Anne-Christin Beatrice Wilde, Ayman Alsheik, et al. (+5)
598 [GO] 2022―Mar―11 Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees Micaela Garziano, Olga Utyro, Mariacristina Poliseno, Teresa Antonia Santantonio, Irma Saulle, Sergio Strizzi, et al. (+4)
599 [GO] 2022―Mar―10 Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study Riccardo Scarpa, Alessandro Dell’Edera, Carla Felice, Roberta Buso, Francesco Muscianisi, Renato Finco Gambier, et al. (+9)
600 [GO] 2022―Mar―10 SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Laura Gebert, Malte C. Kleinschmidt, Alexandra Wald, et al. (+17)
601 [GO] 2022―Mar―10 Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43 Jinsoo Kim, Minyoung Kim, Dongbum Kim, Sangkyu Park, Mijeong Kang, Kyeongbin Baek, et al. (+5)
602 [GO] 2022―Mar―09 Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19 Wouter L. Smit, Sophie van Tol, Sanne van der Wal, Femke van Vulpen, Shannon la Grouw, Lenneke van Lelyveld, et al. (+9)
603 [GO] 2022―Mar―09 Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response Ling Mao, Chang Liu, Jing-Yi Liu, Zi-Li Jin, Zhe Jin, Ruo-Yi Xue, et al. (+6)
604 [GO] 2022―Mar―08 Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients Qinghong Fan, Kai Deng, Huang Huang, Ruiying He, Xizi Deng, Yun Lan, et al. (+6)
605 [GO] 2022―Mar―08 How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment Bo Nilsson, Barbro Persson, Oskar Eriksson, Karin Fromell, Michael Hultström, Robert Frithiof, et al. (+3)
606 [GO] 2022―Mar―08 Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution Ming-Ming Shao, Meier Shi, Juan Du, Xue-Bin Pei, Bei-Bei Gu, Feng-Shuang Yi
607 [GO] 2022―Mar―08 Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies Takuya Tada, Hao Zhou, Marie I. Samanovic, Belinda M. Dcosta, Amber Cornelius, Ramin S. Herati, et al. (+2)
608 [GO] 2022―Mar―07 SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation Luca Perico, Marina Morigi, Miriam Galbusera, Anna Pezzotta, Sara Gastoldi, Barbara Imberti, et al. (+5)
609 [GO] 2022―Mar―07 Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds Diego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, David A. Wells, George W. Carnell, Luis Ohlendorf, et al. (+13)
610 [GO] 2022―Mar―04 Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, Delphine Kemlin, Isabelle Desombere, Margaux Gerbaux, et al. (+4)
611 [GO] 2022―Mar―03 Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation Anthony J. Leonardi, Christos P. Argyropoulos, Adam Hamdy, Rui B. Proenca
612 [GO] 2022―Mar―03 SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection Zeev Elkoshi
613 [GO] 2022―Mar―02 NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond Yuanfeng Zhu, Xiaoli Chen, Xin Liu
614 [GO] 2022―Mar―02 Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, Amélie Brebion, Justine Cosme, Frédéric Dutheil, et al. (+9)
615 [GO] 2022―Mar―01 Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old Giuliana X. Medeiros, Greyce Luri Sasahara, Jhosiene Y. Magawa, João Paulo S. Nunes, Fernanda R. Bruno, Andreia C. Kuramoto, et al. (+14)
616 [GO] 2022―Feb―28 Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study Tomas Milota, Marta Sobotkova, Jitka Smetanova, Marketa Bloomfield, Jana Vydlakova, Zita Chovancova, et al. (+11)
617 [GO] 2022―Feb―28 Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors Marieke Vinkenoog, Maurice Steenhuis, Anja ten Brinke, J. G. Coen van Hasselt, Mart P. Janssen, Matthijs van Leeuwen, et al. (+8)
618 [GO] 2022―Feb―28 A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice Lorena M. Coria, Lucas M. Saposnik, Celeste Pueblas Castro, Eliana F. Castro, Laura A. Bruno, William B. Stone, et al. (+11)
619 [GO] 2022―Feb―28 Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis Chiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, Emanuele Nicastri, Bruno Laganà, Chiara Agrati, et al. (+20)
620 [GO] 2022―Feb―28 Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein Salvador Romero-Pinedo, Marina Quesada, Lydia Horndler, Stela Álvarez-Fernández, Asunción Olmo, David Abia, et al. (+2)
621 [GO] 2022―Feb―25 Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination Ayman Al Jurdi, Rodrigo B. Gassen, Thiago J. Borges, Zhabiz Solhjou, Frank E. Hullekes, Isadora T. Lape, et al. (+12)
622 [GO] 2022―Feb―25 Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques Nongthombam Boby, Xuewei Cao, Kelsey Williams, Shiva Kumar Goud Gadila, Monica N. Shroyer, Peter J. Didier, et al. (+5)
623 [GO] 2022―Feb―25 A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity Bertrand Bellier, Alicia Saura, Lucas A. Luján, Cecilia R. Molina, Hugo D. Luján, David Klatzmann
624 [GO] 2022―Feb―24 SARS-CoV-2 Induces Cytokine Responses in Human Basophils Srinivasa Reddy Bonam, Camille Chauvin, Laurine Levillayer, Mano Joseph Mathew, Anavaj Sakuntabhai, Jagadeesh Bayry
625 [GO] 2022―Feb―24 Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, Tatyana N. Belovezhets, Grigory A. Efimov, Anton N. Chikaev, et al. (+4)
626 [GO] 2022―Feb―24 Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections Yukiya Kurahashi, Silvia Sutandhio, Koichi Furukawa, Lidya Handayani Tjan, Sachiyo Iwata, Shigeru Sano, et al. (+10)
627 [GO] 2022―Feb―24 Multi-Cellular Immunological Interactions Associated With COVID-19 Infections Jitender S. Verma, Claudia R. Libertin, Yash Gupta, Geetika Khanna, Rohit Kumar, Balvinder S. Arora, et al. (+8)
628 [GO] 2022―Feb―24 DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice Jinni Chen, Yao Deng, Baoying Huang, Di Han, Wen Wang, Mengjing Huang, et al. (+7)
629 [GO] 2022―Feb―24 Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern Irina A. Favorskaya, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Inna V. Dolzhikova, Irina A. Alekseeva, Anastasia I. Korobkova, et al. (+15)
630 [GO] 2022―Feb―23 Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection Wei Li, Fahim Syed, Richard Yu, Jing Yang, Ying Xia, Ryan F. Relich, et al. (+7)
631 [GO] 2022―Feb―23 Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine Floriane Gallais, Pierre Gantner, Delphine Planas, Morgane Solis, Timothée Bruel, Florian Pierre, et al. (+6)
632 [GO] 2022―Feb―23 Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls Sebastian Rask Hamm, Dina Leth Møller, Laura Pérez-Alós, Cecilie Bo Hansen, Mia Marie Pries-Heje, Line Dam Heftdal, et al. (+18)
633 [GO] 2022―Feb―22 Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia Günalp Uzun, Lisann Pelzl, Anurag Singh, Tamam Bakchoul
634 [GO] 2022―Feb―22 Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients Xiaorui Wang, Han Bai, Junpeng Ma, Hongyu Qin, Qiqi Zeng, Fang Hu, et al. (+21)
635 [GO] 2022―Feb―22 Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling Gaetano Zizzo, Antonio Tamburello, Laura Castelnovo, Antonella Laria, Nicola Mumoli, Paola Maria Faggioli, et al. (+2)
636 [GO] 2022―Feb―22 Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, Mary Ann Hausner, Jennifer A. Fulcher, Paul Krogstad, et al. (+5)
637 [GO] 2022―Feb―21 Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19 Barbara Prietl, Balazs Odler, Alexander H. Kirsch, Katharina Artinger, Manfred Eigner, Sabine Schmaldienst, et al. (+9)
638 [GO] 2022―Feb―21 Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies Thomas A. Premeaux, Stephen T. Yeung, Zaheer Bukhari, Scott Bowler, Oral Alpan, Raavi Gupta, Lishomwa C. Ndhlovu
639 [GO] 2022―Feb―21 Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection Teding Chang, Jingzhi Yang, Hai Deng, Deng Chen, XiangPing Yang, Zhao-Hui Tang
640 [GO] 2022―Feb―18 Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination Taejoon Won, Nisha Aggarwal Gilotra, Megan Kay Wood, David Matthew Hughes, Monica Vladut Talor, Jana Lovell, et al. (+3)
641 [GO] 2022―Feb―18 Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset Roberto Russo, Giulia Gasparini, Emanuele Cozzani, Federica D’Agostino, Aurora Parodi
642 [GO] 2022―Feb―18 Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts Lívia Teixeira, Jairo R. Temerozo, Filipe S. Pereira-Dutra, André Costa Ferreira, Mayara Mattos, Barbara Simonson Gonçalves, et al. (+19)
643 [GO] 2022―Feb―17 Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2 Xiaocong Pang, Haitao Liu, Xu He, Tianrong Ji, Yizhun Zhu, Yimin Cui
644 [GO] 2022―Feb―17 Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19 Swatantra Kumar, Shailendra K. Saxena, Vimal K. Maurya, Anil K. Tripathi
645 [GO] 2022―Feb―17 Trained Immunity: An Overview and the Impact on COVID-19 Justin M. Brueggeman, Juan Zhao, Madison Schank, Zhi Q. Yao, Jonathan P. Moorman
646 [GO] 2022―Feb―17 ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men Laura E. Martínez-Gómez, Brígida Herrera-López, Carlos Martinez-Armenta, Silvestre Ortega-Peña, María del Carmen Camacho-Rea, Carlos Suarez-Ahedo, et al. (+36)
647 [GO] 2022―Feb―17 Disrupted Peyer’s Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus Silvia C. Trevelin, Suzanne Pickering, Katrina Todd, Cynthia Bishop, Michael Pitcher, Jose Garrido Mesa, et al. (+7)
648 [GO] 2022―Feb―17 Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients Silvia Lucena Lage, Joseph M. Rocco, Elizabeth Laidlaw, Adam Rupert, Frances Galindo, Anela Kellogg, et al. (+6)
649 [GO] 2022―Feb―17 SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics Bhaswati Chatterjee, Suman S. Thakur
650 [GO] 2022―Feb―16 A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine Vijayakumar Jawalagatti, Perumalraja Kirthika, Chamith Hewawaduge, Ji-Young Park, Myeon-Sik Yang, Byungkwan Oh, et al. (+3)
651 [GO] 2022―Feb―16 Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity Darakhshan Sohail Ahmed, Stéphane Isnard, Carolina Berini, John Lin, Jean-Pierre Routy, Léna Royston
652 [GO] 2022―Feb―16 Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection Jingzhi Yang, Teding Chang, Liangsheng Tang, Hai Deng, Deng Chen, Jialiu Luo, et al. (+7)
653 [GO] 2022―Feb―16 A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection Savannah M. Rocha, Anna C. Fagre, Amanda S. Latham, Jason E. Cummings, Tawfik A. Aboellail, Philip Reigan, et al. (+8)
654 [GO] 2022―Feb―16 Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany Alex Dulovic, Barbora Kessel, Manuela Harries, Matthias Becker, Julia Ortmann, Johanna Griesbaum, et al. (+26)
655 [GO] 2022―Feb―15 The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic Sylvia Annabel Dass, Venugopal Balakrishnan, Norsyahida Arifin, Crystale Siew Ying Lim, Fazlina Nordin, Gee Jun Tye
656 [GO] 2022―Feb―15 Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy Susana Santos, Pedro Barata, Adilia Charmier, Inês Lehmann, Suzilaine Rodrigues, Matteo M. Melosini, et al. (+7)
657 [GO] 2022―Feb―14 Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination Kai M. T. Sauerwein, Christoph B. Geier, Roman F. Stemberger, Hüseyin Akyaman, Peter Illes, Michael B. Fischer, et al. (+3)
658 [GO] 2022―Feb―14 Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19 Janina Niederreiter, Christine Eck, Tajana Ries, Arndt Hartmann, Bruno Märkl, Maike Büttner-Herold, et al. (+2)
659 [GO] 2022―Feb―14 Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure Kentaro Nagaoka, Hitoshi Kawasuji, Yushi Murai, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, et al. (+3)
660 [GO] 2022―Feb―14 COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2 Nitya Kumar, Suha Quadri, Abdulla Ismaeel AlAwadhi, Manaf AlQahtani
661 [GO] 2022―Feb―14 SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence Lucia La Sala, Sara Gandini, Antonino Bruno, Raffaele Allevi, Matteo Gallazzi, Pamela Senesi, et al. (+6)
662 [GO] 2022―Feb―11 The Fight Against Severe COVID-19: Can Parasitic Worms Contribute? Pengfei Cai, Yi Mu, Donald P. McManus
663 [GO] 2022―Feb―11 Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation Makoto Miyara, Melissa Saichi, Delphine Sterlin, François Anna, Stéphane Marot, Alexis Mathian, et al. (+27)
664 [GO] 2022―Feb―10 Pregnant Women Develop a Specific Immunological Long-Lived Memory Against SARS-COV-2 Claudio Fenizia, Irene Cetin, Davide Mileto, Claudia Vanetti, Irma Saulle, Maia Di Giminiani, et al. (+6)
665 [GO] 2022―Feb―10 Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals Vera Portillo, Chiara Fedeli, Pilar Ustero Alonso, Ianis Petignat, Ellen Cristina Mereles Costa, Adi Sulstarova, et al. (+3)
666 [GO] 2022―Feb―09 Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection Mariangela Rutigliani, Matteo Bozzo, Andrea Barberis, Marco Greppi, Emanuela Anelli, Luca Castellaro, et al. (+8)
667 [GO] 2022―Feb―09 Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults Lise Lund Berven, Joel Selvakumar, Lise Havdal, Tonje Stiansen-Sonerud, Gunnar Einvik, Truls Michael Leegaard, et al. (+4)
668 [GO] 2022―Feb―09 A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee
669 [GO] 2022―Feb―09 Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques Andrew D. White, Laura Sibley, Charlotte Sarfas, Alexandra L. Morrison, Kevin Bewley, Colin Churchward, et al. (+23)
670 [GO] 2022―Feb―07 Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19 Feihu Yan, Entao Li, Tiecheng Wang, Yuanguo Li, Jun Liu, Weiqi Wang, et al. (+9)
671 [GO] 2022―Feb―07 Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence Francisco Fuentes-Villalobos, Jose L. Garrido, Matías A. Medina, Nicole Zambrano, Natalia Ross, Felipe Bravo, et al. (+18)
672 [GO] 2022―Feb―07 Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis Anselm Jorda, Manuel Kussmann, Nebu Kolenchery, Jolanta M. Siller-Matula, Markus Zeitlinger, Bernd Jilma, Georg Gelbenegger
673 [GO] 2022―Feb―07 Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months Patricia Kaaijk, Verónica Olivo Pimentel, Maarten E. Emmelot, Martien Poelen, Alper Cevirgel, Rutger M. Schepp, et al. (+8)
674 [GO] 2022―Feb―04 Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis Jing Xia, Shuhan Chen, Yaping Li, Hua Li, Minghong Gan, Jiashuo Wu, et al. (+5)
675 [GO] 2022―Feb―04 Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury Theresa M. Rossouw, Ronald Anderson, Pravin Manga, Charles Feldman
676 [GO] 2022―Feb―03 New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19 Soo-Jeung Park, Da-eun Nam, Hae Chang Seong, Young S. Hahn
677 [GO] 2022―Feb―03 HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity Anahit Hovhannisyan, Vergine Madelian, Sevak Avagyan, Mihran Nazaretyan, Armine Hyussyan, Alina Sirunyan, et al. (+5)
678 [GO] 2022―Feb―03 Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, et al. (+11)
679 [GO] 2022―Jan―31 Identifying COVID-19 Infections From a Vaccinated Population Using Specific IgA Antibody Test Zhangkai J. Cheng, Peiyan Zheng, Mingshan Xue, Youpeng Chen, Baoqing Sun
680 [GO] 2022―Jan―31 Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition Agnieszka Katarzyna Maciola, Massimo La Raja, Monia Pacenti, Cristiano Salata, Giustina De Silvestro, Antonio Rosato, Giulia Pasqual
681 [GO] 2022―Jan―31 Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation Elena Díaz-García, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, et al. (+9)
682 [GO] 2022―Jan―31 Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine Jae Hong Choi, Young Ree Kim, Sang Taek Heo, Hyunjoo Oh, Misun Kim, Hyang Ran Lee, Jeong Rae Yoo
683 [GO] 2022―Jan―28 Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19 Carlos Jiménez-Cortegana, Flora Sánchez-Jiménez, Antonio Pérez-Pérez, Nerissa Álvarez, Alberto Sousa, Luisa Cantón-Bulnes, et al. (+8)
684 [GO] 2022―Jan―28 Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein Yunwen Zhang, Zhengrong Yang, Mingyuan Tang, Hao Li, Tian Tang, Guilian Li, et al. (+4)
685 [GO] 2022―Jan―28 SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Marina L. García-Vaquero, Quentin Lecrevisse, Raquel Herrero, Antonio Ferruelo, et al. (+6)
686 [GO] 2022―Jan―28 Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern Daniel López
687 [GO] 2022―Jan―28 Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy Paige K. Marty, Virginia P. Van Keulen, Courtney L. Erskine, Maleeha Shah, Amber Hummel, Michael Stachowitz, et al. (+11)
688 [GO] 2022―Jan―27 Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study Anna Beltrame, Pedro Salguero, Emanuela Rossi, Ana Conesa, Lucia Moro, Laura Rachele Bettini, et al. (+10)
689 [GO] 2022―Jan―27 Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review Pamir Atagündüz, Gökhan Keser, Mehmet Soy
690 [GO] 2022―Jan―27 T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients Yizhe Li, Jian Hu, Yongsi Wang, Dongdong Liu, Yaling Shi, Jiaqi Zhang, et al. (+11)
691 [GO] 2022―Jan―27 Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort Shihan Zhang, Ke Xu, Chuchu Li, Lu Zhou, Xiaoxiao Kong, Jiefu Peng, et al. (+6)
692 [GO] 2022―Jan―27 Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study Yan Chen, Jianfeng Xie, Wenjuan Wu, Shusheng Li, Yu Hu, Ming Hu, et al. (+19)
693 [GO] 2022―Jan―27 Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Rachel M.Y. Cheong, Anusha Yellapragada, Wey Y. Wong, et al. (+5)
694 [GO] 2022―Jan―27 Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts Carlota Dobaño, Selena Alonso, Marta Vidal, Alfons Jiménez, Rocío Rubio, Rebeca Santano, et al. (+29)
695 [GO] 2022―Jan―27 A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pedro J. Sánchez-Cordón, David Astorgano, Joanna Luczkowiak, et al. (+4)
696 [GO] 2022―Jan―27 SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity Haolin Liu, Pengcheng Wei, John W. Kappler, Philippa Marrack, Gongyi Zhang
697 [GO] 2022―Jan―26 Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Michael DePietro, Marc Salzberg
698 [GO] 2022―Jan―26 SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron Alessio Mazzoni, Anna Vanni, Michele Spinicci, Manuela Capone, Giulia Lamacchia, Lorenzo Salvati, et al. (+14)
699 [GO] 2022―Jan―25 Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies Karsten Suhre, Hina Sarwath, Rudolf Engelke, Muhammad Umar Sohail, Soo Jung Cho, William Whalen, et al. (+4)
700 [GO] 2022―Jan―25 Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination Krystallenia Paniskaki, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, Sarah Skrzypczyk, et al. (+15)
701 [GO] 2022―Jan―24 Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies Masaud Shah, Hyun Goo Woo
702 [GO] 2022―Jan―24 Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? Federica Saponaro, Maria Franzini, Chukwuma Okoye, Rachele Antognoli, Beatrice Campi, Marco Scalese, et al. (+7)
703 [GO] 2022―Jan―24 The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs Hoang Oanh Nguyen, Tiziana Schioppa, Laura Tiberio, Fabrizio Facchinetti, Gino Villetti, Maurizio Civelli, et al. (+8)
704 [GO] 2022―Jan―21 mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2 Yingqi Jin, Chen Hou, Yonghao Li, Kang Zheng, Chuan Wang
705 [GO] 2022―Jan―21 Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients Makoto Kurano, Hiroko Ohmiya, Yoshiro Kishi, Jun Okada, Yuki Nakano, Rin Yokoyama, et al. (+10)
706 [GO] 2022―Jan―20 Swine Enteric Coronaviruses (PEDV, TGEV, and PDCoV) Induce Divergent Interferon-Stimulated Gene Responses and Antigen Presentation in Porcine Intestinal Enteroids Lingdan Yin, Xiang Liu, Dongmei Hu, Yi Luo, Guozhong Zhang, Pinghuang Liu
707 [GO] 2022―Jan―20 Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities Hamed Fouladseresht, Atefe Ghamar Talepoor, Nahid Eskandari, Marzieh Norouzian, Behrooz Ghezelbash, Mohammad Reza Beyranvand, et al. (+4)
708 [GO] 2022―Jan―19 Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment André F. Rendeiro, Charles Kyriakos Vorkas, Jan Krumsiek, Harjot K. Singh, Shashi N. Kapadia, Luca Vincenzo Cappelli, et al. (+4)
709 [GO] 2022―Jan―19 CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects Laura Esparcia-Pinedo, Pedro Martínez-Fleta, Noelia Ropero, Paula Vera-Tomé, Hugh T. Reyburn, José M. Casasnovas, et al. (+7)
710 [GO] 2022―Jan―19 Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial Simon Jochum, Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Udo Eichenlaub, et al. (+2)
711 [GO] 2022―Jan―19 Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2 Robert Markewitz, David Juhl, Daniela Pauli, Siegfried Görg, Ralf Junker, Jan Rupp, et al. (+13)
712 [GO] 2022―Jan―19 The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency Isabella Quinti, Franco Locatelli, Rita Carsetti
713 [GO] 2022―Jan―18 Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Leung, Emily S. J. Edwards, Anna E. S. Brooks
714 [GO] 2022―Jan―18 Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2 Marlene Plüß, Kemal Mese, Johannes T. Kowallick, Andreas Schuster, Désirée Tampe, Björn Tampe
715 [GO] 2022―Jan―18 SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection Susan R. Conway, Christopher A. Lazarski, Naomi E. Field, Mariah Jensen-Wachspress, Haili Lang, Vaishnavi Kankate, et al. (+14)
716 [GO] 2022―Jan―18 CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2 Congling Qiu, Chanchan Xiao, Zhigang Wang, Guodong Zhu, Lipeng Mao, Xiongfei Chen, et al. (+13)
717 [GO] 2022―Jan―17 Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response Elisa Pesce, Nicola Manfrini, Chiara Cordiglieri, Spartaco Santi, Alessandra Bandera, Andrea Gobbini, et al. (+17)
718 [GO] 2022―Jan―17 Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients Fatemeh Saheb Sharif-Askari, Swati Goel, Narjes Saheb Sharif-Askari, Shirin Hafezi, Saba Al Heialy, Mahmood Yaseen Hachim, et al. (+10)
719 [GO] 2022―Jan―17 B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications Marco Iannetta, Doriana Landi, Gaia Cola, Laura Campogiani, Vincenzo Malagnino, Elisabetta Teti, et al. (+13)
720 [GO] 2022―Jan―14 The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19 Carla Usai, Joseph M. Gibbons, Corinna Pade, Wenhao Li, Sabina R. M. Jacobs, Áine McKnight, et al. (+2)
721 [GO] 2022―Jan―14 The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19 Gang Xu, Furong Qi, Haiyan Wang, Yu Liu, Xin Wang, Rongrong Zou, et al. (+5)
722 [GO] 2022―Jan―14 Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients Yufei Mo, Kelvin Kai-Wang To, Runhong Zhou, Li Liu, Tianyu Cao, Haode Huang, et al. (+12)
723 [GO] 2022―Jan―14 Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease Progression Min Zhao, Zhen Liu, Fei Shao, Wenjing Zhou, Zhu Chen, Pengyan Xia, et al. (+2)
724 [GO] 2022―Jan―14 In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor Faez Iqbal Khan, Fakhrul Hassan, Dakun Lai
725 [GO] 2022―Jan―14 Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16- Monocytes From COVID-19 Patients Silvia Lucena Lage, Eduardo Pinheiro Amaral, Kerry L. Hilligan, Elizabeth Laidlaw, Adam Rupert, Sivaranjani Namasivayan, et al. (+12)
726 [GO] 2022―Jan―14 Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2 Wael Bahnan, Sebastian Wrighton, Martin Sundwall, Anna Bläckberg, Olivia Larsson, Urban Höglund, et al. (+16)
727 [GO] 2022―Jan―13 Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration Andrea Henriques-Pons, Daniela Gois Beghini, Vanessa dos Santos Silva, Samuel Iwao Horita, Fabrício Alves Barbosa da Silva
728 [GO] 2022―Jan―13 COVID-19 Disease and Dermatomyositis: A Mini-Review Jie Qian, Hui Xu
729 [GO] 2022―Jan―13 Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2 Renata Fioravanti Tarabini, Mauricio Menegatti Rigo, André Faustino Fonseca, Felipe Rubin, Rafael Bellé, Lydia E Kavraki, et al. (+3)
730 [GO] 2022―Jan―12 Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Hiroaki Mon, Keita Sato, Kosuke Oyama, et al. (+19)
731 [GO] 2022―Jan―12 DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model Levi A. Tamming, Diana Duque, Anh Tran, Wanyue Zhang, Annabelle Pfeifle, Emmanuel Laryea, et al. (+16)
732 [GO] 2022―Jan―12 Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study Thais G. Moreira, Kimble T. F. Matos, Giovana S. De Paula, Thais M. M. Santana, Raquel G. Da Mata, Fernando C. Pansera, et al. (+13)
733 [GO] 2022―Jan―11 Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women Kee Thai Yeo, Wan Ni Chia, Chee Wah Tan, Chengsi Ong, Joo Guan Yeo, Jinyan Zhang, et al. (+8)
734 [GO] 2022―Jan―11 A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19 Pedro Martínez-Fleta, Paula Vera-Tomé, María Jiménez-Fernández, Silvia Requena, Emilia Roy-Vallejo, Ancor Sanz-García, et al. (+12)
735 [GO] 2022―Jan―11 Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection Kyu-Young Sim, Gwang-Hoon Ko, So-Eun Bae, Kyu Yeong Choi, Jung Sup Lee, Byeong C. Kim, et al. (+3)
736 [GO] 2022―Jan―10 Evidence of Microglial Immune Response Following Coronavirus PHEV Infection of CNS Jing Zhang, Zi Li, Huijun Lu, Junchao Shi, Rui Gao, Ying Ma, et al. (+5)
737 [GO] 2022―Jan―10 In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
738 [GO] 2022―Jan―10 Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra, Emily Long, Amruta Pise, Hallison Rodrigues, et al. (+11)
739 [GO] 2022―Jan―10 The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis Xinwei Huang, Huazheng Liang, Hong Zhang, Li Tian, Peilin Cong, Tingmei Wu, et al. (+11)
740 [GO] 2022―Jan―07 A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis Yi-Zi Xie, Chen-Wen Peng, Zu-Qing Su, Hui-Ting Huang, Xiao-Hong Liu, Shao-Feng Zhan, Xiu-Fang Huang
741 [GO] 2022―Jan―06 Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals Sergio Gil-Manso, Iria Miguens Blanco, Rocío López-Esteban, Diego Carbonell, Luis Andrés López-Fernández, Lori West, et al. (+2)
742 [GO] 2022―Jan―06 Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters Kyle L. O’Donnell, Chad S. Clancy, Amanda J. Griffin, Kyle Shifflett, Tylisha Gourdine, Tina Thomas, et al. (+3)
743 [GO] 2022―Jan―06 Comprehensive Analysis of CD4+ T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II You-Seok Hyun, Yong-Hun Lee, Hyeong-A Jo, In-Cheol Baek, Sun-Mi Kim, Hyun-Jung Sohn, Tai-Gyu Kim
744 [GO] 2022―Jan―05 Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination Yair Zlotnik, Avi Gadoth, Ibrahim Abu-Salameh, Anat Horev, Rosa Novoa, Gal Ifergane
745 [GO] 2022―Jan―05 Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide Nathalie Vanderheijden, Annelies Stevaert, Jiexiong Xie, Xiaolei Ren, Cyril Barbezange, Sam Noppen, et al. (+9)
746 [GO] 2022―Jan―05 Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis Liwei Zhang, Mingxing Li, Zhiwei Wang, Peng Sun, Shunbo Wei, Cong Zhang, et al. (+2)
747 [GO] 2022―Jan―05 Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era Leila Abdelhamid, Xin M. Luo
748 [GO] 2022―Jan―04 Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response Wenye Xu, Yingzhi Liu, Xuan Zou, Huanle Luo, Weihua Wu, Junjie Xia, et al. (+5)
749 [GO] 2022―Jan―03 Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks Guadalein Tanunliong, Aaron Liu, Rohit Vijh, Tamara Pidduck, Jesse Kustra, Ana Citlali Márquez, et al. (+9)
750 [GO] 2022―Jan―03 Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities Xu Li, Manik Garg, Tingting Jia, Qijun Liao, Lifang Yuan, Mao Li, et al. (+10)
751 [GO] 2022―Jan―03 SARS-CoV-2 Variants, Vaccines, and Host Immunity Priyal Mistry, Fatima Barmania, Juanita Mellet, Kimberly Peta, Adéle Strydom, Ignatius M. Viljoen, et al. (+3)
752 [GO] 2021―Dec―24 Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques Patrick J. Madden, Muhammad S. Arif, Mark E. Becker, Michael D. McRaven, Ann M. Carias, Ramon Lorenzo-Redondo, et al. (+16)
753 [GO] 2021―Dec―23 Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies Ryan M. Pace, Janet E. Williams, Kirsi M. Järvinen, Courtney L. Meehan, Melanie A. Martin, Sylvia H. Ley, et al. (+19)
754 [GO] 2021―Dec―23 Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment Nayoun Kim, Jong-Min Lee, Eun-Jee Oh, Dong Wook Jekarl, Dong-Gun Lee, Keon-Il Im, Seok-Goo Cho
755 [GO] 2021―Dec―23 Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders Bahaa Abu-Raya, Shabir A. Madhi, Saad B. Omer, Gayatri Amirthalingam, Michelle L. Giles, Katie L. Flanagan, et al. (+9)
756 [GO] 2021―Dec―23 Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection Ilias Christodoulou, Ruyan Rahnama, Jonas W. Ravich, Jaesung Seo, Sergey N. Zolov, Andrew N. Marple, et al. (+2)
757 [GO] 2021―Dec―23 SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene Youwei Zhu, Zhaoyang Zhang, Jia Song, Weizhou Qian, Xiangqian Gu, Chaoyong Yang, et al. (+3)
758 [GO] 2021―Dec―22 Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19 Keiji Kuba, Tomokazu Yamaguchi, Josef M. Penninger
759 [GO] 2021―Dec―22 Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection Long-Fang Chen, Cheng-De Yang, Xiao-Bing Cheng
760 [GO] 2021―Dec―22 Role of Exercise Intensity on Th1/Th2 Immune Modulations During the COVID-19 Pandemic Rashmi Supriya, Yang Gao, Yaodong Gu, Julien S. Baker
761 [GO] 2021―Dec―22 Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting Ziwei Li, Tiandan Xiang, Boyun Liang, Hui Deng, Hua Wang, Xuemei Feng, et al. (+14)
762 [GO] 2021―Dec―21 A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques Megan A. O’Connor, Jesse H. Erasmus, Samantha Randall, Jacob Archer, Thomas B. Lewis, Brieann Brown, et al. (+8)
763 [GO] 2021―Dec―20 Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 Sibylle C. Mellinghoff, Kanika Vanshylla, Christine Dahlke, Marylyn M. Addo, Oliver A. Cornely, Florian Klein, et al. (+4)
764 [GO] 2021―Dec―20 Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies Murad Abusukhun, Martin S. Winkler, Stefan Pöhlmann, Onnen Moerer, Konrad Meissner, Björn Tampe, et al. (+4)
765 [GO] 2021―Dec―20 Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals Jéromine Klingler, Gregory S. Lambert, Vincenza Itri, Sean Liu, Juan C. Bandres, Gospel Enyindah-Asonye, et al. (+12)
766 [GO] 2021―Dec―20 Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study Geng Wang, Qian Wang, Yeming Wang, Changzheng Liu, Linghang Wang, Hong Chen, et al. (+11)
767 [GO] 2021―Dec―17 Crystal Structures of Bat and Human Coronavirus ORF8 Protein Ig-Like Domain Provide Insights Into the Diversity of Immune Responses Xiaoxue Chen, Zhechong Zhou, Chunliu Huang, Ziliang Zhou, Sisi Kang, Zhaoxia Huang, et al. (+12)
768 [GO] 2021―Dec―17 Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents Hing Wai Tsang, Gilbert T. Chua, Kelvin K. W. To, Joshua S. C. Wong, Wenwei Tu, Janette S. Y. Kwok, et al. (+14)
769 [GO] 2021―Dec―17 An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection Peter A. van der Ley, Afshin Zariri, Elly van Riet, Dinja Oosterhoff, Corine P. Kruiswijk
770 [GO] 2021―Dec―16 Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19 Daniel Elieh Ali Komi, Yaghoub Rahimi, Rahim Asghari, Reza Jafari, Javad Rasouli, Mehdi Mohebalizadeh, et al. (+4)
771 [GO] 2021―Dec―16 Innate Receptors Expression by Lung Nociceptors: Impact on COVID-19 and Aging Carlos H. Hiroki, Nicole Sarden, Mortaza F. Hassanabad, Bryan G. Yipp
772 [GO] 2021―Dec―16 Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children Chengliang Yang, Hedi Zhao, Scott J. Tebbutt
773 [GO] 2021―Dec―16 Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús-González, Carlos Daniel Cordero-Rivera, Carlos Noe Farfan-Morales, Juan Fidel Osuna-Ramos, Gustavo Martínez-Mier, et al. (+5)
774 [GO] 2021―Dec―15 The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial Nazanin Majidi, Faezeh Rabbani, Somayeh Gholami, Maryam Gholamalizadeh, Fatemeh BourBour, Samira Rastgoo, et al. (+10)
775 [GO] 2021―Dec―15 Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, Behzad Aria, Behzad Hemati, Farhang Fatehi, et al. (+5)
776 [GO] 2021―Dec―15 Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Hatem Zayed, Sang-Soo Lee
777 [GO] 2021―Dec―14 A Recent Update on Advanced Molecular Diagnostic Techniques for COVID-19 Pandemic: An Overview Akanksha Roberts, Raghuraj Singh Chouhan, Deepshikha Shahdeo, Narlawar Sagar Shrikrishna, Veerbhan Kesarwani, Milena Horvat, Sonu Gandhi
778 [GO] 2021―Dec―13 Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population Farhan S. Cyprian, Muhammad Suleman, Ibrahim Abdelhafez, Asmma Doudin, Ibn Mohammed Masud Danjuma, Fayaz Ahmad Mir, et al. (+12)
779 [GO] 2021―Dec―13 A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants Sisi Shan, Chee Keng Mok, Shuyuan Zhang, Jun Lan, Jizhou Li, Ziqing Yang, et al. (+13)
780 [GO] 2021―Dec―13 Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19 Jasmin D. Haslbauer, Carl Zinner, Anna K. Stalder, Jan Schneeberger, Thomas Menter, Stefano Bassetti, et al. (+4)
781 [GO] 2021―Dec―13 The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis Jiting Wang, Yue Tong, Duo Li, Jun Li, Yaling Li
782 [GO] 2021―Dec―09 Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations Haijun Wang, Zili Zhang, Junfen Zhou, Shuqing Han, Zhenyu Kang, Haoyu Chuang, et al. (+11)
783 [GO] 2021―Dec―09 Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome Agnes S. Meidert, Stefanie Hermann, Florian Brandes, Benedikt Kirchner, Dominik Buschmann, Jean-Noël Billaud, et al. (+6)
784 [GO] 2021―Dec―09 Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together Lin Zhang, Josh Poorbaugh, Michael Dougan, Peter Chen, Robert L. Gottlieb, Gregory Huhn, et al. (+11)
785 [GO] 2021―Dec―09 Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis Tyler J. Loftus, Ricardo Ungaro, Marvin Dirain, Philip A. Efron, Monty B. Mazer, Kenneth E. Remy, et al. (+6)
786 [GO] 2021―Dec―09 SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination Yudi T. Pinilla, Constanze Heinzel, Lena-Fabienne Caminada, Douglas Consolaro, Meral Esen, Peter G. Kremsner, et al. (+3)
787 [GO] 2021―Dec―09 SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals Prithivi Chellamuthu, Aaron N. Angel, Melanie A. MacMullan, Nicholas Denny, Aubree Mades, Marilisa Santacruz, et al. (+12)
788 [GO] 2021―Dec―09 A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern Shahbaz Ahmed, Mohammad Suhail Khan, Savitha Gayathri, Randhir Singh, Sahil Kumar, Unnatiben Rajeshbhai Patel, et al. (+21)
789 [GO] 2021―Dec―09 Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case Kevin M. Vannella, Cihan Oguz, Sydney R. Stein, Stefania Pittaluga, Esra Dikoglu, Arjun Kanwal, et al. (+20)
790 [GO] 2021―Dec―07 IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis Chiara Cioccarelli, Ricardo Sánchez-Rodríguez, Roberta Angioni, Francisca C. Venegas, Nicole Bertoldi, Fabio Munari, et al. (+3)
791 [GO] 2021―Dec―07 Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression Manon Ruffin, Jeanne Bigot, Claire Calmel, Julia Mercier, Maëlle Givelet, Justine Oliva, et al. (+6)
792 [GO] 2021―Dec―07 SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-ĸB Activation Jie Xia, Wenqi Tang, Jiangmei Wang, Dengming Lai, Qi Xu, Ruoqiong Huang, et al. (+5)
793 [GO] 2021―Dec―07 A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains Fengxia Gao, Jingjing Huang, Tingting Li, Chao Hu, Meiying Shen, Song Mu, et al. (+11)
794 [GO] 2021―Dec―06 Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection Aifen Lin, Wei-Hua Yan
795 [GO] 2021―Dec―06 Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19 Thi Nhu Mai Tran, Bruce Pearson May, Trong Thuan Ung, Mai Khoi Nguyen, Thi Thuy Trang Nguyen, Van Long Dinh, et al. (+27)
796 [GO] 2021―Dec―06 Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19 Lowell Ling, Zigui Chen, Grace Lui, Chun Kwok Wong, Wai Tat Wong, Rita W. Y. Ng, et al. (+6)
797 [GO] 2021―Dec―02 Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients Sara Caldrer, Cristina Mazzi, Milena Bernardi, Marco Prato, Niccolò Ronzoni, Paola Rodari, et al. (+3)
798 [GO] 2021―Dec―02 Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort Georg Beilhack, Rossella Monteforte, Florian Frommlet, Martina Gaggl, Robert Strassl, Andreas Vychytil
799 [GO] 2021―Dec―02 Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants Wei-Shuo Lin, I-Chen Chen, Hui-Chen Chen, Yi-Chien Lee, Suh-Chin Wu
800 [GO] 2021―Dec―01 Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases Kaushik Sen, Sudeshna Datta, Arup Ghosh, Atimukta Jha, Abdul Ahad, Sanchari Chatterjee, et al. (+10)
801 [GO] 2021―Dec―01 Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection Margherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Mahesh Agarwal, Jenifer Bear, Robert Burns, et al. (+7)
802 [GO] 2021―Dec―01 Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease Ji Yeon Lee, Jee Young Lee, Jae-Hoon Ko, Miri Hyun, Hyun Ah Kim, Seongcheol Cho, et al. (+4)
803 [GO] 2021―Dec―01 Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern Antonio J. Martín-Galiano, Francisco Díez-Fuertes, Michael J. McConnell, Daniel López
804 [GO] 2021―Dec―01 m6A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients Xiangmin Qiu, Xiaoliang Hua, Qianyin Li, Qin Zhou, Juan Chen
805 [GO] 2021―Dec―01 Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost Amar K. Garg, Soumya Mittal, Pranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit
806 [GO] 2021―Dec―01 Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines Waleed H. Mahallawi, Walaa A. Mumena
807 [GO] 2021―Dec―01 The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape Dandan Tian, Yanhong Sun, Jianming Zhou, Qing Ye
808 [GO] 2021―Dec―01 Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities Modjtaba Emadi-Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, Mahnaz Norouzi, Zahra Joz-Abbasalian
809 [GO] 2021―Dec―01 COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study Jian Wu, Quanman Li, Clifford Silver Tarimo, Meiyun Wang, Jianqin Gu, Wei Wei, et al. (+4)
810 [GO] 2021―Dec―01 COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis Clio Bilotta, Giulio Perrone, Valeria Adelfio, Giovanni Francesco Spatola, Maria Laura Uzzo, Antonina Argo, Stefania Zerbo
811 [GO] 2021―Nov―30 Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs Mark C. Howell, Ryan Green, Andrew R. McGill, Roukiah M. Kahlil, Rinku Dutta, Shyam S. Mohapatra, Subhra Mohapatra
812 [GO] 2021―Nov―30 Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature Bruno Fattizzo, Raffaella Pasquale, Valentina Bellani, Wilma Barcellini, Austin G. Kulasekararaj
813 [GO] 2021―Nov―30 Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination Hamad Ali, Abdulmohsen Alterki, Sardar Sindhu, Barrak Alahmad, Maha Hammad, Salman Al-Sabah, et al. (+13)
814 [GO] 2021―Nov―30 Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions Sang Won Lee, Ji-Yong Moon, Sun-Kyung Lee, Hyun Lee, SeolHwa Moon, Sung Jun Chung, et al. (+7)
815 [GO] 2021―Nov―30 Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis Cheng Zhang, Yi-Gang Feng, Chiwing Tam, Ning Wang, Yibin Feng
816 [GO] 2021―Nov―30 Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis Sisse R. Ostrowski, Ole S. Søgaard, Martin Tolstrup, Nina B. Stærke, Jens Lundgren, Lars Østergaard, Anne-Mette Hvas
817 [GO] 2021―Nov―22 Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines Yandi Zhang, Jo-Lewis Banga Ndzouboukou, Mengze Gan, Xiaosong Lin, Xionglin Fan
818 [GO] 2021―Nov―19 Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests Yue Zhou, Xuelian Liao, Xiangrong Song, Min He, Fei Xiao, Xiaodong Jin, et al. (+6)
819 [GO] 2021―Nov―19 Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases Javier Castillo-Olivares, David A. Wells, Matteo Ferrari, Andrew C. Y. Chan, Peter Smith, Angalee Nadesalingam, et al. (+22)
820 [GO] 2021―Nov―19 Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals Jackwee Lim, Kia Joo Puan, Liang Wei Wang, Karen Wei Weng Teng, Chiew Yee Loh, Kim Peng Tan, et al. (+27)
821 [GO] 2021―Nov―19 Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization Jin Wang, Cheng Guo, Lin Cai, Conghui Liao, Huaimin Yi, Qianlin Li, et al. (+6)
822 [GO] 2021―Nov―18 Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge Yaiza Senent, Susana Inogés, Ascensión López-Díaz de Cerio, Andres Blanco, Arantxa Campo, Francisco Carmona-Torre, et al. (+8)
823 [GO] 2021―Nov―18 The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity Carlos del Fresno, Juan García-Arriaza, Sarai Martínez-Cano, Ignacio Heras-Murillo, Aitor Jarit-Cabanillas, Joaquín Amores-Iniesta, et al. (+14)
824 [GO] 2021―Nov―18 Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Hisaaki Kawabata, Dominika Bielak, Weina Sun, et al. (+6)
825 [GO] 2021―Nov―18 MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants Sua Lee, Shina Jang, Jihoon Kang, Soo Bin Park, Young Woo Han, Hyemi Nam, et al. (+13)
826 [GO] 2021―Nov―17 COVID-19, Pre-Eclampsia, and Complement System Chiara Agostinis, Alessandro Mangogna, Andrea Balduit, Azin Aghamajidi, Giuseppe Ricci, Uday Kishore, Roberta Bulla
827 [GO] 2021―Nov―16 Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People Julie Demaret, Bénédicte Corroyer-Simovic, Enagnon Kazali Alidjinou, Anne Goffard, Jacques Trauet, Sophie Miczek, et al. (+15)
828 [GO] 2021―Nov―15 XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants Bernard Vanhove, Stéphane Marot, Ray T. So, Benjamin Gaborit, Gwénaëlle Evanno, Isabelle Malet, et al. (+11)
829 [GO] 2021―Nov―11 Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19 Anna E. Spiering, Teun J. de Vries
830 [GO] 2021―Nov―11 Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo Ruby A. Escobedo, Dhiraj K. Singh, Deepak Kaushal
831 [GO] 2021―Nov―11 Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents Berislav Bošnjak, Ivan Odak, Joana Barros-Martins, Inga Sandrock, Swantje I. Hammerschmidt, Marc Permanyer, et al. (+22)
832 [GO] 2021―Nov―11 Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1 Theodore J. Cory, Russell S. Emmons, Johnathan R. Yarbro, Kierstin L. Davis, Brandt D. Pence
833 [GO] 2021―Nov―11 Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations Damiano Buratto, Abhishek Saxena, Qun Ji, Guang Yang, Sergio Pantano, Francesco Zonta
834 [GO] 2021―Nov―11 Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination Tiphany Chrun, Emmanuel A. Maze, Eleni Vatzia, Veronica Martini, Basudev Paudyal, Matthew D. Edmans, et al. (+7)
835 [GO] 2021―Nov―11 Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19 Hayder M. Al-kuraishy, Ali Ismail Al-Gareeb, Gomaa Mostafa-Hedeab, Keneth Iceland Kasozi, Gerald Zirintunda, Akhmed Aslam, et al. (+3)
836 [GO] 2021―Nov―10 Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19 Hao Zhang, Bo Shao, Qin Dang, Zhuang Chen, Quanbo Zhou, Hong Luo, et al. (+2)
837 [GO] 2021―Nov―10 Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients Sergey G. Shcherbak, Anna Yu Anisenkova, Sergei V. Mosenko, Oleg S. Glotov, Alexander N. Chernov, Svetlana V. Apalko, et al. (+6)
838 [GO] 2021―Nov―10 SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS Weiling Li, Jialu Qiao, Qiang You, Shan Zong, Qian Peng, Yuchen Liu, et al. (+5)
839 [GO] 2021―Nov―10 High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders Dalila Mele, Anna Calastri, Eugenia Maiorano, Antonella Cerino, Michele Sachs, Barbara Oliviero, et al. (+8)
840 [GO] 2021―Nov―10 Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals Charly Gilbert, Caroline Lefeuvre, Laurence Preisser, Adeline Pivert, Raffaella Soleti, Simon Blanchard, et al. (+4)
841 [GO] 2021―Nov―09 A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels Denis A. Kleymenov, Evgeniia N. Bykonia, Liubov I. Popova, Elena P. Mazunina, Vladimir A. Gushchin, Liudmila V. Kolobukhina, et al. (+11)
842 [GO] 2021―Nov―09 Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine Felipe Melo-González, Jorge A. Soto, Liliana A. González, Jorge Fernández, Luisa F. Duarte, Bárbara M. Schultz, et al. (+25)
843 [GO] 2021―Nov―08 SARS-CoV-2 and HIV-1: Should HIV-1-Infected Individuals in Sub-Saharan Africa Be Considered a Priority Group for the COVID-19 Vaccines? Wilson Lewis Mandala, Michael K. P. Liu
844 [GO] 2021―Nov―05 The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies Camila Hartmann, Anna Flavia Ribeiro dos Santos Miggiolaro, Jarbas da Silva Motta, Lucas Baena Carstens, Caroline Busatta Vaz De Paula, Sarah Fagundes Grobe, et al. (+6)
845 [GO] 2021―Nov―05 SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems Anne G. Savitt, Samantha Manimala, Tiara White, Marina Fandaros, Wei Yin, Huiquan Duan, et al. (+6)
846 [GO] 2021―Nov―05 Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape Fuxing Lou, Maochen Li, Zehan Pang, Lin Jiang, Lin Guan, Lili Tian, et al. (+3)
847 [GO] 2021―Nov―03 COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge Anna Furlan, Gabriella Forner, Ludovica Cipriani, Elisa Vian, Roberto Rigoli, Filippo Gherlinzoni, Piergiorgio Scotton
848 [GO] 2021―Nov―03 COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads Yarden Golan, Mary Prahl, Arianna G. Cassidy, Caryl Gay, Alan H. B. Wu, Unurzul Jigmeddagva, et al. (+12)
849 [GO] 2021―Nov―03 Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection Gabriel Siracusano, Chiara Brombin, Claudia Pastori, Federica Cugnata, Maddalena Noviello, Elena Tassi, et al. (+13)
850 [GO] 2021―Nov―03 Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections Liyana Ahmad
851 [GO] 2021―Nov―02 SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation Ida Jarlhelt, Sif Kaas Nielsen, Camilla Xenia Holtermann Jahn, Cecilie Bo Hansen, Laura Pérez-Alós, Anne Rosbjerg, et al. (+3)
852 [GO] 2021―Nov―02 Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses Emelie Marklund, Susannah Leach, Kristina Nyström, Anna Lundgren, Jan-Åke Liljeqvist, Staffan Nilsson, et al. (+4)
853 [GO] 2021―Nov―01 Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia Nina Nurarifah, Herwindo Pudjo Brahmantyo, Shinta Oktya Wardhani, Djoko Heri Hermanto, Putu Moda Arsana
854 [GO] 2021―Nov―01 COVID-19 Mechanisms in the Human Body-What We Know So Far Ashutosh Kumar, Ravi K. Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, et al. (+10)
855 [GO] 2021―Nov―01 Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains Clemens Grimm, Steffen Dickel, Julian Grundmann, Didier Payen, Julie Schanz, Andreas Erich Zautner, et al. (+3)
856 [GO] 2021―Oct―29 The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications Ming Zheng
857 [GO] 2021―Oct―29 Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections Georg von Massow, Steve Oh, Alan Lam, Kenth Gustafsson
858 [GO] 2021―Oct―29 The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes Guoxing Tang, Min Huang, Ying Luo, Wei Liu, Qun Lin, Liyan Mao, et al. (+5)
859 [GO] 2021―Oct―28 Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19 Jafar Sarif, Deblina Raychaudhuri, Ranit D’Rozario, Purbita Bandopadhyay, Praveen Singh, Priyanka Mehta, et al. (+20)
860 [GO] 2021―Oct―28 Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model Judy D. Day, Soojin Park, Benjamin L. Ranard, Harinder Singh, Carson C. Chow, Yoram Vodovotz
861 [GO] 2021―Oct―28 Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study Panteleimon Charitos, Ingmar A. F. M. Heijnen, Adrian Egli, Stefano Bassetti, Marten Trendelenburg, Michael Osthoff
862 [GO] 2021―Oct―28 Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections Katina D. Hulme, Ellesandra C. Noye, Kirsty R. Short, Larisa I. Labzin
863 [GO] 2021―Oct―27 Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19 Sanqi An, Yueqi Li, Yao Lin, Jiemei Chu, Jinming Su, Qiuli Chen, et al. (+7)
864 [GO] 2021―Oct―26 Case Report: The Carotid Body in COVID-19: Histopathological and Virological Analyses of an Autopsy Case Series Andrea Porzionato, Aron Emmi, Martina Contran, Elena Stocco, Silvia Riccetti, Alessandro Sinigaglia, et al. (+3)
865 [GO] 2021―Oct―26 Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency Sabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, Angelo Iacobino, Raffaela Teloni, Maria Laura De Angelis, et al. (+22)
866 [GO] 2021―Oct―25 The Omic Insights on Unfolding Saga of COVID-19 Arvinpreet Kaur, Mehak Chopra, Mahak Bhushan, Sonal Gupta, Hima Kumari P, Narmadhaa Sivagurunathan, et al. (+20)
867 [GO] 2021―Oct―22 Cardiac Fibrosis Is a Risk Factor for Severe COVID-19 Julian Mustroph, Julian Hupf, Maria J. Baier, Katja Evert, Christoph Brochhausen, Katharina Broeker, et al. (+6)
868 [GO] 2021―Oct―22 Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis Amirali Karimi, Parnian Shobeiri, Arutha Kulasinghe, Nima Rezaei
869 [GO] 2021―Oct―21 Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements Paulina García-González, Fabián Tempio, Camila Fuentes, Consuelo Merino, Leonardo Vargas, Valeska Simon, et al. (+18)
870 [GO] 2021―Oct―21 Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route Koen van de Ven, Harry van Dijken, Lisa Wijsman, Angéla Gomersbach, Tanja Schouten, Jolanda Kool, et al. (+5)
871 [GO] 2021―Oct―20 Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19 Collins N. Khwatenge, Marquette Pate, Laura C. Miller, Yongming Sang
872 [GO] 2021―Oct―20 Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19 Zachary M. Holliday, Alexander P. Earhart, Mohammed M. Alnijoumi, Armin Krvavac, Lee-Ann H. Allen, Adam G. Schrum
873 [GO] 2021―Oct―20 Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress Omar Graciano-Machuca, Geannyne Villegas-Rivera, Iván López-Pérez, José Macías-Barragán, Sonia Sifuentes-Franco
874 [GO] 2021―Oct―17 When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak Yassine Taoufik, Marie-Ghislaine de Goër de Herve, Stéphanie Corgnac, Antoine Durrbach, Fathia Mami-Chouaib
875 [GO] 2021―Oct―16 Diphtheria And Tetanus Vaccination History Is Associated With Lower Odds of COVID-19 Hospitalization Jennifer Monereo-Sánchez, Jurjen J. Luykx, Justo Pinzón-Espinosa, Geneviève Richard, Ehsan Motazedi, Lars T. Westlye, et al. (+2)
876 [GO] 2021―Oct―14 Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential Ikram Hussain, Gabriel Liu Yuan Cher, Muhammad Abbas Abid, Muhammad Bilal Abid
877 [GO] 2021―Oct―13 Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape Kavitha Mukund, Priya Nayak, Chethan Ashokkumar, Sohail Rao, Jose Almeda, Monica M. Betancourt-Garcia, et al. (+2)
878 [GO] 2021―Oct―13 Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients Michael Z. Zulu, Suhas Sureshchandra, Amanda N. Pinski, Brianna Doratt, Weining Shen, Ilhem Messaoudi
879 [GO] 2021―Oct―13 Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can Álvaro Tamayo-Velasco, María Jesús Peñarrubia Ponce, Francisco Javier Álvarez, Hugo Gonzalo-Benito, Ignacio de la Fuente, Sonia Pérez-González, et al. (+16)
880 [GO] 2021―Oct―13 Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis Nadim Sharif, Khalid J. Alzahrani, Shamsun Nahar Ahmed, Shuvra Kanti Dey
881 [GO] 2021―Oct―13 The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines Renee W. Y. Chan, Shaojun Liu, Jonathan Y. Cheung, Joseph G. S. Tsun, Kate C. Chan, Kathy Y. Y. Chan, et al. (+3)
882 [GO] 2021―Oct―13 Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure Melanie R. Neeland, Samantha Bannister, Vanessa Clifford, Jill Nguyen, Kate Dohle, Isabella Overmars, et al. (+18)
883 [GO] 2021―Oct―12 The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients Huzeyfe Kulu, Mustafa Atasoy, Kemal Özyurt, Marcus Maurer, Atıl Avcı, Muhammet Reşat Akkuş, Ragıp Ertaş
884 [GO] 2021―Oct―10 COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks Mankgopo Magdeline Kgatle, Ismaheel Opeyemi Lawal, Gabriel Mashabela, Tebatso Moshoeu Gillian Boshomane, Palesa Caroline Koatale, Phetole Walter Mahasha, et al. (+7)
885 [GO] 2021―Oct―10 Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2 Xunyan Ye, Laura S. Angelo, Erin G. Nicholson, Obinna P. Iwuchukwu, Wanderson Cabral de Rezende, Anubama Rajan, et al. (+16)
886 [GO] 2021―Oct―10 Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children Constanze Heinzel, Yudi T. Pinilla, Käthe Elsner, Evelyn Friessinger, Benjamin Mordmüller, Peter G. Kremsner, et al. (+3)
887 [GO] 2021―Oct―10 Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief Tor Kristian Andersen, Johanna Bodin, Fredrik Oftung, Bjarne Bogen, Siri Mjaaland, Gunnveig Grødeland
888 [GO] 2021―Oct―09 Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants Rafael Bayarri-Olmos, Ida Jarlhelt, Laust Bruun Johnsen, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, et al. (+8)
889 [GO] 2021―Oct―07 A Systematic Review and Meta-Analysis of Inpatient Mortality Associated With Nosocomial and Community COVID-19 Exposes the Vulnerability of Immunosuppressed Adults Mark J. Ponsford, Tom J. C. Ward, Simon M. Stoneham, Clare M. Dallimore, Davina Sham, Khalid Osman, et al. (+4)
890 [GO] 2021―Oct―07 Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys Celeste Coleman, Lara A. Doyle-Meyers, Kasi E. Russell-Lodrigue, Nadia Golden, Breanna Threeton, Kejing Song, et al. (+7)
891 [GO] 2021―Oct―04 Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days Sergio Gil-Manso, Diego Carbonell, Luis López-Fernández, Iria Miguens, Roberto Alonso, Ismael Buño, et al. (+4)
892 [GO] 2021―Oct―04 COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases Silvana Valdebenito, Simon Bessis, Djillali Annane, Geoffroy Lorin de la Grandmaison, Elisabeth Cramer-Bordé, Brendan Prideaux, et al. (+2)
893 [GO] 2021―Oct―04 Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, et al. (+12)
894 [GO] 2021―Oct―04 Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies Donato Amodio, Alessandra Ruggiero, Mayla Sgrulletti, Chiara Pighi, Nicola Cotugno, Chiara Medri, et al. (+20)
895 [GO] 2021―Oct―04 Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target Konstantinos Ntatsoulis, Theodoros Karampitsakos, Eliza Tsitoura, Elli-Anna Stylianaki, Alexios N. Matralis, Argyrios Tzouvelekis, et al. (+2)
896 [GO] 2021―Oct―04 Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions Mai M. Abdelmoaty, Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, Vikas Kumar, et al. (+7)
897 [GO] 2021―Oct―01 Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics Sriram Kumar, Duygu Merve Çalışkan, Josua Janowski, Aileen Faist, Beate Claudine Gisela Conrad, Julius Lange, et al. (+2)
898 [GO] 2021―Oct―01 Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS Zhiheng Xu, Yongbo Huang, Jianmeng Zhou, Xiumei Deng, Weiqun He, Xiaoqing Liu, et al. (+3)
899 [GO] 2021―Oct―01 Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines Andrea Picchianti Diamanti, Maria Manuela Rosado, Emanuele Nicastri, Giorgio Sesti, Claudio Pioli, Bruno Laganà
900 [GO] 2021―Oct―01 Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2 Roshan Kumar Roy, Uttam Sharma, Mishi Kaushal Wasson, Aklank Jain, Md. Imtaiyaz Hassan, Hridayesh Prakash
901 [GO] 2021―Sep―30 Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination Samy Hakroush, Björn Tampe
902 [GO] 2021―Sep―30 Identifying Risk Factors for Secondary Infection Post-SARS-CoV-2 Infection in Patients With Severe and Critical COVID-19 Mingquan Guo, Menglu Gao, Jing Gao, Tengfei Zhang, Xin Jin, Jian Fan, et al. (+4)
903 [GO] 2021―Sep―30 Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword Li Yin Tan, Thamil Vaani Komarasamy, Vinod RMT Balasubramaniam
904 [GO] 2021―Sep―30 Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report Martin Kongsbak-Wismann, Fatima A. H. Al-Jaberi, Jonas Damgård Schmidt, Mustafa Ghanizada, Cecilie Bo Hansen, Daniel Villalba Lopez, et al. (+7)
905 [GO] 2021―Sep―30 Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults Maria Raffaella Petrara, Francesco Bonfante, Paola Costenaro, Anna Cantarutti, Francesco Carmona, Elena Ruffoni, et al. (+13)
906 [GO] 2021―Sep―29 Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions Izabela Siemińska, Kazimierz Węglarczyk, Marcin Surmiak, Dorota Kurowska-Baran, Marek Sanak, Maciej Siedlar, Jarek Baran
907 [GO] 2021―Sep―29 COVID-19 Among Patients With Inflammatory Rheumatic Diseases Sinem Nihal Esatoglu, Koray Tascilar, Hakan Babaoğlu, Cemal Bes, Berna Yurttas, Servet Akar, et al. (+17)
908 [GO] 2021―Sep―29 BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents Bernd Jahrsdörfer, Dorit Fabricius, Judith Scholz, Carolin Ludwig, Aline Grempels, Ramin Lotfi, et al. (+3)
909 [GO] 2021―Sep―29 Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, et al. (+23)
910 [GO] 2021―Sep―28 MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals Erick C. Castelli, Mateus V. de Castro, Michel S. Naslavsky, Marilia O. Scliar, Nayane S. B. Silva, Heloisa S. Andrade, et al. (+23)
911 [GO] 2021―Sep―28 Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine Annalisa Ciabattini, Gabiria Pastore, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Elena Pettini, et al. (+8)
912 [GO] 2021―Sep―27 Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis Adriana Albini, Luana Calabrone, Valentina Carlini, Nadia Benedetto, Michele Lombardo, Antonino Bruno, Douglas M. Noonan
913 [GO] 2021―Sep―27 SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans David Forgacs, Hyesun Jang, Rodrigo B. Abreu, Hannah B. Hanley, Jasper L. Gattiker, Alexandria M. Jefferson, Ted M. Ross
914 [GO] 2021―Sep―27 Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants Lok Bahadur Shrestha, Nicodemus Tedla, Rowena A. Bull
915 [GO] 2021―Sep―27 Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, Roberta Reniè, Rachele Bigi, Giulia Pellicciari, et al. (+6)
916 [GO] 2021―Sep―25 Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol Roos S. G. Sablerolles, Abraham Goorhuis, Corine H. GeurtsvanKessel, Rory D. de Vries, Anke L. W. Huckriede, Marion P. G. Koopmans, et al. (+8)
917 [GO] 2021―Sep―25 Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach Veerbhan Kesarwani, Rupal Gupta, Ramesh Raju Vetukuri, Sandeep Kumar Kushwaha, Sonu Gandhi
918 [GO] 2021―Sep―25 α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants Jintao Zou, Haiming Jing, Xiaoli Zhang, Yiheng Liu, Zhuo Zhao, Lianli Duan, et al. (+9)
919 [GO] 2021―Sep―23 Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study Haifeng Hou, Huan Yang, Pengcheng Liu, Changwu Huang, Meng Wang, Yuejin Li, et al. (+8)
920 [GO] 2021―Sep―23 Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Carlos A. Labarrere, Ghassan S. Kassab
921 [GO] 2021―Sep―23 A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants Niklas Vesper, Yaneth Ortiz, Frauke Bartels-Burgahn, Jianying Yang, Kathrin de la Rosa, Matthias Tenbusch, et al. (+6)
922 [GO] 2021―Sep―23 Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody Shuai Yue, Zhirong Li, Yao Lin, Yang Yang, Mengqi Yuan, Zhiwei Pan, et al. (+16)
923 [GO] 2021―Sep―22 Will Auranofin Become a Golden New Treatment Against COVID-19? Karine Sonzogni-Desautels, Momar Ndao
924 [GO] 2021―Sep―22 Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report Karen R. Sherwood, David D. M. Nicholl, Franz Fenninger, Vivian Wu, Paaksum Wong, Vince Benedicto, et al. (+13)
925 [GO] 2021―Sep―22 Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine Jinyoung Yang, Jae-Hoon Ko, Jin Yang Baek, Jinyeong Hong, Soyoung Ha, Beomki Lee, et al. (+7)
926 [GO] 2021―Sep―21 Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective Madhusudhanan Narasimhan, Lenin Mahimainathan, Jungsik Noh, Alagarraju Muthukumar
927 [GO] 2021―Sep―21 Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen Min Jiang, Gaiping Zhang, Hongliang Liu, Peiyang Ding, Yunchao Liu, Yuanyuan Tian, et al. (+2)
928 [GO] 2021―Sep―20 Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU Lorena Vigón, Javier García-Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, María Castillo de la Osa, et al. (+10)
929 [GO] 2021―Sep―20 LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications Behazine Combadière, Lucille Adam, Noëlline Guillou, Paul Quentric, Pierre Rosenbaum, Karim Dorgham, et al. (+12)
930 [GO] 2021―Sep―20 SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril) Tlili Barhoumi, Bandar Alghanem, Hayat Shaibah, Fatmah A. Mansour, Hassan S. Alamri, Maaged A. Akiel, et al. (+2)
931 [GO] 2021―Sep―17 Nutritional Immunity, Zinc Sufficiency, and COVID-19 Mortality in Socially Similar European Populations Samer Singh, Amita Diwaker, Brijesh P. Singh, Rakesh K. Singh
932 [GO] 2021―Sep―17 Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia Anas A. Khan, Ahmed A. Alahmari, Yasir Almuzaini, Fahad Alamri, Yousef Mohammad Alsofayan, Alhanouf Aburas, et al. (+6)
933 [GO] 2021―Sep―17 Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals Liina Tserel, Piia Jõgi, Paul Naaber, Julia Maslovskaja, Annika Häling, Ahto Salumets, et al. (+10)
934 [GO] 2021―Sep―17 IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant Yonas Bekele, Yongjun Sui, Jay A. Berzofsky
935 [GO] 2021―Sep―16 On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers Aarón Vázquez-Jiménez, Ugo Enrique Avila-Ponce De León, Meztli Matadamas-Guzman, Erick Andrés Muciño-Olmos, Yoscelina E. Martínez-López, Thelma Escobedo-Tapia, Osbaldo Resendis-Antonio
936 [GO] 2021―Sep―16 Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge Elizabeth Gabitzsch, Jeffrey T. Safrit, Mohit Verma, Adrian Rice, Peter Sieling, Lise Zakin, et al. (+19)
937 [GO] 2021―Sep―16 Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection Dawei Cui, Yuan Tang, Qi Jiang, Daixi Jiang, Yun Zhang, Yan Lv, et al. (+5)
938 [GO] 2021―Sep―16 A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine Sonia Jangra, Jeffrey J. Landers, Raveen Rathnasinghe, Jessica J. O’Konek, Katarzyna W. Janczak, Marilia Cascalho, et al. (+5)
939 [GO] 2021―Sep―15 The Effects of COVID-19 on the Placenta During Pregnancy Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, Mark C. Allenby, Sajad Razavi Bazaz, Majid E. Warkiani, et al. (+3)
940 [GO] 2021―Sep―14 Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion Oliver F. Wirz, Katharina Röltgen, Bryan A. Stevens, Suchitra Pandey, Malaya K. Sahoo, Lorna Tolentino, et al. (+12)
941 [GO] 2021―Sep―14 ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients Andrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, Chiara Agrati, Concetta Castilletti, Silvia Meschi, et al. (+22)
942 [GO] 2021―Sep―10 Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality Federica Defendi, Corentin Leroy, Olivier Epaulard, Giovanna Clavarino, Antoine Vilotitch, Marion Le Marechal, et al. (+10)
943 [GO] 2021―Sep―09 Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19 Juan Du, Lirong Wei, Guoli Li, Mingxi Hua, Yao Sun, Di Wang, et al. (+8)
944 [GO] 2021―Sep―08 Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19 Alexandra L. Morrison, Sally Sharpe, Andrew D. White, Mark Bodman-Smith
945 [GO] 2021―Sep―08 Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report Liru Qiu, Ji Zhang, Yafei Huang, Gen Chen, Zhishui Chen, Changsheng Ming, et al. (+2)
946 [GO] 2021―Sep―08 Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes Jiram Torres-Ruiz, Alfredo Pérez-Fragoso, José Luis Maravillas-Montero, Luis Llorente, Nancy R. Mejía-Domínguez, José Carlos Páez-Franco, et al. (+11)
947 [GO] 2021―Sep―08 Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology Margarita Villar, José Miguel Urra, Francisco J. Rodríguez-del-Río, Sara Artigas-Jerónimo, Natalia Jiménez-Collados, Elisa Ferreras-Colino, et al. (+5)
948 [GO] 2021―Sep―08 Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm Carolina Boni, Davide Cavazzini, Angelo Bolchi, Marzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al. (+4)
949 [GO] 2021―Sep―07 Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers Evgeny Knyazev, Stepan Nersisyan, Alexander Tonevitsky
950 [GO] 2021―Sep―07 From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling Filippo Castiglione, Debashrito Deb, Anurag P. Srivastava, Pietro Liò, Arcangelo Liso
951 [GO] 2021―Sep―06 The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients Fang Liu, Hong Liu, Wen-Yan Yu, Zhan Liu, Xia Zhang, Yi Wang, et al. (+4)
952 [GO] 2021―Sep―06 SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic Johanna Sjöwall, Mohammad Azharuddin, Martina Frodlund, Yuming Zhang, Laura Sandner, Charlotte Dahle, et al. (+2)
953 [GO] 2021―Sep―06 Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections Byoung-Jun Kim, Hyein Jeong, Hyejun Seo, Mi-Hyun Lee, Hyun Mu Shin, Bum-Joon Kim
954 [GO] 2021―Sep―04 Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study Olga Krysko, Elena Kondakova, Olga Vershinina, Elena Galova, Anna Blagonravova, Ekaterina Gorshkova, et al. (+4)
955 [GO] 2021―Sep―04 Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort Maria J. Pons, Barbara Ymaña, Ana Mayanga-Herrera, Yolanda Sáenz, Lydia Alvarez-Erviti, Salyoc Tapia-Rojas, et al. (+4)
956 [GO] 2021―Sep―04 The Binary Model of Chronic Diseases Applied to COVID-19 Zeev Elkoshi
957 [GO] 2021―Sep―04 Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 Jiajia Xie, Chengchao Ding, Jun He, Yuqing Zhang, Shuangshuang Ni, Xiangyu Zhang, et al. (+9)
958 [GO] 2021―Sep―04 Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study Jamil A. Al-Mughales, Tareq J. Al-Mughales, Omar I. Saadah
959 [GO] 2021―Sep―04 Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era Keda Yang, Guangfu Wen, Jinpeng Wang, Siming Zhou, Wacili Da, Yan Meng, et al. (+2)
960 [GO] 2021―Sep―04 Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals Joseph G. Casian, Aaron N. Angel, Ronell Lopez, Cedie Bagos, Melanie A. MacMullan, Mindy L. Bui, et al. (+5)
961 [GO] 2021―Sep―04 The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity Sonia Tejedor Vaquero, Leire de Campos-Mata, José María Ramada, Pilar Díaz, Juan Navarro-Barriuso, Clara Ribas-Llaurado, et al. (+5)
962 [GO] 2021―Aug―31 COVID-19 Immunobiology: Lessons Learned, New Questions Arise Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. Gorgoulis, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas
963 [GO] 2021―Aug―24 Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19 Yang Liu, Yankang Wu, Bing Liu, Youpeng Zhang, Dan San, Yu Chen, et al. (+8)
964 [GO] 2021―Aug―24 The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis Miao Zou, Xiaoyun Su, Luoying Wang, Xingcheng Yi, Yue Qiu, Xirui Yin, et al. (+4)
965 [GO] 2021―Aug―24 SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients Elise M. N. Ferré, Monica M. Schmitt, Sebastian Ochoa, Lindsey B. Rosen, Elana R. Shaw, Peter D. Burbelo, et al. (+8)
966 [GO] 2021―Aug―23 Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report Mafalda De Rienzo, Maria Laura Foddai, Laura Conti, Chiara Mandoj, Stefano Iaboni, Ilenia Saladini, et al. (+10)
967 [GO] 2021―Aug―23 Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach Patil Pranita Uttamrao, Chakkarai Sathyaseelan, L. Ponoop Prasad Patro, Thenmalarchelvi Rathinavelan
968 [GO] 2021―Aug―20 Cytokine Signature Associated With Disease Severity in COVID-19 Jing Guo, Shuting Wang, He Xia, Ding Shi, Yu Chen, Shufa Zheng, et al. (+17)
969 [GO] 2021―Aug―19 Serological Testing for COVID-19, Immunological Surveillance, and Exploration of Protective Antibodies Luis A. Peroni, Jessica M. Toscaro, Camila Canateli, Celisa C. C. Tonoli, Renata R. de Olivera, Celso E. Benedetti, et al. (+12)
970 [GO] 2021―Aug―19 Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients Yaolin Guo, Tianyi Li, Xinyi Xia, Bin Su, Hanping Li, Yingmei Feng, et al. (+7)
971 [GO] 2021―Aug―19 Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients Baolin Liao, Zhao Chen, Peiyan Zheng, Linghua Li, Jianfen Zhuo, Fang Li, et al. (+18)
972 [GO] 2021―Aug―19 Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities Chang-Feng Chu, Florian Sabath, Silvia Fibi-Smetana, Shan Sun, Rupert Öllinger, Elfriede Noeßner, et al. (+7)
973 [GO] 2021―Aug―18 Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19 Ellinor I. Peerschke, Alisa Valentino, Rachel J. So, Scott Shulman,   Ravinder
974 [GO] 2021―Aug―18 Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women Suriya Rehman, Vijaya Ravinayagam, Insha Nahvi, Hanan Aldossary, Maha Al-Shammari, Mai Saad Al Amiri, et al. (+2)
975 [GO] 2021―Aug―17 Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies Chengchao Ding, Jun He, Xiangyu Zhang, Chengcheng Jiang, Yong Sun, Yuqing Zhang, et al. (+6)
976 [GO] 2021―Aug―16 Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity Jun Wu, Bo-Yun Liang, Yao-Hui Fang, Hua Wang, Xiao-Li Yang, Shu Shen, et al. (+12)
977 [GO] 2021―Aug―13 Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain Linda Francistiová, Adrián Klepe, Géza Curley, Károly Gulya, András Dinnyés, Kata Filkor
978 [GO] 2021―Aug―12 Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study Thais G. Moreira, Kimble T. F. Matos, Giovana S. De Paula, Thais M. M. Santana, Raquel G. Da Mata, Fernando C. Pansera, et al. (+12)
979 [GO] 2021―Aug―12 DAMPening COVID-19 Severity by Attenuating Danger Signals Luis A. Silva-Lagos, Janesh Pillay, Matijs van Meurs, Alexandra Smink, Peter H. J. van der Voort, Paul de Vos
980 [GO] 2021―Aug―10 Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections Ying-yi Luan, Cheng-hong Yin, Yong-ming Yao
981 [GO] 2021―Aug―10 COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial Chiara Agrati, Serena Di Cosimo, Daniela Fenoglio, Giovanni Apolone, Fabio Ciceri, Gennaro Ciliberto, et al. (+12)
982 [GO] 2021―Aug―10 SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage Mohsen Karami Fath, Abolfazl Jahangiri, Mahmoud Ganji, Fatemeh Sefid, Zahra Payandeh, Zahra Sadat Hashemi, et al. (+6)
983 [GO] 2021―Aug―09 The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men Gizem Kilic, Ozlem Bulut, Martin Jaeger, Rob ter Horst, Valerie A. C. M. Koeken, Simone J. C. F. M. Moorlag, et al. (+5)
984 [GO] 2021―Aug―06 Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study Shengjie Li, Yichao Qiu, Li Tang, Zhujian Wang, Wenjun Cao, Xingtao Zhou, Xinghuai Sun
985 [GO] 2021―Aug―05 Corrigendum: Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children Ming-Ren Chen, Ho-Chang Kuo, Yann-Jinn Lee, Hsin Chi, Sung Chou Li, Hung-Chang Lee, Kuender D. Yang
986 [GO] 2021―Aug―05 BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Ashleigh L. Fell, Rachel M. Y. Cheong, Wey Y. Wong, et al. (+3)
987 [GO] 2021―Aug―04 Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19 Philipp Jörrißen, Paula Schütz, Matthias Weiand, Richard Vollenberg, Inga Marie Schrempf, Kevin Ochs, et al. (+4)
988 [GO] 2021―Aug―02 Long Noncoding RNAs as Emerging Regulators of COVID-19 Qinzhi Yang, Fang Lin, Yanan Wang, Min Zeng, Mao Luo
989 [GO] 2021―Aug―02 Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase Jens Ringel, Anja Ramlow, Christopher Bock, Ahmed Sheriff
990 [GO] 2021―Aug―02 Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study Jiao Liu, Yanfei Shen, Zhenliang Wen, Qianghong Xu, Zhixiong Wu, Huibin Feng, et al. (+15)
991 [GO] 2021―Jul―30 Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19 Jijing Shi, Jianglin Zhou, Xiaochang Zhang, Wei Hu, Jin-Fang Zhao, Shengqi Wang, et al. (+2)
992 [GO] 2021―Jul―29 Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients Jiaqi Zhang, Dongzi Lin, Kui Li, Xiangming Ding, Lin Li, Yuntao Liu, et al. (+11)
993 [GO] 2021―Jul―29 Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients Xiaolu Li, Deqing Yin, Yanyan Yang, Chunhua Bi, Zhibin Wang, Guangren Ma, et al. (+4)
994 [GO] 2021―Jul―29 Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity Antonella Scaglione, Silvana Opp, Alicia Hurtado, Ziyan Lin, Christine Pampeno, Maria G. Noval, et al. (+3)
995 [GO] 2021―Jul―28 Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses Wenjiang Zheng, Hui Wu, Chengxin Liu, Qian Yan, Ting Wang, Peng Wu, et al. (+3)
996 [GO] 2021―Jul―28 Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments Sangiliyandi Gurunathan, Min Hee Kang, Jin-Hoi Kim
997 [GO] 2021―Jul―28 Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma Xiaoli Zhou, Ya-Na Zhou, Ashaq Ali, Cuiqin Liang, Zhiqin Ye, Xiaomin Chen, et al. (+13)
998 [GO] 2021―Jul―28 Swine Dendritic Cell Response to Porcine Reproductive and Respiratory Syndrome Virus: An Update Jesús Hernández, Yanli Li, Enric Mateu
999 [GO] 2021―Jul―27 Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography Jiong Wang, Dongmei Li, Qian Zhou, Alexander Wiltse, Martin S. Zand
1000 [GO] 2021―Jul―27 SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects Orianne Constant, Jonathan Barthelemy, Karine Bolloré, Edouard Tuaillon, Fabien Gosselet, Christine Chable-Bessia, et al. (+5)
1001 [GO] 2021―Jul―26 Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity Johannes Schetelig, Falk Heidenreich, Henning Baldauf, Sarah Trost, Bose Falk, Christian Hoßbach, et al. (+16)
1002 [GO] 2021―Jul―26 Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies Qiaozhen Ye, Shan Lu, Kevin D. Corbett
1003 [GO] 2021―Jul―26 Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study Laura Sánchez García, Natalia Gómez-Torres, Fernando Cabañas, Raquel González-Sánchez, Manuela López-Azorín, M. Teresa Moral-Pumarega, et al. (+6)
1004 [GO] 2021―Jul―26 The Ability of Porcine Reproductive and Respiratory Syndrome Virus Isolates to Induce Broadly Reactive Neutralizing Antibodies Correlates With In Vivo Protection Francisco Javier Martínez-Lobo, Francisco Díez-Fuertes, Isabel Simarro, José M. Castro, Cinta Prieto
1005 [GO] 2021―Jul―23 Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19 Po-Ku Chen, Joung-Liang Lan, Po-Hao Huang, Jye-Lin Hsu, Ching-Kun Chang, Ni Tien, et al. (+2)
1006 [GO] 2021―Jul―23 Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19 Xavier Solanich, Gardenia Vargas-Parra, Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Arnau Antolí, et al. (+13)
1007 [GO] 2021―Jul―23 CAR Macrophages for SARS-CoV-2 Immunotherapy Wenyan Fu, Changhai Lei, Zetong Ma, Kewen Qian, Tian Li, Jian Zhao, Shi Hu
1008 [GO] 2021―Jul―23 CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro Minh Tuyet Ma, Saiaditya Badeti, Chih-Hsiung Chen, James Kim, Alok Choudhary, Bill Honnen, et al. (+10)
1009 [GO] 2021―Jul―21 Monocytes and Macrophages in COVID-19 Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
1010 [GO] 2021―Jul―20 Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study Danrong Shi, Tianhao Weng, Jie Wu, Chunyan Dai, Rui Luo, Keda Chen, et al. (+13)
1011 [GO] 2021―Jul―19 Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level Hannah C. Copley, Loren Gragert, Andrew R. Leach, Vasilis Kosmoliaptsis
1012 [GO] 2021―Jul―16 High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals Jeremy W. Prokop, Nicholas L. Hartog, Dave Chesla, William Faber, Chanise P. Love, Rachid Karam, et al. (+24)
1013 [GO] 2021―Jul―15 Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19 Nathalie Acevedo, Jose Miguel Escamilla-Gil, Héctor Espinoza, Ronald Regino, Jonathan Ramírez, Lucila Florez de Arco, et al. (+3)
1014 [GO] 2021―Jul―15 Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients Xiangyun Teng, Jiaqi Zhang, Yaling Shi, Yuntao Liu, Yanqing Yang, Jinyong He, et al. (+9)
1015 [GO] 2021―Jul―14 Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells Matthew J. Dean, Juan B. Ochoa, Maria Dulfary Sanchez-Pino, Jovanny Zabaleta, Jone Garai, Luis Del Valle, et al. (+20)
1016 [GO] 2021―Jul―14 The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion? Zhihui Wang, Ming Zhou, Zhenfang Fu, Ling Zhao
1017 [GO] 2021―Jul―14 Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19 Alessandra Oliva, Maria Claudia Miele, Federica Di Timoteo, Massimiliano De Angelis, Vera Mauro, Raissa Aronica, et al. (+6)
1018 [GO] 2021―Jul―13 The Many Faces of JAKs and STATs Within the COVID-19 Storm Alice H. Grant, Armando Estrada, Yoshira M. Ayala-Marin, America Y. Alvidrez-Camacho, Georgialina Rodriguez, Elisa Robles-Escajeda, et al. (+3)
1019 [GO] 2021―Jul―13 Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects Eleonora Gallerani, Davide Proietto, Beatrice Dallan, Marco Campagnaro, Salvatore Pacifico, Valentina Albanese, et al. (+6)
1020 [GO] 2021―Jul―12 Erratum: Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
1021 [GO] 2021―Jul―12 Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Franziska Sotzny, Sandra Bauer, Christian Drosten, et al. (+3)
1022 [GO] 2021―Jul―12 Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine Jules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, Maxime Meylan, Nadine Ben Hamouda, Amos Kirilovsky, et al. (+12)
1023 [GO] 2021―Jul―12 SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants Daniel Martínez-Flores, Jesús Zepeda-Cervantes, Adolfo Cruz-Reséndiz, Sergio Aguirre-Sampieri, Alicia Sampieri, Luis Vaca
1024 [GO] 2021―Jul―12 A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients Florian Bieberich, Rodrigo Vazquez-Lombardi, Alexander Yermanos, Roy A. Ehling, Derek M. Mason, Bastian Wagner, et al. (+6)
1025 [GO] 2021―Jul―09 Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19 Lei Shi, Rong Ding, Tingting Zhang, Wei Wu, Ziyu Wang, Xiuzhi Jia, et al. (+17)
1026 [GO] 2021―Jul―08 Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era Dan Lv, Jing Peng, Rui Long, Xingguang Lin, Renjie Wang, Di Wu, et al. (+4)
1027 [GO] 2021―Jul―08 The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence Mengyuan Zhang, Xiaoyin Bai, Wei Cao, Junyi Ji, Luo Wang, Yang Yang, Hong Yang
1028 [GO] 2021―Jul―08 Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis Lakhveer Singh, Sakshi Bajaj, Manoj Gadewar, Nitin Verma, Mohd Nazam Ansari, Abdulaziz S. Saeedan, et al. (+2)
1029 [GO] 2021―Jul―08 The Spike of SARS-CoV-2: Uniqueness and Applications Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flavia Figueira Aburjaile, Athira Ch, et al. (+7)
1030 [GO] 2021―Jul―07 From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee
1031 [GO] 2021―Jul―07 SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido, Maria Montoya
1032 [GO] 2021―Jul―07 Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1 Jing Yang, Edith A. Perez, Changchun Hou, Pin Zhang, Michelle Van Scoyk, Robert A. Winn, et al. (+2)
1033 [GO] 2021―Jul―07 ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait (‘CoV-MAC-TED’) for Combating SARS-CoV-2-Induced Cell Reprogramming José Hélio Costa, Gunasekaran Mohanapriya, Revuru Bharadwaj, Carlos Noceda, Karine Leitão Lima Thiers, Shahid Aziz, et al. (+10)
1034 [GO] 2021―Jul―05 Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins Youssif M. Ali, Matteo Ferrari, Nicholas J. Lynch, Sadam Yaseen, Thomas Dudler, Sasha Gragerov, et al. (+3)
1035 [GO] 2021―Jul―05 Hypopharyngeal Ulcers in COVID-19: Histopathological and Virological Analyses - A Case Report Andrea Porzionato, Elena Stocco, Aron Emmi, Martina Contran, Veronica Macchi, Silvia Riccetti, et al. (+3)
1036 [GO] 2021―Jul―05 Commentary: Why Haven’t We Found an Effective Treatment for COVID-19? Josef Brzoska, Harald von Eick, Manfred Hündgen
1037 [GO] 2021―Jul―01 AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19 Anastasia Meshcheryakova, Peter Pietschmann, Philip Zimmermann, Igor B. Rogozin, Diana Mechtcheriakova
1038 [GO] 2021―Jul―01 Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient Changchun Lai, Xinglong Liu, Qihong Yan, Hualiang Lv, Lei Zhou, Longbo Hu, et al. (+19)
1039 [GO] 2021―Jul―01 Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, Abdullah Z. Almutairi, Ahmed A. Alrashed, Abdullah AlJuryyan, et al. (+3)
1040 [GO] 2021―Jun―30 Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19 Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, Rabih Halwani, Imad M. Tleyjeh
1041 [GO] 2021―Jun―30 Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis Eva Schrezenmeier, Leon Bergfeld, David Hillus, Joerg-Detlev Lippert, Ulrike Weber, Pinkus Tober-Lau, et al. (+13)
1042 [GO] 2021―Jun―30 Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Samrein B. M. Ahmed, Suad Hannawi, Rifat Hamoudi, Qutayba Hamid, Rabih Halwani
1043 [GO] 2021―Jun―30 Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update Uttpal Anand, Shweta Jakhmola, Omkar Indari, Hem Chandra Jha, Zhe-Sheng Chen, Vijay Tripathi, José M. Pérez de la Lastra
1044 [GO] 2021―Jun―29 Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design Daniel Ellis, Natalie Brunette, Katharine H. D. Crawford, Alexandra C. Walls, Minh N. Pham, Chengbo Chen, et al. (+21)
1045 [GO] 2021―Jun―28 Case Report: Systemic Sclerosis After Covid-19 Infection Serena Fineschi
1046 [GO] 2021―Jun―28 Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients Sarah Musa Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, Habiba Al Safar, Bassam Mahboub, Axel Künstner, et al. (+5)
1047 [GO] 2021―Jun―28 Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir Yi-Hao Chan, Barnaby E. Young, Siew-Wai Fong, Ying Ding, Yun Shan Goh, Rhonda Sin-Ling Chee, et al. (+7)
1048 [GO] 2021―Jun―28 Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning Bruce K. Patterson, Jose Guevara-Coto, Ram Yogendra, Edgar B. Francisco, Emily Long, Amruta Pise, et al. (+4)
1049 [GO] 2021―Jun―28 Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, Francesco Di Pierro
1050 [GO] 2021―Jun―28 Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection Mingxi Li, Jingao Guo, Shuaiyao Lu, Runhong Zhou, Hongyang Shi, Xuanling Shi, et al. (+25)
1051 [GO] 2021―Jun―25 Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism Ying Shao, Jason Saredy, Keman Xu, Yu Sun, Fatma Saaoud, Charles Drummer, et al. (+7)
1052 [GO] 2021―Jun―25 RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses Takahisa Kouwaki, Tasuku Nishimura, Guanming Wang, Hiroyuki Oshiumi
1053 [GO] 2021―Jun―25 Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets Shane Riddell, Sarah Goldie, Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Kim R. Blasdell, et al. (+5)
1054 [GO] 2021―Jun―24 A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm Mohd Rehan, Firoz Ahmed, Saad M. Howladar, Mohammed Y. Refai, Hanadi M. Baeissa, Torki A. Zughaibi, et al. (+2)
1055 [GO] 2021―Jun―23 Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19 Akash Gupta, Hyung J. Chun
1056 [GO] 2021―Jun―23 EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients Thomas Luft, Clemens-Martin Wendtner, Florentina Kosely, Aleksandar Radujkovic, Axel Benner, Felix Korell, et al. (+4)
1057 [GO] 2021―Jun―23 Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk Claudia Strafella, Valerio Caputo, Gisella Guerrera, Andrea Termine, Carlo Fabrizio, Raffaella Cascella, et al. (+8)
1058 [GO] 2021―Jun―23 SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages Ioanna Pantazi, Ahmed A. Al-Qahtani, Fatimah S Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, et al. (+2)
1059 [GO] 2021―Jun―23 Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype Amelia C. Trombetta, Guilherme B. Farias, André M. C. Gomes, Ana Godinho-Santos, Pedro Rosmaninho, Carolina M. Conceição, et al. (+9)
1060 [GO] 2021―Jun―21 Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Hashim Islam, Thomas C. Chamberlain, Alice L. Mui, Jonathan P. Little
1061 [GO] 2021―Jun―21 Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey Leslie Y. T. Leung, Srijit Khan, Patrick Budylowski, Zhijie Li, Sofiya Goroshko, Yanling Liu, et al. (+5)
1062 [GO] 2021―Jun―21 Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Christina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen
1063 [GO] 2021―Jun―18 Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19 Marianna Rowlands, Florencia Segal, Dominik Hartl
1064 [GO] 2021―Jun―18 COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality Radheshyam Maurya, Prince Sebastian, Madhulika Namdeo, Moodu Devender, Arieh Gertler
1065 [GO] 2021―Jun―17 Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2 Diego Fernández-Lázaro, Cesar I. Fernandez-Lazaro, Juan Mielgo-Ayuso, David P. Adams, Juan Luis García Hernández, Jerónimo González-Bernal, Marcela González-Gross
1066 [GO] 2021―Jun―17 Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy Dawit Wolday, Francis M. Ndungu, Gloria P. Gómez-Pérez, Tobias F. Rinke de Wit
1067 [GO] 2021―Jun―17 The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom Jiajing Wu, Li Zhang, Yue Zhang, Haixin Wang, Ruxia Ding, Jianhui Nie, et al. (+8)
1068 [GO] 2021―Jun―16 Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset Tiandan Xiang, Boyun Liang, Yaohui Fang, Sihong Lu, Sumeng Li, Hua Wang, et al. (+13)
1069 [GO] 2021―Jun―16 A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I Yan Liu, Qi-Zhang Liang, Wan Lu, Yong-Le Yang, Ruiai Chen, Yao-Wei Huang, Bin Wang
1070 [GO] 2021―Jun―16 The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients Emanuel Zitt, Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Beatrix Mutschlechner, Hanno Ulmer, et al. (+4)
1071 [GO] 2021―Jun―15 Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses Georgia Bullen, Jacob D. Galson, Gareth Hall, Pedro Villar, Lien Moreels, Line Ledsgaard, et al. (+29)
1072 [GO] 2021―Jun―14 Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients Eliott Lafon, Gabriel Diem, Christina Witting, Viktoria Zaderer, Rosa Maria Bellmann-Weiler, Markus Reindl, et al. (+10)
1073 [GO] 2021―Jun―14 Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients Ikram Omar Osman, Cléa Melenotte, Philippe Brouqui, Matthieu Million, Jean-Christophe Lagier, Philippe Parola, et al. (+6)
1074 [GO] 2021―Jun―14 Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States Shu-Fang Shih, Abram L. Wagner, Nina B. Masters, Lisa A. Prosser, Yihan Lu, Brian J. Zikmund-Fisher
1075 [GO] 2021―Jun―14 sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection Dhanashree Jagtap, Vikrant M. Bhor, Shilpa Bhowmick, Nandini Kasarpalkar, Pooja Sagvekar, Bhalchandra Kulkarni, et al. (+14)
1076 [GO] 2021―Jun―11 Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies Satoshi Gando, Takeshi Wada
1077 [GO] 2021―Jun―11 Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics Krzysztof Laudanski, Hajj Jihane, Brook Antalosky, Danyal Ghani, Uyen Phan, Ruth Hernandez, et al. (+4)
1078 [GO] 2021―Jun―11 How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility Magdalena Anna Massalska, Hans-Jürgen Gober
1079 [GO] 2021―Jun―11 SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology Augusta Ortolan, Mariagrazia Lorenzin, Chiara Cosma, Giacomo Cozzi, Andrea Padoan, Andrea Doria, et al. (+2)
1080 [GO] 2021―Jun―11 Targeting Future Pandemics, a Case for De Novo Purine Synthesis and Basic Research Randall C. Mazzarino
1081 [GO] 2021―Jun―10 Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI Fabian Bohländer, Dennis Riehl, Sabrina Weißmüller, Marcus Gutscher, Jörg Schüttrumpf, Stefanie Faust
1082 [GO] 2021―Jun―10 Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease Siggeir F. Brynjolfsson, Hildur Sigurgrimsdottir, Elin D. Einarsdottir, Gudrun A. Bjornsdottir, Brynja Armannsdottir, Gudrun E. Baldvinsdottir, et al. (+7)
1083 [GO] 2021―Jun―09 SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells Hua Geng, Saravanan Subramanian, Longtao Wu, Heng-Fu Bu, Xiao Wang, Chao Du, et al. (+2)
1084 [GO] 2021―Jun―09 Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients Liwen Wei, Yuqi Shang, Xi Liu, Xinghua Li, Gongqi Chen, Siping Liang, et al. (+5)
1085 [GO] 2021―Jun―09 Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, et al. (+12)
1086 [GO] 2021―Jun―09 Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection Irene Ramos, Carl Goforth, Alessandra Soares-Schanoski, Dawn L. Weir, Emily C. Samuels, Shreshta Phogat, et al. (+22)
1087 [GO] 2021―Jun―07 Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis? Sandra M. Gonzalez, Abu Bakar Siddik, Ruey-Chyi Su
1088 [GO] 2021―Jun―07 PD-L1 Dysregulation in COVID-19 Patients Francesco Sabbatino, Valeria Conti, Gianluigi Franci, Carmine Sellitto, Valentina Manzo, Pasquale Pagliano, et al. (+14)
1089 [GO] 2021―Jun―07 Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression Angelo Zinellu, Arduino A. Mangoni
1090 [GO] 2021―Jun―04 SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage Yongjun Sui, Jianping Li, David J. Venzon, Jay A. Berzofsky
1091 [GO] 2021―Jun―04 Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern Ashlesha Deshpande, Bethany D. Harris, Luis Martinez-Sobrido, James J. Kobie, Mark R. Walter
1092 [GO] 2021―Jun―03 Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients Zhenyan Wang, Jun Chen, Cuiyun Zhu, Li Liu, Tangkai Qi, Yinzhong Shen, et al. (+6)
1093 [GO] 2021―Jun―03 Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy Ann-Christin Tallarek, Christopher Urbschat, Luis Fonseca Brito, Stephanie Stanelle-Bertram, Susanne Krasemann, Giada Frascaroli, et al. (+11)
1094 [GO] 2021―Jun―02 Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients Marcela Valverde-Monge, José A. Cañas, Blanca Barroso, Diana Betancor, Laura Ortega-Martin, Alicia Gómez-López, et al. (+4)
1095 [GO] 2021―Jun―02 Immunothrombosis in Acute Respiratory Dysfunction of COVID-19 Xiang-Zhi Fang, Ya-Xin Wang, Ji-Qain Xu, Ya-Jun He, Zhe-Kang Peng, You Shang
1096 [GO] 2021―Jun―02 Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients Andrzej Lange, Janusz Lange, Emilia Jaskuła
1097 [GO] 2021―Jun―02 Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets Jon Hazeldine, Janet M. Lord
1098 [GO] 2021―Jun―02 Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells Yanli Li, Enric Mateu
1099 [GO] 2021―Jun―01 Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report Juan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Clara Palmada, Adolf Ruiz-Sanmartin, Marina García-de-Acilu, Erika Plata-Menchaca, et al. (+5)
1100 [GO] 2021―May―28 Potent and Persistent Antibody Response in COVID-19 Recovered Patients Xiaodong Tian, Ling Liu, Wenguo Jiang, He Zhang, Wenjun Liu, Jing Li
1101 [GO] 2021―May―28 Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses Yingying Cao, Xintian Xu, Simo Kitanovski, Lina Song, Jun Wang, Pei Hao, Daniel Hoffmann
1102 [GO] 2021―May―28 Prospects of Neutralizing Nanobodies Against SARS-CoV-2 Fangfang Chen, Zhihong Liu, Fan Jiang
1103 [GO] 2021―May―28 Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity Alexander A. Lehmann, Greg A. Kirchenbaum, Ting Zhang, Pedro A. Reche, Paul V. Lehmann
1104 [GO] 2021―May―26 Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity Lorena Vigón, Daniel Fuertes, Javier García-Pérez, Montserrat Torres, Sara Rodríguez-Mora, Elena Mateos, et al. (+11)
1105 [GO] 2021―May―26 Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features Patricia Zadorosnei Rebutini, Aline Cristina Zanchettin, Emanuele Therezinha Schueda Stonoga, Daniele Margarita Marani Prá, André Luiz Parmegiani de Oliveira, Felipe da Silva Dezidério, et al. (+14)
1106 [GO] 2021―May―26 Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection Marc A. Niles, Patricia Gogesch, Stefanie Kronhart, Samira Ortega Iannazzo, Georg Kochs, Zoe Waibler, Martina Anzaghe
1107 [GO] 2021―May―25 A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19 Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, Karen Donceras Nadua, Danielle E. Anderson, Amanda Jin Mei Lim, et al. (+27)
1108 [GO] 2021―May―24 Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19 Vanessa Chilunda, Pablo Martinez-Aguado, Li C. Xia, Laura Cheney, Aniella Murphy, Veronica Veksler, et al. (+3)
1109 [GO] 2021―May―24 Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, et al. (+6)
1110 [GO] 2021―May―21 COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says Gang Chen, Xiaolin Li, Meixing Sun, Yangzhong Zhou, Meifang Yin, Bin Zhao, Xuemei Li
1111 [GO] 2021―May―20 Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay Isabel Brand, Leonard Gilberg, Jan Bruger, Mercè Garí, Andreas Wieser, Tabea M. Eser, et al. (+16)
1112 [GO] 2021―May―19 Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19? Giovanni A. Rossi, Oliviero Sacco, Antonino Capizzi, Paola Mastromarino
1113 [GO] 2021―May―18 SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1 Liyan Sui, Yinghua Zhao, Wenfang Wang, Ping Wu, Zedong Wang, Yang Yu, et al. (+3)
1114 [GO] 2021―May―18 Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003 Wen-Pin Tseng, Jhong-Lin Wu, Chen-Chi Wu, Kuan-Ting Kuo, Chien-Hao Lin, Ming-Yi Chung, et al. (+7)
1115 [GO] 2021―May―14 Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients Esther J. Nossent, Alex R. Schuurman, Tom D.Y. Reijnders, Anno Saris, Ilse Jongerius, Siebe G. Blok, et al. (+8)
1116 [GO] 2021―May―14 Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles Miao-Hsi Hsieh, Nazar Beirag, Valarmathy Murugaiah, Yu-Chi Chou, Wen-Shuo Kuo, Hui-Fang Kao, et al. (+3)
1117 [GO] 2021―May―13 Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19 Hassan A. Alhazmi, Asim Najmi, Sadique A. Javed, Shahnaz Sultana, Mohammed Al Bratty, Hafiz A. Makeen, et al. (+5)
1118 [GO] 2021―May―13 The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19? Xiaofang Wang, Panpan Yi, Yuejin Liang
1119 [GO] 2021―May―13 Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019 Freimut D. Juengling, Antonio Maldonado, Frank Wuest, Thomas H. Schindler
1120 [GO] 2021―May―13 Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, et al. (+23)
1121 [GO] 2021―May―12 Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, Felipe Barreto Schuch, Ana Paula Duarte de Souza
1122 [GO] 2021―May―11 Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure Pedro Rosa-Guerrero, Antonio Trujillo-Aguilera, Juan Molina, Ana Navas, Cristina López-Martín, Aurora Jurado, et al. (+2)
1123 [GO] 2021―May―11 Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2 Pankaj Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis K. Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra Kolhe
1124 [GO] 2021―May―10 SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms Shahrzad Shoraka, Maria Lucia Brito Ferreira, Seyed Reza Mohebbi, Amir Ghaemi
1125 [GO] 2021―May―10 Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial Harri Hemilä, Anitra Carr, Elizabeth Chalker
1126 [GO] 2021―May―10 The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome Anna Kosyreva, Dzhuliia Dzhalilova, Anastasia Lokhonina, Polina Vishnyakova, Timur Fatkhudinov
1127 [GO] 2021―May―07 Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health Liam Townsend, Adam H. Dyer, Aifric Naughton, Rachel Kiersey, Dean Holden, Mary Gardiner, et al. (+12)
1128 [GO] 2021―May―07 Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression Runzhen Zhao, Zhenlei Su, Andrey A. Komissarov, Shan-Lu Liu, Guohua Yi, Steven Idell, et al. (+2)
1129 [GO] 2021―May―07 Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality Zena Wehbe, Safaa Hisham Hammoud, Hadi M. Yassine, Manal Fardoun, Ahmed F. El-Yazbi, Ali H. Eid
1130 [GO] 2021―May―06 Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling Esra’a Keewan, Shazia Beg, Saleh A. Naser
1131 [GO] 2021―May―05 Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis Ayat Zawawi, Abdallah Y. Naser, Hassan Alwafi, Faisal Minsahwi
1132 [GO] 2021―May―03 Immune Response to COVID-19 During Pregnancy Ge Chen, Qiuyue Liao, Jihui Ai, Bin Yang, Hualin Bai, Jing Chen, et al. (+4)
1133 [GO] 2021―May―03 Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients Esperanza Martín-Sánchez, Juan José Garcés, Catarina Maia, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Carmona-Torre, et al. (+21)
1134 [GO] 2021―May―03 False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases Nastya Kharlamova, Nicky Dunn, Sahl K. Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, et al. (+11)
1135 [GO] 2021―May―03 CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein Pavla Taborska, Zuzana Strizova, Dmitry Stakheev, Ludek Sojka, Jirina Bartunkova, Daniel Smrz
1136 [GO] 2021―May―03 Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure Verena Keitel, Johannes Georg Bode, Torsten Feldt, Andreas Walker, Lisa Müller, Anselm Kunstein, et al. (+21)
1137 [GO] 2021―Apr―30 Cellular Immune Response to COVID-19 and Potential Immune Modulators Xi Zhou, Qing Ye
1138 [GO] 2021―Apr―29 Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease Nicholas R. Medjeral-Thomas, Anne Troldborg, Annette G. Hansen, Jack Gisby, Candice L. Clarke, Maria Prendecki, et al. (+9)
1139 [GO] 2021―Apr―29 Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation Emanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Alessandro Tomelleri, et al. (+10)
1140 [GO] 2021―Apr―29 Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment Juliana Lott Carvalho, Amandda Evelin Silva-Carvalho, Emãnuella Melgaço Garcez, Felipe Saldanha-Araujo
1141 [GO] 2021―Apr―29 NSP2 Is Important for Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus to Trigger High Fever-Related COX-2-PGE2 Pathway in Pigs Li Du, Honglei Wang, Fang Liu, Zeyu Wei, Changjiang Weng, Jun Tang, Wen-hai Feng
1142 [GO] 2021―Apr―28 Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration Ruirong Chen, Zhien Lan, Jujian Ye, Limin Pang, Yi Liu, Wei Wu, et al. (+3)
1143 [GO] 2021―Apr―28 High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, et al. (+15)
1144 [GO] 2021―Apr―28 SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses Katja G. Schmidt, Krystelle Nganou-Makamdop, Matthias Tenbusch, Boutaina El Kenz, Clara Maier, Dennis Lapuente, et al. (+5)
1145 [GO] 2021―Apr―28 SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs Qun Xiang, Zeqing Feng, Bo Diao, Chao Tu, Qinghua Qiao, Han Yang, et al. (+10)
1146 [GO] 2021―Apr―28 A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain Ling Niu, Kathryn N. Wittrock, Gage C. Clabaugh, Vikram Srivastava, Michael W. Cho
1147 [GO] 2021―Apr―26 Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One! Francesca Coperchini, Luca Chiovato, Mario Rotondi
1148 [GO] 2021―Apr―26 Neurological Symptoms of COVID-19: The Zonulin Hypothesis Sílvia Llorens, Eduardo Nava, Mónica Muñoz-López, Álvaro Sánchez-Larsen, Tomás Segura
1149 [GO] 2021―Apr―26 Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222) Gustavo C. Román, Fernando Gracia, Antonio Torres, Alexis Palacios, Karla Gracia, Diógenes Harris
1150 [GO] 2021―Apr―22 Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective Yury O. Nunez Lopez, Anna Casu, Richard E. Pratley
1151 [GO] 2021―Apr―22 Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design Timothy P. Riley, Hui-Ting Chou, Ruozhen Hu, Krzysztof P. Bzymek, Ana R. Correia, Alexander C. Partin, et al. (+6)
1152 [GO] 2021―Apr―21 Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1) José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Tatiana Sofía Rodríguez-Reyna, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, et al. (+34)
1153 [GO] 2021―Apr―20 Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 Tanja M. Müller, Emily Becker, Maximilian Wiendl, Lisa Lou Schulze, Caroline Voskens, Simon Völkl, et al. (+3)
1154 [GO] 2021―Apr―19 Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China Wei Cao, Xiaosheng Liu, Ke Hong, Zhiyong Ma, Yuelun Zhang, Ling Lin, et al. (+5)
1155 [GO] 2021―Apr―16 Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus Yufeng Shang, Tao Liu, Jingfeng Li, Natasha Mupeta Kaweme, Xinghuan Wang, Fuling Zhou
1156 [GO] 2021―Apr―16 Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab Jo Linda Sinagra, Claudio Vedovelli, Raffaella Binazzi, Adele Salemme, Francesco Moro, Cinzia Mazzanti, et al. (+2)
1157 [GO] 2021―Apr―15 How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group Francesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, Stefania Carmagnola, Emilio Clementi, Piergiorgio Danelli, et al. (+21)
1158 [GO] 2021―Apr―15 Antibody Responses in COVID-19: A Review Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo J. Patiño, Paula A. Velilla, Maria T. Rugeles
1159 [GO] 2021―Apr―15 SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights Qiao Zhou, Jayakumar Vadakekolathu, Abdulla Watad, Kassem Sharif, Tobias Russell, Hannah Rowe, et al. (+13)
1160 [GO] 2021―Apr―14 Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019 Furong Qi, Wenbo Zhang, Jialu Huang, Lili Fu, Jinfang Zhao
1161 [GO] 2021―Apr―14 Corrigendum: Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen
1162 [GO] 2021―Apr―14 SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia Ritu Mishra, Akhil C. Banerjea
1163 [GO] 2021―Apr―13 Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
1164 [GO] 2021―Apr―12 Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19 Jintao Zhang, Chunyuan Zhao, Wei Zhao
1165 [GO] 2021―Apr―12 COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations Qian He, Qunying Mao, Jialu Zhang, Lianlian Bian, Fan Gao, Junzhi Wang, et al. (+2)
1166 [GO] 2021―Apr―12 Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2 Kathrin Becker, Georg Beythien, Nicole de Buhr, Stephanie Stanelle-Bertram, Berfin Tuku, Nancy Mounogou Kouassi, et al. (+6)
1167 [GO] 2021―Apr―09 Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection Rachel R. Yuen, Dylan Steiner, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Erika L. Smith, et al. (+17)
1168 [GO] 2021―Apr―07 Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19 Nicholas Stoy
1169 [GO] 2021―Apr―07 Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome Steffen Dickel, Clemens Grimm, Katharina Amschler, Sebastian Uwe Schnitzler, Julie Schanz, Onnen Moerer, et al. (+3)
1170 [GO] 2021―Apr―07 Breastfeeding and COVID-19: From Nutrition to Immunity Emilia Vassilopoulou, Gavriela Feketea, Lemonica Koumbi, Christina Mesiari, Elena Camelia Berghea, George N. Konstantinou
1171 [GO] 2021―Apr―01 Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19 Harri Hemilä, Elizabeth Chalker
1172 [GO] 2021―Apr―01 Genetics Insight for COVID-19 Susceptibility and Severity: A Review Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
1173 [GO] 2021―Mar―31 Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19 Marina Luise Viola Azevedo, Aline Cristina Zanchettin, Caroline Busatta Vaz de Paula, Jarbas da Silva Motta Júnior, Mineia Alessandra Scaranello Malaquias, Sonia Mara Raboni, et al. (+10)
1174 [GO] 2021―Mar―31 Why Haven’t We Found an Effective Treatment for COVID-19? Alexander James Spicer, Sirpa Jalkanen
1175 [GO] 2021―Mar―30 Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity Patricia Lamadrid, Marta Alonso-Peña, David San Segundo, Mayte Arias-Loste, Javier Crespo, Marcos Lopez-Hoyos
1176 [GO] 2021―Mar―30 Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities Zena Wehbe, Maya Wehbe, Rabah Iratni, Gianfranco Pintus, Hassan Zaraket, Hadi M. Yassine, Ali H. Eid
1177 [GO] 2021―Mar―29 Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19 Nobunao Ikewaki, Vidyasagar Devaprasad Dedeepiya, Masaru Iwasaki, Samuel J. K. Abraham
1178 [GO] 2021―Mar―29 Age-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19 Nick P. Goplen, In Su Cheon, Jie Sun
1179 [GO] 2021―Mar―29 Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity Anna Schöllhorn, Juliane Schuhmacher, Luciana Besedovsky, Rolf Fendel, Anja T. R. Jensen, Stefan Stevanović, et al. (+5)
1180 [GO] 2021―Mar―29 How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era Jonathan Caron, Laura Alice Ridgley, Mark Bodman-Smith
1181 [GO] 2021―Mar―26 Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, Naseem Ahmed Khan, Adarsh Kumar Chiranjivi, Shailendra Mani, et al. (+7)
1182 [GO] 2021―Mar―26 Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2 Diana Garcia-del-Barco, Daniela Risco-Acevedo, Jorge Berlanga-Acosta, Frank Daniel Martos-Benítez, Gerardo Guillén-Nieto
1183 [GO] 2021―Mar―25 Neutrophils in COVID-19 Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Kevin Baßler, Joachim L. Schultze, Anna C. Aschenbrenner
1184 [GO] 2021―Mar―25 Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection György Sinkovits, Blanka Mező, Marienn Réti, Veronika Müller, Zsolt Iványi, János Gál, et al. (+16)